sample_id,Sample coverage,Tumor Purity,age_at_diagnosis,age_at_seq_reported_years,ethnicity,exon_number,gender,metastic_site,mitotic_rate,msi_score,msi_type,mutated_genes,note,order,os_months,os_status,patient_id,ped_ind,pre_therapy_group,primary_site,primary_site_group,race,recurrence_free_months,recurrence_status,sample_type,stage_at_diagnosis,tmb_nonsynonymous,treatment,treatment_details,treatment_duration_days,treatment_response,tumor_size,variant_type
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Male,Not Applicable,50.0,5.107079982757568,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Male,Not Applicable,50.0,5.051200866699219,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Male,Not Applicable,50.0,5.105975151062012,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Male,Not Applicable,50.0,5.107101917266846,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Male,Not Applicable,50.0,5.107079982757568,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Male,Not Applicable,50.0,5.051200866699219,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Male,Not Applicable,50.0,5.105975151062012,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Male,Not Applicable,50.0,5.107101917266846,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Male,Not Applicable,50.0,5.107079982757568,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Male,Not Applicable,50.0,5.051200866699219,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,5.105975151062012,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,5.107101917266846,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,5.107079982757568,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,5.051200866699219,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Male,Not Applicable,50.0,5.105975151062012,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Male,Not Applicable,50.0,5.107101917266846,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Male,Liver,50.0,3.0622270107269287,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.595550298690796,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Male,Liver,50.0,3.0622270107269287,Indeterminate,RB1,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.595550298690796,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.0620017051696777,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.0620017051696777,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.0620017051696777,Indeterminate,PDGFRA,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.0620017051696777,Indeterminate,PDGFRA,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT;TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.0620017051696777,Indeterminate,KIT;TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.0620017051696777,Indeterminate,KIT;TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT;PDGFRA,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.0620017051696777,Indeterminate,KIT;PDGFRA,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.0620017051696777,Indeterminate,KIT;PDGFRA,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.0620017051696777,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,IMATINIB,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.0620017051696777,Indeterminate,RB1,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,IMATINIB,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.0620017051696777,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,SUNITINIB,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.0620017051696777,Indeterminate,RB1,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,SUNITINIB,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Small Intestine,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.0620017051696777,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.0620017051696777,Indeterminate,RB1,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Colon,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.0620017051696777,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.0620017051696777,Indeterminate,RB1,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Rectum,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.0620017051696777,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.0620017051696777,Indeterminate,RB1,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106465816497803,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.050983428955078,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.105485916137695,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106487274169922,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106465816497803,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.050983428955078,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.105485916137695,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106487274169922,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106465816497803,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.050983428955078,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.105485916137695,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106487274169922,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106465816497803,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.050983428955078,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.105485916137695,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,SNP
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106487274169922,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.0620017051696777,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,SNP
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.0620017051696777,Indeterminate,RB1,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,DEL
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.0620017051696777,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.0620017051696777,Indeterminate,RB1,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,DEL
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,13/27,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,RB1,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,6/11,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,TP53,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.10670280456543,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NR,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,5.0511250495910645,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,395.0,SD,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.105716228485107,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,182.0,NR,13.6,INS
P-0000134-T01-IM3,761.0,90.0,68.0,69.0,Non-Hispanic,16/21,Female,Not Applicable,50.0,5.106723308563232,Indeterminate,KIT,NS,1.0,11.079,DECEASED,P-0000134,NS,Neoadjuvant,Stomach,Gastric,White,12.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,13.6,INS
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,6/11,Female,Liver,50.0,3.0620017051696777,Indeterminate,TP53,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,INS
P-0000134-T02-IM3,661.0,88.4,68.0,70.0,Non-Hispanic,11/21,Female,Liver,50.0,3.0620017051696777,Indeterminate,RB1,NS,2.0,11.079,DECEASED,P-0000134,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.5955562591552734,OTHER,Medical Therapy,209.51929378700075,UNKNOWN,13.6,INS
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Female,Not Applicable,5.0,0.6328656673431396,Stable,KIT,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1376.0,CR,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.6771426796913147,Stable,KIT,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.4528288245201111,OTHER,Medical Therapy,778.0001929165606,UNKNOWN,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.6328885555267334,Stable,TP53,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1376.0,CR,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.6772576570510864,Stable,TP53,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.4528166651725769,OTHER,Medical Therapy,778.0001929165606,UNKNOWN,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.6328885555267334,Stable,PDGFRA,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1376.0,CR,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.6772576570510864,Stable,PDGFRA,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.4528166651725769,OTHER,Medical Therapy,778.0001929165606,UNKNOWN,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.6328885555267334,Stable,KIT;TP53,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1376.0,CR,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.6772576570510864,Stable,KIT;TP53,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.4528166651725769,OTHER,Medical Therapy,778.0001929165606,UNKNOWN,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.6328885555267334,Stable,KIT;PDGFRA,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1376.0,CR,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.6772576570510864,Stable,KIT;PDGFRA,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.4528166651725769,OTHER,Medical Therapy,778.0001929165606,UNKNOWN,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.6328885555267334,Stable,KIT,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,1376.0,CR,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.6772576570510864,Stable,KIT,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.4528166651725769,SUNITINIB,Medical Therapy,778.0001929165606,UNKNOWN,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.6328885555267334,Stable,KIT,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,1376.0,CR,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.6772576570510864,Stable,KIT,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.4528166651725769,REGORAFENIB,Medical Therapy,778.0001929165606,UNKNOWN,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.6328885555267334,Stable,KIT,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1376.0,CR,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.6772576570510864,Stable,KIT,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,0.4528166651725769,OTHER,Medical Therapy,778.0001929165606,UNKNOWN,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.6328885555267334,Stable,KIT,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Colon,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1376.0,CR,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.6772576570510864,Stable,KIT,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,0.4528166651725769,OTHER,Medical Therapy,778.0001929165606,UNKNOWN,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.6328885555267334,Stable,KIT,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1376.0,CR,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.6772576570510864,Stable,KIT,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,0.4528166651725769,OTHER,Medical Therapy,778.0001929165606,UNKNOWN,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.6329095363616943,Stable,KIT,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,89.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1376.0,CR,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.6772024631500244,Stable,KIT,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.4528328776359558,OTHER,Medical Therapy,778.0001929165606,UNKNOWN,13.0,SNP
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.6328885555267334,Stable,KIT,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1376.0,CR,13.0,DEL
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.6772576570510864,Stable,KIT,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.4528166651725769,OTHER,Medical Therapy,778.0001929165606,UNKNOWN,13.0,DEL
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Not Provided,11/21,Male,Not Applicable,5.0,0.6328885555267334,Stable,KIT,ONGOING,1.0,63.06445000000007,UNKNOWN,P-0000306,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,89.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1376.0,CR,13.0,INS
P-0000306-T01-IM3,212.0,90.0,48.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.6772576570510864,Stable,KIT,NS,1.0,92.351,ALIVE,P-0000306,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.4528166651725769,OTHER,Medical Therapy,778.0001929165606,UNKNOWN,13.0,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Female,Liver,2.0,0.028697356581687927,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Female,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Female,Liver,2.0,0.028697356581687927,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Female,Liver,2.0,0.05224841833114624,Stable,MTOR,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Female,Liver,2.0,0.02889673411846161,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Female,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Female,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Female,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Female,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Female,Liver,2.0,0.05224841833114624,Stable,SDHB,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Female,Liver,2.0,0.02889673411846161,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Female,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.623142957687378,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Female,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.623142957687378,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Female,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,KIT,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,KIT,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,KIT,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,KIT,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,KIT,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,KIT,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,KIT,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,KIT,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,KIT,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,KIT,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,KIT,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,KIT,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,KIT,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,KIT,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,TP53,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,TP53,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,TP53,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,TP53,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,PDGFRA,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,PDGFRA,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,KIT;TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,KIT;TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,KIT;TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,KIT;TP53,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,KIT;TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,KIT;TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,KIT;TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,KIT;TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,KIT;TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,KIT;TP53,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,KIT;TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,KIT;TP53,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,KIT;TP53,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,KIT;TP53,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,KIT;PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,KIT;PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,KIT;PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,KIT;PDGFRA,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,KIT;PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,KIT;PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,KIT;PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,KIT;PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,KIT;PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,KIT;PDGFRA,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,KIT;PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,KIT;PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,KIT;PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,KIT;PDGFRA,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,MTOR,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,SDHB,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,IMATINIB,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,IMATINIB,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,MTOR,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,SDHB,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,SUNITINIB,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,SUNITINIB,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,MTOR,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,SDHB,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,REGORAFENIB,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,REGORAFENIB,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Small Intestine,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Small Intestine,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Small Intestine,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,MTOR,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Small Intestine,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Small Intestine,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Small Intestine,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Small Intestine,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Small Intestine,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Small Intestine,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,SDHB,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Small Intestine,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Small Intestine,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Small Intestine,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Colon,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Colon,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Colon,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,MTOR,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Colon,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Colon,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Colon,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Colon,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Colon,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Colon,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,SDHB,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Colon,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Colon,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Colon,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Rectum,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Rectum,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Rectum,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,MTOR,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Rectum,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Rectum,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Rectum,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Rectum,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Rectum,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Rectum,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,SDHB,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Rectum,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Rectum,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Rectum,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0285005122423172,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0285005122423172,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.05217413604259491,Stable,MTOR,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Metastasis,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0287005752325058,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.05217413604259491,Stable,SDHB,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Metastasis,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0287005752325058,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,SNP
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,MTOR,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,SDHB,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,DEL
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.02874349057674408,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.02874349057674408,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,336.0,CR,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.052408501505851746,Stable,MTOR,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.028943106532096863,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,516.0,CR,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,580.0,CR,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.052408501505851746,Stable,SDHB,ONGOING,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,EVEROLIMUS,Medical Therapy,191.0,NE,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.028943106532096863,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,335.0,CR,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,2/8,Male,Liver,2.0,0.0,Stable,SDHB,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,1.6231307983398438,OTHER,Medical Therapy,423.0897737520476,UNKNOWN,10.2,INS
P-0000501-T02-IM3,811.0,60.0,37.0,42.0,Non-Hispanic,30/58,Male,Liver,2.0,0.0,Stable,MTOR,NS,1.0,27.518,ALIVE,P-0000501,NS,NS,Stomach,Gastric,Black or African American,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,547.0,UNKNOWN,10.2,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Female,Liver,48.0,2.3354427814483643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Female,Liver,48.0,2.3030107021331787,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Female,Liver,48.0,2.3030107021331787,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Female,Liver,48.0,2.3354427814483643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Female,Liver,48.0,2.3354427814483643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Female,Liver,48.0,2.260563373565674,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Female,Liver,48.0,2.3353593349456787,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Female,Liver,48.0,2.3275065422058105,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Female,Liver,48.0,2.260563373565674,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Female,Liver,48.0,2.277539014816284,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Female,Liver,48.0,2.3275065422058105,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Female,Liver,48.0,2.3354427814483643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Female,Liver,48.0,2.3030107021331787,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Female,Liver,48.0,2.3030107021331787,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Female,Liver,48.0,2.3354427814483643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Female,Liver,48.0,2.3030107021331787,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Female,Liver,48.0,2.3354427814483643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Female,Liver,48.0,2.3353593349456787,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Female,Liver,48.0,2.260563373565674,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Female,Liver,48.0,2.3354427814483643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Female,Liver,48.0,2.3275065422058105,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Female,Liver,48.0,2.277539014816284,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Female,Liver,48.0,2.277539014816284,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Female,Liver,48.0,2.3354427814483643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Female,Liver,48.0,2.3354427814483643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Female,Liver,48.0,2.3353593349456787,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Female,Liver,48.0,2.3030107021331787,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Female,Liver,48.0,2.3030107021331787,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Female,Liver,48.0,2.3354427814483643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Female,Liver,48.0,2.3354427814483643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Female,Liver,48.0,2.3354427814483643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Female,Liver,48.0,2.3354427814483643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Female,Liver,48.0,2.3354427814483643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Female,Liver,48.0,2.3354427814483643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Female,Liver,48.0,2.3353593349456787,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Female,Liver,48.0,2.3353593349456787,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Female,Liver,48.0,2.260563373565674,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Female,Liver,48.0,2.3354427814483643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Female,Liver,48.0,2.3354427814483643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Female,Liver,48.0,2.3030107021331787,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Female,Liver,48.0,2.3030107021331787,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Female,Liver,48.0,2.3354427814483643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Female,Liver,48.0,2.3354427814483643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Female,Liver,48.0,2.3275065422058105,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Female,Liver,48.0,2.277539014816284,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Female,Liver,48.0,2.260563373565674,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Female,Liver,48.0,2.3353593349456787,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Female,Liver,48.0,2.3354427814483643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Female,Liver,48.0,2.3354427814483643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Female,Liver,48.0,2.3354427814483643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Female,Liver,48.0,2.3354427814483643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Female,Liver,48.0,2.277539014816284,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Female,Liver,48.0,2.260563373565674,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Female,Liver,48.0,2.277539014816284,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Female,Liver,48.0,2.3275065422058105,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Female,Liver,48.0,2.3030107021331787,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Female,Liver,48.0,2.3354427814483643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Female,Liver,48.0,2.3030107021331787,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Female,Liver,48.0,2.3354427814483643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Female,Liver,48.0,2.3354427814483643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Female,Liver,48.0,2.3354427814483643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Female,Liver,48.0,2.3354427814483643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Female,Liver,48.0,2.3354427814483643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Female,Liver,48.0,2.3354427814483643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Female,Liver,48.0,2.3275065422058105,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Female,Liver,48.0,2.3030107021331787,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Female,Skin,48.0,2.4555583000183105,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740341186523,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Female,Skin,48.0,2.4555583000183105,Stable,TSC2,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740341186523,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Female,Skin,48.0,2.4555583000183105,Stable,BRAF,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740341186523,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Female,Skin,48.0,2.4555583000183105,Stable,EP300,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740341186523,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Female,Skin,48.0,2.4555583000183105,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740341186523,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Female,Skin,48.0,2.4555583000183105,Stable,RB1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740341186523,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,KIT,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,KIT,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,KIT,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,KIT,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,KIT,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,KIT,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,KIT,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,TP53,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,TP53,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,TP53,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,TP53,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,TP53,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,TP53,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,PDGFRA,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,PDGFRA,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,PDGFRA,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,PDGFRA,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,PDGFRA,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,PDGFRA,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,KIT;TP53,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,KIT;TP53,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,KIT;TP53,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,KIT;TP53,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,KIT;TP53,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,KIT;TP53,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,KIT;TP53,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,KIT;PDGFRA,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,KIT;PDGFRA,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,KIT;PDGFRA,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,KIT;PDGFRA,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,KIT;PDGFRA,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,KIT;PDGFRA,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,KIT;PDGFRA,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,IMATINIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,TSC2,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,IMATINIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,BRAF,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,IMATINIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,EP300,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,IMATINIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,IMATINIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,RB1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,IMATINIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,SUNITINIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,TSC2,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,SUNITINIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,BRAF,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,SUNITINIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,EP300,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,SUNITINIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,SUNITINIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,RB1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,SUNITINIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,REGORAFENIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,TSC2,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,REGORAFENIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,BRAF,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,REGORAFENIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,EP300,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,REGORAFENIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,REGORAFENIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,RB1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,REGORAFENIB,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Stomach,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,TSC2,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,BRAF,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,EP300,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,RB1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Colon,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,TSC2,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,BRAF,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,EP300,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,RB1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Rectum,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,TSC2,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,BRAF,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,EP300,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,RB1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3358676433563232,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3031911849975586,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3031911849975586,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3358676433563232,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3358676433563232,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260709047317505,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356258869171143,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3276500701904297,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260709047317505,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277712821960449,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3276500701904297,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3358676433563232,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3031911849975586,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3031911849975586,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3358676433563232,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3031911849975586,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3358676433563232,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356258869171143,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260709047317505,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3358676433563232,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3276500701904297,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277712821960449,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277712821960449,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3358676433563232,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3358676433563232,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356258869171143,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3031911849975586,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3031911849975586,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3358676433563232,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3358676433563232,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3358676433563232,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3358676433563232,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3358676433563232,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3358676433563232,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356258869171143,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356258869171143,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260709047317505,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3358676433563232,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3358676433563232,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3031911849975586,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3031911849975586,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3358676433563232,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3358676433563232,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3276500701904297,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277712821960449,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260709047317505,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356258869171143,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3358676433563232,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3358676433563232,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3358676433563232,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3358676433563232,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277712821960449,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260709047317505,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277712821960449,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3276500701904297,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3031911849975586,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3358676433563232,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3031911849975586,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3358676433563232,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3358676433563232,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3358676433563232,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3358676433563232,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3358676433563232,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3358676433563232,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3276500701904297,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3031911849975586,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Primary,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.4557108879089355,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,5.246735572814941,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.4557108879089355,Stable,TSC2,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,5.246735572814941,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.4557108879089355,Stable,BRAF,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,5.246735572814941,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.4557108879089355,Stable,EP300,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,5.246735572814941,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.4557108879089355,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,5.246735572814941,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.4557108879089355,Stable,RB1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,5.246735572814941,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,DEL
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,TSC2,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,BRAF,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,EP300,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,RB1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,SNP
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.260610580444336,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.335462808609009,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3275632858276367,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.260610580444336,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.277620553970337,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3275632858276367,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3030431270599365,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.335462808609009,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.260610580444336,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3275632858276367,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.277620553970337,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.277620553970337,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.335462808609009,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3030431270599365,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,2/31,Male,Liver,48.0,2.3356869220733643,Stable,EP300,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,15/18,Male,Liver,48.0,2.3356869220733643,Stable,BRAF,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.335462808609009,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3030431270599365,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3356869220733643,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.3275632858276367,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.277620553970337,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.260610580444336,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,19/42,Male,Liver,48.0,2.335462808609009,Stable,TSC2,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,214.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.260610580444336,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,638.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.277620553970337,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,578.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3030431270599365,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,SIROLIMUS,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3356869220733643,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,11/21,Male,Liver,48.0,2.3356869220733643,Stable,RB1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,3/57,Male,Liver,48.0,2.3275632858276367,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,VEMURAFENIB,Medical Therapy,304.0,CR,8.0,INS
P-0001315-T01-IM3,1132.0,70.0,31.0,36.0,Non-Hispanic,28/57,Male,Liver,48.0,2.3030431270599365,Stable,NF1,NS,1.0,97.348,ALIVE,P-0001315,NS,NS,Small Intestine,Small Bowel,White,5.0,Recurrence,Metastasis,Metastatic,0.0,MEKI,Medical Therapy,455.0,NR,8.0,INS
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,INS
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,19/42,Male,Skin,48.0,2.455613851547241,Stable,TSC2,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,INS
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,15/18,Male,Skin,48.0,2.455613851547241,Stable,BRAF,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,INS
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,2/31,Male,Skin,48.0,2.455613851547241,Stable,EP300,NS,2.0,97.348,ALIVE,P-0001315,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,INS
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,28/57,Male,Skin,48.0,2.455613851547241,Stable,NF1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,INS
P-0001315-T02-IM5,1023.0,90.0,31.0,39.0,Non-Hispanic,11/21,Male,Skin,48.0,2.455613851547241,Stable,RB1,NS,2.0,97.348,ALIVE,P-0001315,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,5.246740818023682,OTHER,Medical Therapy,284.26938216056317,UNKNOWN,8.0,INS
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Female,Not Applicable,15.0,1.456191062927246,Stable,TSC1,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,1.456191062927246,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Female,Not Applicable,15.0,1.456191062927246,Stable,KMT2D,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,1.537784457206726,Stable,KIT,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.726353645324707,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Female,Not Applicable,15.0,1.537784457206726,Stable,TSC1,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.726353645324707,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,1.537784457206726,Stable,KMT2B,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.726353645324707,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4561858177185059,Stable,TP53,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4561858177185059,Stable,TP53,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4561858177185059,Stable,TP53,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,TP53,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5377665758132935,Stable,TP53,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,TP53,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4561858177185059,Stable,PDGFRA,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4561858177185059,Stable,PDGFRA,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4561858177185059,Stable,PDGFRA,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,PDGFRA,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5377665758132935,Stable,PDGFRA,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,PDGFRA,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT;TP53,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT;TP53,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT;TP53,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT;TP53,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT;TP53,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT;TP53,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT;PDGFRA,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT;PDGFRA,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT;PDGFRA,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT;PDGFRA,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT;PDGFRA,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT;PDGFRA,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4561858177185059,Stable,TSC1,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4561858177185059,Stable,KMT2D,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,SUNITINIB,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5377665758132935,Stable,TSC1,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,SUNITINIB,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KMT2B,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,SUNITINIB,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4561858177185059,Stable,TSC1,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4561858177185059,Stable,KMT2D,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,REGORAFENIB,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5377665758132935,Stable,TSC1,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,REGORAFENIB,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KMT2B,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,REGORAFENIB,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4561858177185059,Stable,TSC1,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Small Intestine,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Small Intestine,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4561858177185059,Stable,KMT2D,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Small Intestine,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5377665758132935,Stable,TSC1,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KMT2B,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4561858177185059,Stable,TSC1,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Colon,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Colon,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4561858177185059,Stable,KMT2D,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Colon,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5377665758132935,Stable,TSC1,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KMT2B,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4561858177185059,Stable,TSC1,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Rectum,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Rectum,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4561858177185059,Stable,KMT2D,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Rectum,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5377665758132935,Stable,TSC1,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KMT2B,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4560768604278564,Stable,TSC1,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4560768604278564,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4560768604278564,Stable,KMT2D,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5375967025756836,Stable,KIT,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7263269424438477,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5375967025756836,Stable,TSC1,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7263269424438477,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,DEL
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5375967025756836,Stable,KMT2B,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7263269424438477,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4561858177185059,Stable,TSC1,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4561858177185059,Stable,KMT2D,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5377665758132935,Stable,TSC1,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KMT2B,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,SNP
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,9/23,Male,Not Applicable,15.0,1.4561858177185059,Stable,TSC1,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,INS
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.4561858177185059,Stable,KIT,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,INS
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,39/54,Male,Not Applicable,15.0,1.4561858177185059,Stable,KMT2D,ONGOING,1.0,101.26,ALIVE,P-0001410,NS,Neoadjuvant,Stomach,Gastric,White,69.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,8.0,INS
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KIT,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,INS
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,3/23,Male,Not Applicable,15.0,1.5377665758132935,Stable,TSC1,NS,1.0,95.277,ALIVE,P-0001410,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,INS
P-0001410-T01-IM3,810.0,60.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.5377665758132935,Stable,KMT2B,ONGOING,1.0,95.277,ALIVE,P-0001410,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7263336181640625,OTHER,Medical Therapy,574.9848129991536,UNKNOWN,8.0,INS
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,17.0,1.2265045642852783,Stable,KIT,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748714566230774,OTHER,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,17.0,1.2069151401519775,Stable,KIT,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Stomach,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226637840270996,Stable,TP53,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748694896697998,OTHER,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071632146835327,Stable,TP53,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Stomach,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226637840270996,Stable,PDGFRA,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748694896697998,OTHER,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071632146835327,Stable,PDGFRA,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Stomach,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226637840270996,Stable,KIT;TP53,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748694896697998,OTHER,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071632146835327,Stable,KIT;TP53,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Stomach,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226637840270996,Stable,KIT;PDGFRA,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748694896697998,OTHER,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071632146835327,Stable,KIT;PDGFRA,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Stomach,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226637840270996,Stable,KIT,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748694896697998,IMATINIB,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071632146835327,Stable,KIT,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Stomach,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226637840270996,Stable,KIT,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748694896697998,SUNITINIB,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071632146835327,Stable,KIT,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Stomach,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226637840270996,Stable,KIT,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748694896697998,REGORAFENIB,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071632146835327,Stable,KIT,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Stomach,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226637840270996,Stable,KIT,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748694896697998,OTHER,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071632146835327,Stable,KIT,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226637840270996,Stable,KIT,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748694896697998,OTHER,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071632146835327,Stable,KIT,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Colon,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226637840270996,Stable,KIT,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748694896697998,OTHER,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071632146835327,Stable,KIT,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Rectum,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226474642753601,Stable,KIT,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,0.4748794436454773,OTHER,Medical Therapy,611.0409975582381,UNKNOWN,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071348428726196,Stable,KIT,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Stomach,Gastric,Black or African American,72.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,9.0,DEL
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226637840270996,Stable,KIT,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748694896697998,OTHER,Medical Therapy,611.0409975582381,UNKNOWN,9.0,SNP
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071632146835327,Stable,KIT,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Stomach,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,9.0,SNP
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.226637840270996,Stable,KIT,NS,1.0,97.151,ALIVE,P-0001461,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,0.4748694896697998,OTHER,Medical Therapy,611.0409975582381,UNKNOWN,9.0,INS
P-0001461-T01-IM3,459.0,80.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,17.0,1.2071632146835327,Stable,KIT,ONGOING,1.0,103.562,ALIVE,P-0001461,NS,Neoadjuvant,Stomach,Gastric,Black or African American,72.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,830.0,NE,9.0,INS
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Male,Not Applicable,32.0,0.88851398229599,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Male,Not Applicable,32.0,0.8857279419898987,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Male,Not Applicable,32.0,0.8869670033454895,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Male,Not Applicable,32.0,0.8869670033454895,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Male,Not Applicable,32.0,0.88851398229599,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Male,Not Applicable,32.0,0.8869670033454895,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Male,Not Applicable,32.0,0.8869670033454895,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Male,Not Applicable,32.0,0.8857279419898987,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Male,Not Applicable,32.0,0.8844711780548096,Stable,FOXP1,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6030042171478271,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Male,Not Applicable,32.0,0.8844711780548096,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6030042171478271,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,KIT,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,KIT,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,KIT,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,KIT,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,KIT,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,KIT,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,KIT,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,KIT,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,KIT,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,KIT,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,TP53,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,TP53,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,KIT;TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,KIT;TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,KIT;TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,KIT;TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,KIT;TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,KIT;TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,KIT;TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,KIT;TP53,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,KIT;TP53,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,KIT;TP53,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,KIT;PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,KIT;PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,KIT;PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,KIT;PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,KIT;PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,KIT;PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,KIT;PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,KIT;PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,KIT;PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,KIT;PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,FOXP1,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,IMATINIB,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,IMATINIB,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,FOXP1,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,SUNITINIB,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,SUNITINIB,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,FOXP1,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,REGORAFENIB,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,REGORAFENIB,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Small Intestine,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Small Intestine,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Small Intestine,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Small Intestine,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Small Intestine,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Small Intestine,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Small Intestine,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Small Intestine,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,FOXP1,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Colon,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Colon,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Colon,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Colon,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Colon,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Colon,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Colon,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Colon,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,FOXP1,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Rectum,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Rectum,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Rectum,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Rectum,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Rectum,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Rectum,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Rectum,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Rectum,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,FOXP1,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8878817558288574,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8849714994430542,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8861587643623352,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8861587643623352,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8878817558288574,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8861587643623352,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8861587643623352,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8849714994430542,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8838176727294922,Stable,FOXP1,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6030058860778809,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8838176727294922,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6030058860778809,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,SNP
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,DEL
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,DEL
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,DEL
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,DEL
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,DEL
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,DEL
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,DEL
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,DEL
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,FOXP1,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,DEL
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,DEL
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,INS
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,INS
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,INS
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,INS
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8881508111953735,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,122.0,NR,19.5,INS
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NE,19.5,INS
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8865585923194885,Stable,FOXP1,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,0.0,NR,19.5,INS
P-0001512-T01-IM3,659.0,80.0,60.0,61.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.8853073120117188,Stable,PDGFRA,NS,1.0,28.833,DECEASED,P-0001512,NS,Neoadjuvant,Stomach,Gastric,White,11.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,19.5,INS
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,FOXP1,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,INS
P-0001512-T01-IM3,659.0,80.0,60.0,62.0,Non-Hispanic,18/23,Female,Not Applicable,32.0,0.884139895439148,Stable,PDGFRA,NS,2.0,28.833,DECEASED,P-0001512,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.6029942035675049,OTHER,Medical Therapy,96.7534796140378,UNKNOWN,19.5,INS
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Female,Not Applicable,8.0,0.6412311792373657,Stable,KIT,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Female,Not Applicable,8.0,0.6412311792373657,Stable,KMT2D,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Female,Not Applicable,8.0,0.6822161674499512,Stable,KMT2B,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683600902557373,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Female,Not Applicable,8.0,0.6822161674499512,Stable,KIT,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683600902557373,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.641370952129364,Stable,TP53,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.641370952129364,Stable,TP53,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,TP53,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,TP53,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.641370952129364,Stable,PDGFRA,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.641370952129364,Stable,PDGFRA,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,PDGFRA,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,PDGFRA,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.641370952129364,Stable,KIT;TP53,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.641370952129364,Stable,KIT;TP53,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KIT;TP53,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KIT;TP53,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.641370952129364,Stable,KIT;PDGFRA,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.641370952129364,Stable,KIT;PDGFRA,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KIT;PDGFRA,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KIT;PDGFRA,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.641370952129364,Stable,KIT,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,799.0,NE,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.641370952129364,Stable,KMT2D,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KMT2B,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,SUNITINIB,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KIT,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,SUNITINIB,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.641370952129364,Stable,KIT,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,799.0,NE,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.641370952129364,Stable,KMT2D,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KMT2B,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,REGORAFENIB,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KIT,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,REGORAFENIB,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.641370952129364,Stable,KIT,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Stomach,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.641370952129364,Stable,KMT2D,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Stomach,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KMT2B,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KIT,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.641370952129364,Stable,KIT,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Colon,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.641370952129364,Stable,KMT2D,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Colon,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KMT2B,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KIT,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.641370952129364,Stable,KIT,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Rectum,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.641370952129364,Stable,KMT2D,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Rectum,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KMT2B,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KIT,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6413764953613281,Stable,KIT,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.6413764953613281,Stable,KMT2D,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822040677070618,Stable,KMT2B,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.5683661699295044,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822040677070618,Stable,KIT,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.5683661699295044,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,ONP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.641370952129364,Stable,KIT,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.641370952129364,Stable,KMT2D,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KMT2B,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KIT,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,SNP
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.641370952129364,Stable,KIT,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,DEL
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.641370952129364,Stable,KMT2D,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,DEL
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KMT2B,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,DEL
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KIT,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,DEL
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.641370952129364,Stable,KIT,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,INS
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/54,Male,Not Applicable,8.0,0.641370952129364,Stable,KMT2D,ONGOING,1.0,100.471,ALIVE,P-0001517,NS,Neoadjuvant,Small Intestine,Small Bowel,White,66.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,799.0,NE,6.0,INS
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KMT2B,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,INS
P-0001517-T01-IM3,359.0,80.0,57.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,8.0,0.6822023987770081,Stable,KIT,NS,1.0,95.901,ALIVE,P-0001517,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.5683505535125732,OTHER,Medical Therapy,1134.0072896825395,UNKNOWN,6.0,INS
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Female,Not Applicable,1.0,2.5760128498077393,Stable,POLE,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Female,Not Applicable,1.0,2.4838433265686035,Stable,PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Female,Not Applicable,1.0,2.5760128498077393,Stable,PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Female,Not Applicable,1.0,2.4838433265686035,Stable,POLE,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Female,Mesentery,1.0,0.0,Stable,FLT4,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.623457908630371,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Female,Mesentery,1.0,0.0,Stable,PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.623457908630371,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760223865509033,Stable,KIT,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4851999282836914,Stable,KIT,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760223865509033,Stable,KIT,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4851999282836914,Stable,KIT,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,KIT,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,KIT,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760223865509033,Stable,TP53,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4851999282836914,Stable,TP53,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760223865509033,Stable,TP53,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4851999282836914,Stable,TP53,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,TP53,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,TP53,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760223865509033,Stable,PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4851999282836914,Stable,PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760223865509033,Stable,PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4851999282836914,Stable,PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760223865509033,Stable,KIT;TP53,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4851999282836914,Stable,KIT;TP53,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760223865509033,Stable,KIT;TP53,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4851999282836914,Stable,KIT;TP53,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,KIT;TP53,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,KIT;TP53,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760223865509033,Stable,KIT;PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4851999282836914,Stable,KIT;PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760223865509033,Stable,KIT;PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4851999282836914,Stable,KIT;PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,KIT;PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,KIT;PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760223865509033,Stable,POLE,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4851999282836914,Stable,PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760223865509033,Stable,PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4851999282836914,Stable,POLE,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,FLT4,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,SUNITINIB,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,SUNITINIB,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760223865509033,Stable,POLE,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4851999282836914,Stable,PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760223865509033,Stable,PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4851999282836914,Stable,POLE,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,FLT4,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,REGORAFENIB,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,REGORAFENIB,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760223865509033,Stable,POLE,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Small Intestine,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4851999282836914,Stable,PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Small Intestine,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760223865509033,Stable,PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Small Intestine,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4851999282836914,Stable,POLE,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Small Intestine,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,FLT4,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760223865509033,Stable,POLE,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Colon,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4851999282836914,Stable,PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Colon,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760223865509033,Stable,PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Colon,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4851999282836914,Stable,POLE,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Colon,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,FLT4,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760223865509033,Stable,POLE,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Rectum,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4851999282836914,Stable,PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Rectum,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760223865509033,Stable,PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Rectum,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4851999282836914,Stable,POLE,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Rectum,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,FLT4,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760576725006104,Stable,POLE,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4855523109436035,Stable,PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760576725006104,Stable,PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Stomach,Gastric,White,33.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4855523109436035,Stable,POLE,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,FLT4,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,SNP
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760223865509033,Stable,POLE,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,DEL
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4851999282836914,Stable,PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,DEL
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760223865509033,Stable,PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,DEL
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4851999282836914,Stable,POLE,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,DEL
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,FLT4,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,DEL
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,DEL
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.5760223865509033,Stable,POLE,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,INS
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.4851999282836914,Stable,PDGFRA,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,INS
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,2.5760223865509033,Stable,PDGFRA,ONGOING,1.0,48.657,DECEASED,P-0001692,NS,Neoadjuvant,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,973.0,UNKNOWN,13.8,INS
P-0001692-T01-IM3,106.0,60.0,65.0,68.0,Non-Hispanic,21/49,Male,Not Applicable,1.0,2.4851999282836914,Stable,POLE,NO END DATE,1.0,48.657,DECEASED,P-0001692,NS,NS,Stomach,Gastric,White,33.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,30.0,NE,13.8,INS
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,FLT4,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,INS
P-0001692-T02-IM3,413.0,40.0,65.0,68.0,Non-Hispanic,18/23,Male,Mesentery,1.0,0.0,Stable,PDGFRA,ONGOING,2.0,48.657,DECEASED,P-0001692,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.6234784126281738,OTHER,Medical Therapy,1079.7949908963587,UNKNOWN,13.8,INS
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Male,Small Bowel,30.0,0.9345146417617798,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Male,Small Bowel,30.0,0.9304237365722656,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Male,Small Bowel,30.0,1.0038095712661743,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Male,Small Bowel,30.0,1.0943944454193115,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Male,Small Bowel,30.0,1.0813019275665283,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Male,Small Bowel,30.0,1.0982359647750854,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Male,Small Bowel,30.0,1.0922313928604126,Stable,MAX,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Male,Small Bowel,30.0,1.0959599018096924,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Male,Small Bowel,30.0,1.008542776107788,Stable,MAX,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126028060913086,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344542622566223,Stable,KIT,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.930465817451477,Stable,KIT,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037353038787842,Stable,KIT,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0942362546920776,Stable,KIT,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0811508893966675,Stable,KIT,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09807288646698,Stable,KIT,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.091835618019104,Stable,KIT,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0956387519836426,Stable,KIT,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0084961652755737,Stable,KIT,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126203894615173,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344542622566223,Stable,TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.930465817451477,Stable,TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037353038787842,Stable,TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0942362546920776,Stable,TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0811508893966675,Stable,TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09807288646698,Stable,TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.091835618019104,Stable,TP53,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0956387519836426,Stable,TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0084961652755737,Stable,TP53,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126203894615173,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344542622566223,Stable,PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.930465817451477,Stable,PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037353038787842,Stable,PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0942362546920776,Stable,PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0811508893966675,Stable,PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09807288646698,Stable,PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.091835618019104,Stable,PDGFRA,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0956387519836426,Stable,PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0084961652755737,Stable,PDGFRA,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126203894615173,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344542622566223,Stable,KIT;TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.930465817451477,Stable,KIT;TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037353038787842,Stable,KIT;TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0942362546920776,Stable,KIT;TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0811508893966675,Stable,KIT;TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09807288646698,Stable,KIT;TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.091835618019104,Stable,KIT;TP53,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0956387519836426,Stable,KIT;TP53,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0084961652755737,Stable,KIT;TP53,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126203894615173,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344542622566223,Stable,KIT;PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.930465817451477,Stable,KIT;PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037353038787842,Stable,KIT;PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0942362546920776,Stable,KIT;PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0811508893966675,Stable,KIT;PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09807288646698,Stable,KIT;PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.091835618019104,Stable,KIT;PDGFRA,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0956387519836426,Stable,KIT;PDGFRA,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0084961652755737,Stable,KIT;PDGFRA,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126203894615173,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344542622566223,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.930465817451477,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037353038787842,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0942362546920776,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0811508893966675,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09807288646698,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.091835618019104,Stable,MAX,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0956387519836426,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0084961652755737,Stable,MAX,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126203894615173,SUNITINIB,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344542622566223,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.930465817451477,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037353038787842,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0942362546920776,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0811508893966675,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09807288646698,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.091835618019104,Stable,MAX,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0956387519836426,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0084961652755737,Stable,MAX,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126203894615173,REGORAFENIB,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344542622566223,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Stomach,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.930465817451477,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Stomach,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037353038787842,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Stomach,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0942362546920776,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Stomach,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0811508893966675,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Stomach,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09807288646698,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Stomach,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.091835618019104,Stable,MAX,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Stomach,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0956387519836426,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Stomach,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0084961652755737,Stable,MAX,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126203894615173,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344542622566223,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Colon,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.930465817451477,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Colon,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037353038787842,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Colon,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0942362546920776,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Colon,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0811508893966675,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Colon,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09807288646698,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Colon,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.091835618019104,Stable,MAX,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Colon,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0956387519836426,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Colon,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0084961652755737,Stable,MAX,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126203894615173,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344542622566223,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Rectum,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.930465817451477,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Rectum,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037353038787842,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Rectum,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0942362546920776,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Rectum,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0811508893966675,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Rectum,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09807288646698,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Rectum,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.091835618019104,Stable,MAX,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Rectum,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0956387519836426,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Rectum,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0084961652755737,Stable,MAX,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126203894615173,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344760179519653,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1520.0,SD,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9305628538131714,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,669.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037899017333984,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,427.0,CR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0944970846176147,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.081326961517334,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0983293056488037,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,153.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0922060012817383,Stable,MAX,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Primary,Localized,0.0,NILOTINIB,Medical Therapy,1.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.095913290977478,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0085740089416504,Stable,MAX,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.5126070976257324,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,SNP
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344542622566223,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1520.0,SD,11.0,DEL
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.930465817451477,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,669.0,CR,11.0,DEL
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037353038787842,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,427.0,CR,11.0,DEL
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0942362546920776,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,DEL
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0811508893966675,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,DEL
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09807288646698,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,153.0,NR,11.0,DEL
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.091835618019104,Stable,MAX,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,1.0,NR,11.0,DEL
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0956387519836426,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,DEL
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0084961652755737,Stable,MAX,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126203894615173,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,DEL
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.9344542622566223,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1520.0,SD,11.0,INS
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,0.930465817451477,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,669.0,CR,11.0,INS
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0037353038787842,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,427.0,CR,11.0,INS
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0942362546920776,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,184.0,NR,11.0,INS
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0811508893966675,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,244.0,NR,11.0,INS
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.09807288646698,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,153.0,NR,11.0,INS
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.091835618019104,Stable,MAX,NO END DATE,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,1.0,NR,11.0,INS
P-0002276-T01-IM3,674.0,60.0,32.0,46.0,Non-Hispanic,3/5,Female,Small Bowel,30.0,1.0956387519836426,Stable,MAX,NS,1.0,6.411,DECEASED,P-0002276,NS,NS,Small Intestine,Small Bowel,White,45.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,11.0,INS
P-0002276-T01-IM3,674.0,60.0,32.0,48.0,Non-Hispanic,11/21,Female,Small Bowel,30.0,1.0084961652755737,Stable,MAX,NS,2.0,6.411,DECEASED,P-0002276,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5126203894615173,OTHER,Medical Therapy,398.90318628141455,UNKNOWN,11.0,INS
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Male,Liver,24.0,2.2917051315307617,Stable,KIT,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Male,Liver,24.0,2.2917051315307617,Stable,TSC1,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Male,Liver,24.0,2.2917051315307617,Stable,KIT,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Male,Liver,24.0,2.2927775382995605,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568891048431396,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Male,Liver,24.0,2.2927775382995605,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568891048431396,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Male,Liver,24.0,2.2927775382995605,Stable,TSC1,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568891048431396,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2916195392608643,Stable,TP53,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2916195392608643,Stable,TP53,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.2916195392608643,Stable,TP53,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,TP53,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,TP53,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2927494049072266,Stable,TP53,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2916195392608643,Stable,PDGFRA,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2916195392608643,Stable,PDGFRA,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.2916195392608643,Stable,PDGFRA,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,PDGFRA,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,PDGFRA,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2927494049072266,Stable,PDGFRA,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT;TP53,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2916195392608643,Stable,KIT;TP53,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT;TP53,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT;TP53,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT;TP53,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2927494049072266,Stable,KIT;TP53,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT;PDGFRA,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2916195392608643,Stable,KIT;PDGFRA,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT;PDGFRA,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT;PDGFRA,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT;PDGFRA,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2927494049072266,Stable,KIT;PDGFRA,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2916195392608643,Stable,TSC1,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,SUNITINIB,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,SUNITINIB,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2927494049072266,Stable,TSC1,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,SUNITINIB,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2916195392608643,Stable,TSC1,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,REGORAFENIB,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,REGORAFENIB,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2927494049072266,Stable,TSC1,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,REGORAFENIB,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Small Intestine,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2916195392608643,Stable,TSC1,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Small Intestine,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Small Intestine,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2927494049072266,Stable,TSC1,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Colon,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2916195392608643,Stable,TSC1,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Colon,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Colon,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2927494049072266,Stable,TSC1,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Rectum,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2916195392608643,Stable,TSC1,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Rectum,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Rectum,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2927494049072266,Stable,TSC1,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.291623830795288,Stable,KIT,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.291623830795288,Stable,TSC1,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.291623830795288,Stable,KIT,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2928366661071777,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7568931579589844,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2928366661071777,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7568931579589844,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2928366661071777,Stable,TSC1,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.7568931579589844,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,DEL
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2916195392608643,Stable,TSC1,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2927494049072266,Stable,TSC1,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,SNP
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,INS
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2916195392608643,Stable,TSC1,ONGOING,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,INS
P-0002293-T01-IM3,1132.0,40.0,85.0,88.0,Non-Hispanic,17/21,Female,Liver,24.0,2.2916195392608643,Stable,KIT,NS,1.0,4.011,DECEASED,P-0002293,NS,NS,Stomach,Gastric,White,32.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1400.0,SD,7.0,INS
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,INS
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,11/21,Female,Liver,24.0,2.2927494049072266,Stable,KIT,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,INS
P-0002293-T01-IM3,1132.0,40.0,85.0,90.0,Non-Hispanic,3/23,Female,Liver,24.0,2.2927494049072266,Stable,TSC1,NS,2.0,4.011,DECEASED,P-0002293,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.7568938732147217,OTHER,Medical Therapy,1271.3963938618926,UNKNOWN,7.0,INS
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Male,Liver,50.0,1.5827780961990356,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Male,Liver,50.0,1.4215039014816284,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Male,Liver,50.0,1.556151270866394,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Male,Liver,50.0,1.5827780961990356,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Male,Liver,50.0,1.584404706954956,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Male,Liver,50.0,1.556151270866394,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Male,Liver,50.0,1.5834643840789795,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Male,Liver,50.0,1.4215039014816284,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Male,Liver,50.0,1.584404706954956,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Male,Liver,50.0,1.5827780961990356,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Male,Liver,50.0,1.584404706954956,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Male,Liver,50.0,1.556151270866394,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Male,Liver,50.0,1.4215039014816284,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Male,Liver,50.0,1.5834643840789795,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Male,Liver,50.0,1.5834643840789795,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Male,Liver,50.0,1.5814588069915771,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.7087433338165283,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Male,Liver,50.0,1.5814588069915771,Stable,JAK1,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.7087433338165283,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Male,Liver,50.0,1.5814588069915771,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.7087433338165283,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,TP53,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,TP53,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,TP53,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,PDGFRA,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,PDGFRA,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,PDGFRA,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT;TP53,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT;TP53,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT;TP53,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT;TP53,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT;PDGFRA,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT;PDGFRA,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT;PDGFRA,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT;PDGFRA,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,IMATINIB,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,JAK1,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,IMATINIB,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,IMATINIB,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,SUNITINIB,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,JAK1,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,SUNITINIB,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,SUNITINIB,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,REGORAFENIB,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,JAK1,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,REGORAFENIB,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,REGORAFENIB,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,JAK1,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,JAK1,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,JAK1,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5827796459197998,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4216161966323853,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5562866926193237,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5827796459197998,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5844019651412964,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5562866926193237,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5833523273468018,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4216161966323853,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5844019651412964,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5827796459197998,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5844019651412964,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5562866926193237,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,SNP
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4216161966323853,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5833523273468018,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,SNP
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5833523273468018,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5813242197036743,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.7087419033050537,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5813242197036743,Stable,JAK1,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.7087419033050537,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,SNP
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5813242197036743,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.7087419033050537,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,DEL
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,JAK1,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,DEL
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.582513689994812,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,INS
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,INS
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,INS
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,INS
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,INS
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5561001300811768,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,INS
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,INS
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,13/21,Female,Liver,50.0,1.4215370416641235,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,INS
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.58406400680542,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,INS
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.582513689994812,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,7.3,INS
P-0002409-T01-IM3,794.0,81.1,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.58406400680542,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,0.0,NR,7.3,INS
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5561001300811768,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.3,INS
P-0002409-T01-IM3,794.0,81.4,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.4215370416641235,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,792.0,UNKNOWN,7.3,INS
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,22/25,Female,Liver,50.0,1.5831122398376465,Stable,JAK1,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,INS
P-0002409-T01-IM3,794.0,81.2,56.0,60.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5831122398376465,Stable,KIT,NS,1.0,6.575,DECEASED,P-0002409,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NE,7.3,INS
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,INS
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,JAK1,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,INS
P-0002409-T01-IM3,794.0,80.9,56.0,61.0,Non-Hispanic,11/21,Female,Liver,50.0,1.5810877084732056,Stable,KIT,NS,2.0,6.575,DECEASED,P-0002409,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.708745002746582,OTHER,Medical Therapy,42.374380392156866,UNKNOWN,7.3,INS
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Female,Liver,90.0,0.8099340796470642,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Female,Liver,90.0,0.951784610748291,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Female,Liver,90.0,0.9459977149963379,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Female,Liver,90.0,0.9227394461631775,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Female,Liver,90.0,0.9383101463317871,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Female,Liver,90.0,0.9354451894760132,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Female,Liver,90.0,0.8099340796470642,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Female,Liver,90.0,0.9459977149963379,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Female,Liver,90.0,0.9533160924911499,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Female,Liver,90.0,0.9227394461631775,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Female,Liver,90.0,0.9383101463317871,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Female,Liver,90.0,0.9354451894760132,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Female,Liver,90.0,0.9533160924911499,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Female,Liver,90.0,0.951784610748291,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Female,Liver,90.0,0.8117023706436157,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930328369140625,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Female,Liver,90.0,0.8117023706436157,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930328369140625,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.8102226257324219,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9524613618850708,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9465832710266113,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9228969216346741,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9387929439544678,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.935805082321167,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8102226257324219,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9465832710266113,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.953988254070282,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9228969216346741,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9387929439544678,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.935805082321167,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.953988254070282,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9524613618850708,Stable,TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,TP53,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,TP53,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.8102226257324219,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9524613618850708,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9465832710266113,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9228969216346741,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9387929439544678,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.935805082321167,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8102226257324219,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9465832710266113,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.953988254070282,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9228969216346741,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9387929439544678,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.935805082321167,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.953988254070282,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9524613618850708,Stable,PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,PDGFRA,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,PDGFRA,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.935805082321167,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.953988254070282,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.935805082321167,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.953988254070282,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT;TP53,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT;TP53,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT;TP53,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.935805082321167,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.953988254070282,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.935805082321167,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.953988254070282,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT;PDGFRA,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT;PDGFRA,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT;PDGFRA,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,SUNITINIB,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,SUNITINIB,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,REGORAFENIB,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,REGORAFENIB,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.81031334400177,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9527177214622498,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9468370676040649,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9230711460113525,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9389143586158752,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9359056949615479,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.81031334400177,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9468370676040649,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9542627930641174,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9230711460113525,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9389143586158752,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9359056949615479,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9542627930641174,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9527177214622498,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8119789958000183,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.593022108078003,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8119789958000183,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.593022108078003,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,SNP
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,DEL
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,DEL
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,DEL
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,DEL
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,DEL
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,DEL
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,DEL
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,DEL
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,DEL
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,DEL
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,DEL
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,DEL
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,DEL
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,DEL
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,DEL
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,DEL
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,INS
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,INS
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,INS
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,INS
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,INS
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,INS
P-0002477-T01-IM3,434.0,75.5,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8102226257324219,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,579.0,SD,16.0,INS
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9465832710266113,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,92.0,NR,16.0,INS
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,INS
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9228969216346741,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,16.0,INS
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9387929439544678,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,123.0,NR,16.0,INS
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.935805082321167,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,CR,16.0,INS
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,11/21,Male,Liver,90.0,0.953988254070282,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,30.0,NR,16.0,INS
P-0002477-T01-IM3,434.0,75.2,49.0,53.0,Non-Hispanic,13/21,Male,Liver,90.0,0.9524613618850708,Stable,KIT,NS,1.0,12.69,DECEASED,P-0002477,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,16.0,INS
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,INS
P-0002477-T01-IM3,434.0,76.0,49.0,54.0,Non-Hispanic,11/21,Male,Liver,90.0,0.8117367029190063,Stable,KIT,NS,2.0,12.69,DECEASED,P-0002477,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.5930135250091553,OTHER,Medical Therapy,427.7088996493431,UNKNOWN,16.0,INS
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Male,Liver,16.0,0.0,Stable,SDHA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Male,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Male,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Male,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Male,Liver,16.0,0.0,Stable,SDHA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280248641967773,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Male,Liver,16.0,0.0,Stable,KDR,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280248641967773,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,TP53,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,TP53,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,TP53,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,TP53,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,TP53,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,TP53,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,PDGFRA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,PDGFRA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,PDGFRA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,PDGFRA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,PDGFRA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,PDGFRA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT;TP53,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT;TP53,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT;TP53,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT;TP53,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT;TP53,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT;TP53,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT;PDGFRA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT;PDGFRA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT;PDGFRA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT;PDGFRA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KIT;PDGFRA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,IMATINIB,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KDR,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,IMATINIB,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,SUNITINIB,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KDR,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,SUNITINIB,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,REGORAFENIB,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KDR,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,REGORAFENIB,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Small Intestine,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Small Intestine,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Small Intestine,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Small Intestine,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KDR,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Colon,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Colon,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Colon,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Colon,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Colon,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KDR,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Colon,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Rectum,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Rectum,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Rectum,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Rectum,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KDR,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3280365467071533,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KDR,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3280365467071533,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,SNP
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,DEL
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,DEL
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,DEL
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,DEL
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,DEL
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KDR,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,DEL
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,ONGOING,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,1042.0,UNKNOWN,7.0,INS
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,334.0,CR,7.0,INS
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,549.0,CR,7.0,INS
P-0002594-T01-IM3,444.0,50.0,19.0,31.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,1.0,99.189,ALIVE,P-0002594,NS,NS,Stomach,Gastric,White,217.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,607.0,SD,7.0,INS
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,SDHA,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,INS
P-0002594-T02-IM5,1022.0,80.0,19.0,33.0,Non-Hispanic,2/15,Female,Liver,16.0,0.0,Stable,KDR,NS,2.0,94.159,ALIVE,P-0002594,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3280364274978638,OTHER,Medical Therapy,938.1543389472846,UNKNOWN,7.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Female,Not Applicable,112.0,0.29916316270828247,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Female,Not Applicable,112.0,0.29916316270828247,Stable,NF1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Female,Not Applicable,112.0,0.29916316270828247,Stable,SOCS1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Female,Not Applicable,112.0,0.29916316270828247,Stable,CREBBP,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Female,Not Applicable,112.0,0.29916316270828247,Stable,RB1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Female,Not Applicable,112.0,0.29916316270828247,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Female,Not Applicable,112.0,0.29916316270828247,Stable,MYOD1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Female,Not Applicable,112.0,0.29916316270828247,Stable,PTEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Female,Not Applicable,112.0,0.29916316270828247,Stable,KMT2C,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Female,Not Applicable,112.0,0.29916316270828247,Stable,PLK2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Female,Not Applicable,112.0,0.29916316270828247,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Female,Not Applicable,112.0,0.29916316270828247,Stable,SETD2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Female,Not Applicable,112.0,0.29916316270828247,Stable,SPEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Female,Not Applicable,112.0,0.29916316270828247,Stable,PIK3C2G,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Female,Not Applicable,112.0,0.29916316270828247,Stable,ATRX,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Female,Not Applicable,112.0,0.29916316270828247,Stable,YES1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.0027579069137573242,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Female,Not Applicable,112.0,0.314046710729599,Stable,ATRX,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Female,Not Applicable,112.0,0.314046710729599,Stable,SPEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Female,Not Applicable,112.0,0.314046710729599,Stable,SETD2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Female,Not Applicable,112.0,0.314046710729599,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Female,Not Applicable,112.0,0.314046710729599,Stable,PLK2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Female,Not Applicable,112.0,0.314046710729599,Stable,KMT2C,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Female,Not Applicable,112.0,0.314046710729599,Stable,PTEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Female,Not Applicable,112.0,0.314046710729599,Stable,MYOD1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Female,Not Applicable,112.0,0.314046710729599,Stable,PIK3C2G,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Female,Not Applicable,112.0,0.314046710729599,Stable,RB1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Female,Not Applicable,112.0,0.314046710729599,Stable,CREBBP,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Female,Not Applicable,112.0,0.314046710729599,Stable,SOCS1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Female,Not Applicable,112.0,0.314046710729599,Stable,NF1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Female,Not Applicable,112.0,0.314046710729599,Stable,YES1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Female,Not Applicable,112.0,0.314046710729599,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Female,Not Applicable,112.0,0.314046710729599,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.210769653320312,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.2993452548980713,Stable,PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.31424063444137573,Stable,PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT;PDGFRA,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT;PDGFRA,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.2993452548980713,Stable,NF1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.2993452548980713,Stable,SOCS1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,CREBBP,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.2993452548980713,Stable,RB1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.2993452548980713,Stable,MYOD1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.2993452548980713,Stable,PTEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.2993452548980713,Stable,KMT2C,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.2993452548980713,Stable,PLK2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,SETD2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.2993452548980713,Stable,SPEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,PIK3C2G,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.2993452548980713,Stable,ATRX,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.2993452548980713,Stable,YES1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,SUNITINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.31424063444137573,Stable,ATRX,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.31424063444137573,Stable,SPEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,SETD2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.31424063444137573,Stable,PLK2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.31424063444137573,Stable,KMT2C,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.31424063444137573,Stable,PTEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.31424063444137573,Stable,MYOD1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,PIK3C2G,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,RB1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,CREBBP,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.31424063444137573,Stable,SOCS1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.31424063444137573,Stable,NF1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.31424063444137573,Stable,YES1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,SUNITINIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.2993452548980713,Stable,NF1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.2993452548980713,Stable,SOCS1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,CREBBP,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.2993452548980713,Stable,RB1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.2993452548980713,Stable,MYOD1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.2993452548980713,Stable,PTEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.2993452548980713,Stable,KMT2C,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.2993452548980713,Stable,PLK2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,SETD2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.2993452548980713,Stable,SPEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,PIK3C2G,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.2993452548980713,Stable,ATRX,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.2993452548980713,Stable,YES1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,REGORAFENIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.31424063444137573,Stable,ATRX,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.31424063444137573,Stable,SPEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,SETD2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.31424063444137573,Stable,PLK2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.31424063444137573,Stable,KMT2C,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.31424063444137573,Stable,PTEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.31424063444137573,Stable,MYOD1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,PIK3C2G,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,RB1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,CREBBP,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.31424063444137573,Stable,SOCS1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.31424063444137573,Stable,NF1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.31424063444137573,Stable,YES1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,REGORAFENIB,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.2993452548980713,Stable,NF1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.2993452548980713,Stable,SOCS1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,CREBBP,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.2993452548980713,Stable,RB1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.2993452548980713,Stable,MYOD1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.2993452548980713,Stable,PTEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.2993452548980713,Stable,KMT2C,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.2993452548980713,Stable,PLK2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,SETD2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.2993452548980713,Stable,SPEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,PIK3C2G,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.2993452548980713,Stable,ATRX,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.2993452548980713,Stable,YES1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Small Intestine,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.31424063444137573,Stable,ATRX,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.31424063444137573,Stable,SPEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,SETD2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.31424063444137573,Stable,PLK2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.31424063444137573,Stable,KMT2C,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.31424063444137573,Stable,PTEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.31424063444137573,Stable,MYOD1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,PIK3C2G,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,RB1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,CREBBP,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.31424063444137573,Stable,SOCS1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.31424063444137573,Stable,NF1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.31424063444137573,Stable,YES1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.2993452548980713,Stable,NF1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.2993452548980713,Stable,SOCS1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,CREBBP,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.2993452548980713,Stable,RB1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.2993452548980713,Stable,MYOD1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.2993452548980713,Stable,PTEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.2993452548980713,Stable,KMT2C,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.2993452548980713,Stable,PLK2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,SETD2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.2993452548980713,Stable,SPEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,PIK3C2G,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.2993452548980713,Stable,ATRX,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.2993452548980713,Stable,YES1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Colon,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.31424063444137573,Stable,ATRX,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.31424063444137573,Stable,SPEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,SETD2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.31424063444137573,Stable,PLK2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.31424063444137573,Stable,KMT2C,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.31424063444137573,Stable,PTEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.31424063444137573,Stable,MYOD1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,PIK3C2G,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,RB1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,CREBBP,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.31424063444137573,Stable,SOCS1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.31424063444137573,Stable,NF1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.31424063444137573,Stable,YES1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.2993452548980713,Stable,NF1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.2993452548980713,Stable,SOCS1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,CREBBP,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.2993452548980713,Stable,RB1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.2993452548980713,Stable,MYOD1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.2993452548980713,Stable,PTEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.2993452548980713,Stable,KMT2C,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.2993452548980713,Stable,PLK2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,SETD2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.2993452548980713,Stable,SPEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,PIK3C2G,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.2993452548980713,Stable,ATRX,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.2993452548980713,Stable,YES1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Rectum,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.31424063444137573,Stable,ATRX,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.31424063444137573,Stable,SPEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,SETD2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.31424063444137573,Stable,PLK2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.31424063444137573,Stable,KMT2C,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.31424063444137573,Stable,PTEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.31424063444137573,Stable,MYOD1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,PIK3C2G,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,RB1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,CREBBP,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.31424063444137573,Stable,SOCS1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.31424063444137573,Stable,NF1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.31424063444137573,Stable,YES1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.29929569363594055,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.29929569363594055,Stable,NF1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.29929569363594055,Stable,SOCS1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.29929569363594055,Stable,CREBBP,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.29929569363594055,Stable,RB1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.29929569363594055,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.29929569363594055,Stable,MYOD1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.29929569363594055,Stable,PTEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.29929569363594055,Stable,KMT2C,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.29929569363594055,Stable,PLK2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.29929569363594055,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.29929569363594055,Stable,SETD2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.29929569363594055,Stable,SPEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.29929569363594055,Stable,PIK3C2G,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.29929569363594055,Stable,ATRX,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.29929569363594055,Stable,YES1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Metastasis,Localized,0.0027891993522644043,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.3141779601573944,Stable,ATRX,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.3141779601573944,Stable,SPEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.3141779601573944,Stable,SETD2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.3141779601573944,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.3141779601573944,Stable,PLK2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.3141779601573944,Stable,KMT2C,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.3141779601573944,Stable,PTEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.3141779601573944,Stable,MYOD1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.3141779601573944,Stable,PIK3C2G,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.3141779601573944,Stable,RB1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.3141779601573944,Stable,CREBBP,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.3141779601573944,Stable,SOCS1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.3141779601573944,Stable,NF1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.3141779601573944,Stable,YES1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.3141779601573944,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,DEL
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.3141779601573944,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,17.210786819458008,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.2993452548980713,Stable,NF1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.2993452548980713,Stable,SOCS1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,CREBBP,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.2993452548980713,Stable,RB1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.2993452548980713,Stable,MYOD1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.2993452548980713,Stable,PTEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.2993452548980713,Stable,KMT2C,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.2993452548980713,Stable,PLK2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,SETD2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.2993452548980713,Stable,SPEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,PIK3C2G,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.2993452548980713,Stable,ATRX,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.2993452548980713,Stable,YES1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.31424063444137573,Stable,ATRX,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.31424063444137573,Stable,SPEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,SETD2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.31424063444137573,Stable,PLK2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.31424063444137573,Stable,KMT2C,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.31424063444137573,Stable,PTEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.31424063444137573,Stable,MYOD1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,PIK3C2G,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,RB1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,CREBBP,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.31424063444137573,Stable,SOCS1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.31424063444137573,Stable,NF1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.31424063444137573,Stable,YES1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,SNP
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/57,Male,Not Applicable,112.0,0.2993452548980713,Stable,NF1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.2993452548980713,Stable,SOCS1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,CREBBP,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,2/27,Male,Not Applicable,112.0,0.2993452548980713,Stable,RB1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,10/11,Male,Not Applicable,112.0,0.2993452548980713,Stable,TP53,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.2993452548980713,Stable,MYOD1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.2993452548980713,Stable,PTEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,52/59,Male,Not Applicable,112.0,0.2993452548980713,Stable,KMT2C,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.2993452548980713,Stable,PLK2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,4/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,KIT,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.2993452548980713,Stable,SETD2,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.2993452548980713,Stable,SPEN,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,1/31,Male,Not Applicable,112.0,0.2993452548980713,Stable,PIK3C2G,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.2993452548980713,Stable,ATRX,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,60.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.2993452548980713,Stable,YES1,ONGOING,1.0,98.696,ALIVE,P-0002672,NS,Neoadjuvant,Stomach,Gastric,White,75.0,No recurrence,Primary,Localized,0.002763986587524414,IMATINIB,Medical Therapy,1042.0,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,25/35,Male,Not Applicable,112.0,0.31424063444137573,Stable,ATRX,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/15,Male,Not Applicable,112.0,0.31424063444137573,Stable,SPEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,3/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,SETD2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/14,Male,Not Applicable,112.0,0.31424063444137573,Stable,PLK2,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,43/59,Male,Not Applicable,112.0,0.31424063444137573,Stable,KMT2C,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,5/9,Male,Not Applicable,112.0,0.31424063444137573,Stable,PTEN,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,1/3,Male,Not Applicable,112.0,0.31424063444137573,Stable,MYOD1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,PIK3C2G,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,RB1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,13/31,Male,Not Applicable,112.0,0.31424063444137573,Stable,CREBBP,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,2/2,Male,Not Applicable,112.0,0.31424063444137573,Stable,SOCS1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,28/57,Male,Not Applicable,112.0,0.31424063444137573,Stable,NF1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,9/12,Male,Not Applicable,112.0,0.31424063444137573,Stable,YES1,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,112.0,0.31424063444137573,Stable,KIT,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002672-T01-IM3,597.0,30.0,59.0,61.0,Non-Hispanic,6/11,Male,Not Applicable,112.0,0.31424063444137573,Stable,TP53,NS,2.0,92.646,ALIVE,P-0002672,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,17.2108097076416,OTHER,Medical Therapy,787.888310069087,UNKNOWN,4.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Female,Small Bowel,5.0,0.665252149105072,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Female,Small Bowel,5.0,0.5326907634735107,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Female,Small Bowel,5.0,0.5464251041412354,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Female,Small Bowel,5.0,0.6598250269889832,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Female,Small Bowel,5.0,0.6629123687744141,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Female,Small Bowel,5.0,0.6629123687744141,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Female,Small Bowel,5.0,0.6598250269889832,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Female,Small Bowel,5.0,0.5464251041412354,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Female,Small Bowel,5.0,0.5326907634735107,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Female,Small Bowel,5.0,0.665252149105072,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Female,Small Bowel,5.0,0.5174546837806702,Stable,KMT2C,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565964221954346,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Female,Small Bowel,5.0,0.5174546837806702,Stable,KIT,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565964221954346,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.665760338306427,Stable,TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5326154828071594,Stable,TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463970899581909,Stable,TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6603418588638306,Stable,TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6631991267204285,Stable,TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6631991267204285,Stable,TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6603418588638306,Stable,TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463970899581909,Stable,TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5326154828071594,Stable,TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.665760338306427,Stable,TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5173746347427368,Stable,TP53,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5173746347427368,Stable,TP53,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.665760338306427,Stable,PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5326154828071594,Stable,PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463970899581909,Stable,PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6603418588638306,Stable,PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6631991267204285,Stable,PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6631991267204285,Stable,PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6603418588638306,Stable,PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463970899581909,Stable,PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5326154828071594,Stable,PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.665760338306427,Stable,PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5173746347427368,Stable,PDGFRA,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5173746347427368,Stable,PDGFRA,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.665760338306427,Stable,KIT;TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5326154828071594,Stable,KIT;TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463970899581909,Stable,KIT;TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6603418588638306,Stable,KIT;TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6631991267204285,Stable,KIT;TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6631991267204285,Stable,KIT;TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6603418588638306,Stable,KIT;TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463970899581909,Stable,KIT;TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5326154828071594,Stable,KIT;TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.665760338306427,Stable,KIT;TP53,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5173746347427368,Stable,KIT;TP53,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5173746347427368,Stable,KIT;TP53,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.665760338306427,Stable,KIT;PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5326154828071594,Stable,KIT;PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463970899581909,Stable,KIT;PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6603418588638306,Stable,KIT;PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6631991267204285,Stable,KIT;PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6631991267204285,Stable,KIT;PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6603418588638306,Stable,KIT;PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463970899581909,Stable,KIT;PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5326154828071594,Stable,KIT;PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.665760338306427,Stable,KIT;PDGFRA,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5173746347427368,Stable,KIT;PDGFRA,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5173746347427368,Stable,KIT;PDGFRA,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.665760338306427,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5326154828071594,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463970899581909,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6603418588638306,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6631991267204285,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6631991267204285,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6603418588638306,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463970899581909,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5326154828071594,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.665760338306427,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5173746347427368,Stable,KMT2C,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,IMATINIB,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5173746347427368,Stable,KIT,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,IMATINIB,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.665760338306427,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5326154828071594,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463970899581909,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6603418588638306,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6631991267204285,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6631991267204285,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6603418588638306,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463970899581909,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5326154828071594,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.665760338306427,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5173746347427368,Stable,KMT2C,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,SUNITINIB,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5173746347427368,Stable,KIT,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,SUNITINIB,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.665760338306427,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5326154828071594,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463970899581909,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6603418588638306,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6631991267204285,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6631991267204285,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6603418588638306,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463970899581909,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5326154828071594,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.665760338306427,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5173746347427368,Stable,KMT2C,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,REGORAFENIB,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5173746347427368,Stable,KIT,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,REGORAFENIB,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.665760338306427,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Stomach,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5326154828071594,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Stomach,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463970899581909,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Stomach,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6603418588638306,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Stomach,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6631991267204285,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Stomach,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6631991267204285,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Stomach,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6603418588638306,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Stomach,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463970899581909,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Stomach,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5326154828071594,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Stomach,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.665760338306427,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Stomach,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5173746347427368,Stable,KMT2C,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5173746347427368,Stable,KIT,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.665760338306427,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Colon,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5326154828071594,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Colon,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463970899581909,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Colon,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6603418588638306,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Colon,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6631991267204285,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Colon,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6631991267204285,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Colon,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6603418588638306,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Colon,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463970899581909,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Colon,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5326154828071594,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Colon,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.665760338306427,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Colon,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5173746347427368,Stable,KMT2C,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5173746347427368,Stable,KIT,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.665760338306427,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Rectum,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5326154828071594,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Rectum,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463970899581909,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Rectum,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6603418588638306,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Rectum,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6631991267204285,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Rectum,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6631991267204285,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Rectum,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6603418588638306,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Rectum,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463970899581909,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Rectum,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5326154828071594,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Rectum,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.665760338306427,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Rectum,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5173746347427368,Stable,KMT2C,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5173746347427368,Stable,KIT,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.666212797164917,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5328357815742493,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463764667510986,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6607962846755981,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6636727452278137,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6636727452278137,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6607962846755981,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463764667510986,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5328357815742493,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.666212797164917,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5175861120223999,Stable,KMT2C,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.6565735340118408,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5175861120223999,Stable,KIT,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.6565735340118408,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,INS
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.665760338306427,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5326154828071594,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463970899581909,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6603418588638306,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6631991267204285,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6631991267204285,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6603418588638306,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463970899581909,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5326154828071594,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.665760338306427,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5173746347427368,Stable,KMT2C,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5173746347427368,Stable,KIT,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,SNP
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.665760338306427,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5326154828071594,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,DEL
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.5463970899581909,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,DEL
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6603418588638306,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,DEL
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,9/21,Male,Small Bowel,5.0,0.6631991267204285,Stable,KIT,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,DEL
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6631991267204285,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,NR,8.0,DEL
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.6603418588638306,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,31.0,NR,8.0,DEL
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5463970899581909,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1644.0,CR,8.0,DEL
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5326154828071594,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,366.0,UNKNOWN,8.0,DEL
P-0002680-T01-IM3,425.0,40.0,44.0,52.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.665760338306427,Stable,KMT2C,NS,1.0,8.778,DECEASED,P-0002680,NS,NS,Small Intestine,Small Bowel,White,35.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,8.0,DEL
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,43/59,Male,Small Bowel,5.0,0.5173746347427368,Stable,KMT2C,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,DEL
P-0002680-T01-IM3,425.0,40.0,44.0,53.0,Non-Hispanic,11/21,Male,Small Bowel,5.0,0.5173746347427368,Stable,KIT,NS,2.0,8.778,DECEASED,P-0002680,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.6565641164779663,OTHER,Medical Therapy,395.1308045973989,UNKNOWN,8.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,1.1101189851760864,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Female,Not Applicable,15.0,1.1101189851760864,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Female,Not Applicable,15.0,1.1665536165237427,Stable,MAX,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Female,Not Applicable,15.0,1.1610673666000366,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Female,Not Applicable,15.0,1.1665536165237427,Stable,FAM46C,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Female,Not Applicable,15.0,1.1610673666000366,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Female,Not Applicable,15.0,1.1101189851760864,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Female,Not Applicable,15.0,1.1610673666000366,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Female,Not Applicable,15.0,1.1101189851760864,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,1.1610673666000366,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,1.1665536165237427,Stable,KIT,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Female,Not Applicable,15.0,1.1665536165237427,Stable,DNMT1,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Female,Not Applicable,15.0,1.8168028593063354,Stable,MAX,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062904834747314,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Female,Not Applicable,15.0,1.8168028593063354,Stable,DNMT1,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062904834747314,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Female,Not Applicable,15.0,1.8168028593063354,Stable,TENT5C,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062904834747314,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,1.8168028593063354,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062904834747314,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,1.8168028593063354,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062904834747314,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1102290153503418,Stable,TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1102290153503418,Stable,TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1667524576187134,Stable,TP53,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1611558198928833,Stable,TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1667524576187134,Stable,TP53,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1611558198928833,Stable,TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1102290153503418,Stable,TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1611558198928833,Stable,TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1102290153503418,Stable,TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1611558198928833,Stable,TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1667524576187134,Stable,TP53,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1667524576187134,Stable,TP53,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,TP53,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.8168749809265137,Stable,TP53,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,TP53,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,TP53,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,TP53,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1102290153503418,Stable,PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1102290153503418,Stable,PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1667524576187134,Stable,PDGFRA,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1611558198928833,Stable,PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1667524576187134,Stable,PDGFRA,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1611558198928833,Stable,PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1102290153503418,Stable,PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1611558198928833,Stable,PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1102290153503418,Stable,PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1611558198928833,Stable,PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1667524576187134,Stable,PDGFRA,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1667524576187134,Stable,PDGFRA,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,PDGFRA,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.8168749809265137,Stable,PDGFRA,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,PDGFRA,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,PDGFRA,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,PDGFRA,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT;TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT;TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT;TP53,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT;TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT;TP53,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT;TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT;TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT;TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT;TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT;TP53,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT;TP53,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT;TP53,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT;TP53,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT;TP53,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT;TP53,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT;TP53,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT;TP53,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT;PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT;PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT;PDGFRA,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT;PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT;PDGFRA,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT;PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT;PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT;PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT;PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT;PDGFRA,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT;PDGFRA,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT;PDGFRA,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT;PDGFRA,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT;PDGFRA,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT;PDGFRA,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT;PDGFRA,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT;PDGFRA,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,336.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1102290153503418,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1667524576187134,Stable,MAX,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1611558198928833,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1667524576187134,Stable,FAM46C,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1611558198928833,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1102290153503418,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1611558198928833,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1102290153503418,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,181.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1667524576187134,Stable,DNMT1,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,MAX,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,SUNITINIB,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.8168749809265137,Stable,DNMT1,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,SUNITINIB,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,TENT5C,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,SUNITINIB,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,SUNITINIB,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,SUNITINIB,Medical Therapy,290.1938289480763,UNKNOWN,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,336.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1102290153503418,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1667524576187134,Stable,MAX,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1611558198928833,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1667524576187134,Stable,FAM46C,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1611558198928833,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1102290153503418,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1611558198928833,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1102290153503418,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,181.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,130.0,NE,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1667524576187134,Stable,DNMT1,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,MAX,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,REGORAFENIB,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.8168749809265137,Stable,DNMT1,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,REGORAFENIB,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,TENT5C,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,REGORAFENIB,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,REGORAFENIB,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,REGORAFENIB,Medical Therapy,290.1938289480763,UNKNOWN,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1102290153503418,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1667524576187134,Stable,MAX,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Stomach,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1611558198928833,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1667524576187134,Stable,FAM46C,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1611558198928833,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1102290153503418,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1611558198928833,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1102290153503418,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Stomach,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1667524576187134,Stable,DNMT1,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,MAX,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Stomach,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.8168749809265137,Stable,DNMT1,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Stomach,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,TENT5C,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Stomach,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Stomach,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Stomach,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Colon,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1102290153503418,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Colon,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1667524576187134,Stable,MAX,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Colon,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1611558198928833,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Colon,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1667524576187134,Stable,FAM46C,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Colon,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1611558198928833,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Colon,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1102290153503418,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Colon,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1611558198928833,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Colon,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1102290153503418,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Colon,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Colon,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Colon,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1667524576187134,Stable,DNMT1,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Colon,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,MAX,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Colon,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.8168749809265137,Stable,DNMT1,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Colon,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,TENT5C,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Colon,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Colon,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Colon,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1102290153503418,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1667524576187134,Stable,MAX,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Rectum,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1611558198928833,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1667524576187134,Stable,FAM46C,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1611558198928833,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1102290153503418,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1611558198928833,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1102290153503418,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Rectum,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1667524576187134,Stable,DNMT1,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,MAX,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Rectum,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.8168749809265137,Stable,DNMT1,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Rectum,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,TENT5C,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Rectum,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Rectum,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Rectum,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1100531816482544,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1100531816482544,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1663713455200195,Stable,MAX,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.160937786102295,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1663713455200195,Stable,FAM46C,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.160937786102295,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1100531816482544,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.160937786102295,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1100531816482544,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.160937786102295,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1663713455200195,Stable,KIT,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1663713455200195,Stable,DNMT1,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,MAX,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.8168749809265137,Stable,DNMT1,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,TENT5C,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,DEL
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1102290153503418,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1667524576187134,Stable,MAX,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1611558198928833,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1667524576187134,Stable,FAM46C,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1611558198928833,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1102290153503418,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1611558198928833,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1102290153503418,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1667524576187134,Stable,DNMT1,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,MAX,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.8168749809265137,Stable,DNMT1,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,TENT5C,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,SNP
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1102290153503418,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,INS
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1102290153503418,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,INS
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1667524576187134,Stable,MAX,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,INS
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1611558198928833,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,INS
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1667524576187134,Stable,FAM46C,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,INS
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1611558198928833,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,INS
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,2/2,Male,Not Applicable,15.0,1.1102290153503418,Stable,FAM46C,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,INS
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1611558198928833,Stable,DNMT1,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,INS
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,4/5,Male,Not Applicable,15.0,1.1102290153503418,Stable,MAX,NS,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,336.0,CR,9.0,INS
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1611558198928833,Stable,KIT,NS,1.0,49.907,DECEASED,P-0003162,NS,NS,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,181.0,CR,9.0,INS
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.1667524576187134,Stable,KIT,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,INS
P-0003162-T01-IM5,642.0,90.0,47.0,47.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.1667524576187134,Stable,DNMT1,ONGOING,1.0,49.907,DECEASED,P-0003162,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,2.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,9.0,INS
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,MAX,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,INS
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,39/40,Male,Not Applicable,15.0,1.8168749809265137,Stable,DNMT1,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,INS
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,3/5,Male,Not Applicable,15.0,1.8168749809265137,Stable,TENT5C,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,INS
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,INS
P-0003162-T02-IM6,820.0,80.0,47.0,50.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,1.8168749809265137,Stable,KIT,NS,2.0,49.907,DECEASED,P-0003162,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,3.7062883377075195,OTHER,Medical Therapy,290.1938289480763,UNKNOWN,9.0,INS
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Male,Not Applicable,104.0,0.0,Stable,TP53,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34863191843032837,OTHER,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Male,Not Applicable,104.0,0.0,Stable,TP53,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Stomach,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,KIT,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34864121675491333,OTHER,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,KIT,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Stomach,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,PDGFRA,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34864121675491333,OTHER,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,PDGFRA,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Stomach,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,KIT;TP53,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34864121675491333,OTHER,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,KIT;TP53,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Stomach,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,KIT;PDGFRA,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34864121675491333,OTHER,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Stomach,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,TP53,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34864121675491333,IMATINIB,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,TP53,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Stomach,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,TP53,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34864121675491333,SUNITINIB,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,TP53,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Stomach,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,TP53,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34864121675491333,REGORAFENIB,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,TP53,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Stomach,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,TP53,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Small Intestine,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34864121675491333,OTHER,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,TP53,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Small Intestine,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,TP53,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Colon,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34864121675491333,OTHER,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,TP53,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Colon,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,TP53,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Rectum,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34864121675491333,OTHER,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,TP53,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Rectum,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,TP53,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Metastasis,Metastatic,0.348621666431427,OTHER,Medical Therapy,503.79998051948047,UNKNOWN,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,TP53,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Stomach,Gastric,Asian,62.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,587.0,CR,3.4,SNP
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,TP53,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34864121675491333,OTHER,Medical Therapy,503.79998051948047,UNKNOWN,3.4,DEL
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,TP53,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Stomach,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,587.0,CR,3.4,DEL
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,6/11,Female,Not Applicable,104.0,0.0,Stable,TP53,NS,1.0,60.329,DECEASED,P-0003457,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Metastatic,0.34864121675491333,OTHER,Medical Therapy,503.79998051948047,UNKNOWN,3.4,INS
P-0003457-T01-IM5,479.0,80.0,59.0,60.0,Non-Hispanic,8/11,Female,Not Applicable,104.0,0.0,Stable,TP53,ONGOING,1.0,60.329,DECEASED,P-0003457,NS,Neoadjuvant,Stomach,Gastric,Asian,62.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,587.0,CR,3.4,INS
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Female,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Stomach,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Female,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588334321975708,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,KIT,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Stomach,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,KIT,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588219881057739,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,TP53,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Stomach,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,TP53,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588219881057739,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,PDGFRA,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Stomach,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,PDGFRA,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588219881057739,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,KIT;TP53,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Stomach,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,KIT;TP53,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588219881057739,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Stomach,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,KIT;PDGFRA,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588219881057739,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Stomach,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588219881057739,SUNITINIB,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Stomach,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588219881057739,REGORAFENIB,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Small Intestine,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588219881057739,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Colon,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588219881057739,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Rectum,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588219881057739,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Stomach,Gastric,White,65.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.3588157296180725,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,SNP
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Stomach,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,DEL
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588219881057739,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,DEL
P-0003471-T01-IM5,721.0,80.0,75.0,76.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,1.0,73.907,ALIVE,P-0003471,NS,Neoadjuvant,Stomach,Gastric,White,65.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,120.0,UNKNOWN,6.0,INS
P-0003471-T01-IM5,721.0,80.0,75.0,77.0,Non-Hispanic,28/43,Male,Not Applicable,6.0,0.0,Stable,ROS1,ONGOING,2.0,73.907,ALIVE,P-0003471,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3588219881057739,OTHER,Medical Therapy,434.103737984238,UNKNOWN,6.0,INS
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Stomach,Gastric,White,70.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,861.0,NE,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Male,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.5912277698516846,OTHER,Medical Therapy,991.2080871212122,UNKNOWN,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,TP53,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Stomach,Gastric,White,70.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,861.0,NE,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,TP53,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.5912469029426575,OTHER,Medical Therapy,991.2080871212122,UNKNOWN,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,PDGFRA,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Stomach,Gastric,White,70.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,861.0,NE,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,PDGFRA,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.5912469029426575,OTHER,Medical Therapy,991.2080871212122,UNKNOWN,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT;TP53,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Stomach,Gastric,White,70.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,861.0,NE,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT;TP53,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.5912469029426575,OTHER,Medical Therapy,991.2080871212122,UNKNOWN,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Stomach,Gastric,White,70.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,861.0,NE,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT;PDGFRA,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.5912469029426575,OTHER,Medical Therapy,991.2080871212122,UNKNOWN,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Stomach,Gastric,White,70.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,861.0,NE,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.5912469029426575,SUNITINIB,Medical Therapy,991.2080871212122,UNKNOWN,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Stomach,Gastric,White,70.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,861.0,NE,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.5912469029426575,REGORAFENIB,Medical Therapy,991.2080871212122,UNKNOWN,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Small Intestine,Gastric,White,70.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,861.0,NE,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,0.5912469029426575,OTHER,Medical Therapy,991.2080871212122,UNKNOWN,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Colon,Gastric,White,70.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,861.0,NE,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,0.5912469029426575,OTHER,Medical Therapy,991.2080871212122,UNKNOWN,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Rectum,Gastric,White,70.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,861.0,NE,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,0.5912469029426575,OTHER,Medical Therapy,991.2080871212122,UNKNOWN,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Stomach,Gastric,White,70.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,861.0,NE,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.5912460684776306,OTHER,Medical Therapy,991.2080871212122,UNKNOWN,7.5,SNP
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Stomach,Gastric,White,70.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,861.0,NE,7.5,DEL
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.5912469029426575,OTHER,Medical Therapy,991.2080871212122,UNKNOWN,7.5,DEL
P-0003927-T01-IM3,1072.0,30.0,67.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,1.0,99.156,ALIVE,P-0003927,NS,Neoadjuvant,Stomach,Gastric,White,70.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,861.0,NE,7.5,INS
P-0003927-T01-IM3,1072.0,30.0,67.0,68.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,0.0,Stable,KIT,ONGOING,2.0,92.482,ALIVE,P-0003927,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.5912469029426575,OTHER,Medical Therapy,991.2080871212122,UNKNOWN,7.5,INS
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Female,Not Applicable,35.0,0.26136431097984314,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Female,Not Applicable,35.0,0.2511553168296814,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Female,Not Applicable,35.0,0.26030081510543823,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Female,Not Applicable,35.0,0.26136431097984314,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Female,Not Applicable,35.0,0.2511553168296814,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Female,Not Applicable,35.0,0.26030081510543823,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Female,Not Applicable,35.0,0.2586689591407776,Stable,PLCG2,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.341019630432129,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Female,Not Applicable,35.0,0.2586689591407776,Stable,EGFR,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.341019630432129,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26149457693099976,Stable,KIT,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2512627840042114,Stable,KIT,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2605395019054413,Stable,KIT,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26149457693099976,Stable,KIT,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2512627840042114,Stable,KIT,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2605395019054413,Stable,KIT,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25876450538635254,Stable,KIT,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25876450538635254,Stable,KIT,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26149457693099976,Stable,TP53,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2512627840042114,Stable,TP53,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2605395019054413,Stable,TP53,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26149457693099976,Stable,TP53,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2512627840042114,Stable,TP53,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2605395019054413,Stable,TP53,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25876450538635254,Stable,TP53,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25876450538635254,Stable,TP53,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26149457693099976,Stable,PDGFRA,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2512627840042114,Stable,PDGFRA,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2605395019054413,Stable,PDGFRA,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26149457693099976,Stable,PDGFRA,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2512627840042114,Stable,PDGFRA,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2605395019054413,Stable,PDGFRA,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25876450538635254,Stable,PDGFRA,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25876450538635254,Stable,PDGFRA,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26149457693099976,Stable,KIT;TP53,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2512627840042114,Stable,KIT;TP53,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2605395019054413,Stable,KIT;TP53,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26149457693099976,Stable,KIT;TP53,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2512627840042114,Stable,KIT;TP53,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2605395019054413,Stable,KIT;TP53,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25876450538635254,Stable,KIT;TP53,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25876450538635254,Stable,KIT;TP53,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26149457693099976,Stable,KIT;PDGFRA,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2512627840042114,Stable,KIT;PDGFRA,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2605395019054413,Stable,KIT;PDGFRA,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26149457693099976,Stable,KIT;PDGFRA,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2512627840042114,Stable,KIT;PDGFRA,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2605395019054413,Stable,KIT;PDGFRA,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25876450538635254,Stable,KIT;PDGFRA,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25876450538635254,Stable,KIT;PDGFRA,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26149457693099976,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2512627840042114,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2605395019054413,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26149457693099976,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2512627840042114,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2605395019054413,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25876450538635254,Stable,PLCG2,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,SUNITINIB,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25876450538635254,Stable,EGFR,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,SUNITINIB,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26149457693099976,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2512627840042114,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2605395019054413,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26149457693099976,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2512627840042114,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2605395019054413,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25876450538635254,Stable,PLCG2,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,REGORAFENIB,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25876450538635254,Stable,EGFR,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,REGORAFENIB,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26149457693099976,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2512627840042114,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2605395019054413,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26149457693099976,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2512627840042114,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2605395019054413,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25876450538635254,Stable,PLCG2,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25876450538635254,Stable,EGFR,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26149457693099976,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2512627840042114,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2605395019054413,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26149457693099976,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2512627840042114,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2605395019054413,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25876450538635254,Stable,PLCG2,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25876450538635254,Stable,EGFR,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26149457693099976,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2512627840042114,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2605395019054413,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26149457693099976,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2512627840042114,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2605395019054413,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25876450538635254,Stable,PLCG2,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25876450538635254,Stable,EGFR,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26128387451171875,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25109344720840454,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26026779413223267,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26128387451171875,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25109344720840454,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26026779413223267,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25863412022590637,Stable,PLCG2,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3410274982452393,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25863412022590637,Stable,EGFR,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3410274982452393,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,SNP
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26149457693099976,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,DEL
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2512627840042114,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,DEL
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2605395019054413,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,DEL
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26149457693099976,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,DEL
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2512627840042114,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,DEL
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2605395019054413,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,DEL
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25876450538635254,Stable,PLCG2,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,DEL
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25876450538635254,Stable,EGFR,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,DEL
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.26149457693099976,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,INS
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2512627840042114,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,INS
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.2605395019054413,Stable,EGFR,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,INS
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.26149457693099976,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,181.0,NR,6.0,INS
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2512627840042114,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,243.0,CR,6.0,INS
P-0004225-T01-IM5,809.0,80.0,42.0,43.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.2605395019054413,Stable,PLCG2,NS,1.0,13.118,DECEASED,P-0004225,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,6.0,INS
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,18/33,Male,Not Applicable,35.0,0.25876450538635254,Stable,PLCG2,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,INS
P-0004225-T01-IM5,809.0,80.0,42.0,44.0,Non-Hispanic,12/28,Male,Not Applicable,35.0,0.25876450538635254,Stable,EGFR,NS,2.0,13.118,DECEASED,P-0004225,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.3410205841064453,OTHER,Medical Therapy,195.9580789350556,UNKNOWN,6.0,INS
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Female,Liver,1.0,0.46492284536361694,Stable,KIT,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Female,Liver,1.0,0.5121015906333923,Stable,KIT,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746922969818115,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491873264312744,Stable,TP53,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120958685874939,Stable,TP53,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746630907058716,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491873264312744,Stable,PDGFRA,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120958685874939,Stable,PDGFRA,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746630907058716,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491873264312744,Stable,KIT;TP53,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120958685874939,Stable,KIT;TP53,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746630907058716,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491873264312744,Stable,KIT;PDGFRA,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120958685874939,Stable,KIT;PDGFRA,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746630907058716,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491873264312744,Stable,KIT,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120958685874939,Stable,KIT,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746630907058716,SUNITINIB,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491873264312744,Stable,KIT,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120958685874939,Stable,KIT,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746630907058716,REGORAFENIB,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491873264312744,Stable,KIT,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120958685874939,Stable,KIT,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746630907058716,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491873264312744,Stable,KIT,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120958685874939,Stable,KIT,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746630907058716,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491873264312744,Stable,KIT,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120958685874939,Stable,KIT,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746630907058716,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491873264312744,Stable,KIT,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120958685874939,Stable,KIT,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746630907058716,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491390466690063,Stable,KIT,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,5033.0,SD,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120933055877686,Stable,KIT,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.32746148109436035,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,DEL
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491873264312744,Stable,KIT,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,5033.0,SD,11.0,SNP
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120958685874939,Stable,KIT,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746630907058716,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,SNP
P-0004235-T01-IM5,372.0,70.0,55.0,67.0,Non-Hispanic,11/21,Male,Liver,1.0,0.46491873264312744,Stable,KIT,ONGOING,1.0,24.921,ALIVE,P-0004235,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,5033.0,SD,11.0,INS
P-0004235-T01-IM5,372.0,70.0,55.0,68.0,Non-Hispanic,11/21,Male,Liver,1.0,0.5120958685874939,Stable,KIT,ONGOING,2.0,24.921,ALIVE,P-0004235,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.32746630907058716,OTHER,Medical Therapy,3027.3115000000003,UNKNOWN,11.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Male,Abdomen,38.0,0.4776577651500702,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Male,Abdomen,38.0,0.5017837882041931,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Male,Abdomen,38.0,0.5010796189308167,Stable,MAX,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Male,Abdomen,38.0,0.5017837882041931,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Male,Abdomen,38.0,0.5010796189308167,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Male,Abdomen,38.0,0.4776577651500702,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Male,Abdomen,38.0,0.5017837882041931,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Male,Abdomen,38.0,0.40553075075149536,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Male,Abdomen,38.0,0.4776577651500702,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Male,Abdomen,38.0,0.40553075075149536,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Male,Abdomen,38.0,0.5017837882041931,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Male,Abdomen,38.0,0.5017837882041931,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Male,Abdomen,38.0,0.5010796189308167,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Male,Abdomen,38.0,0.5017837882041931,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Male,Abdomen,38.0,0.40553075075149536,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Male,Abdomen,38.0,0.4939180910587311,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.3449623584747314,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Male,Abdomen,38.0,0.4939180910587311,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.3449623584747314,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Male,Abdomen,38.0,0.4939180910587311,Stable,MAX,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.3449623584747314,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.47756141424179077,Stable,TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5008339285850525,Stable,TP53,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5008339285850525,Stable,TP53,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.47756141424179077,Stable,TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4055383801460266,Stable,TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.47756141424179077,Stable,TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4055383801460266,Stable,TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5008339285850525,Stable,TP53,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4055383801460266,Stable,TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,TP53,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,TP53,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.49379706382751465,Stable,TP53,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.47756141424179077,Stable,PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5008339285850525,Stable,PDGFRA,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5008339285850525,Stable,PDGFRA,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.47756141424179077,Stable,PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4055383801460266,Stable,PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.47756141424179077,Stable,PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4055383801460266,Stable,PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5008339285850525,Stable,PDGFRA,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4055383801460266,Stable,PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,PDGFRA,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,PDGFRA,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.49379706382751465,Stable,PDGFRA,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT;TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT;TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT;TP53,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT;TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT;TP53,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT;TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT;TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT;TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT;TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT;TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT;TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT;TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT;TP53,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT;TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT;TP53,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT;TP53,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT;TP53,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT;TP53,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT;PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT;PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT;PDGFRA,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT;PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT;PDGFRA,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT;PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT;PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT;PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT;PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT;PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT;PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT;PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT;PDGFRA,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT;PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT;PDGFRA,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT;PDGFRA,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT;PDGFRA,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT;PDGFRA,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5008339285850525,Stable,MAX,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4055383801460266,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.47756141424179077,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,IMATINIB,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,IMATINIB,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.49379706382751465,Stable,MAX,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,IMATINIB,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5008339285850525,Stable,MAX,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4055383801460266,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.47756141424179077,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,SUNITINIB,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,SUNITINIB,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.49379706382751465,Stable,MAX,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,SUNITINIB,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5008339285850525,Stable,MAX,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4055383801460266,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.47756141424179077,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.49379706382751465,Stable,MAX,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5008339285850525,Stable,MAX,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4055383801460266,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.47756141424179077,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.49379706382751465,Stable,MAX,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5008339285850525,Stable,MAX,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4055383801460266,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.47756141424179077,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.49379706382751465,Stable,MAX,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5008339285850525,Stable,MAX,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4055383801460266,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.47756141424179077,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.49379706382751465,Stable,MAX,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4777665138244629,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5016878247261047,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5011638402938843,Stable,MAX,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5016878247261047,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5011638402938843,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4777665138244629,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5016878247261047,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.40570133924484253,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4777665138244629,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.40570133924484253,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5016878247261047,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5016878247261047,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5011638402938843,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5016878247261047,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.40570133924484253,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4939708709716797,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,2.3449513912200928,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,DEL
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4939708709716797,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,2.3449513912200928,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4939708709716797,Stable,MAX,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,2.3449513912200928,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5008339285850525,Stable,MAX,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4055383801460266,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.47756141424179077,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.49379706382751465,Stable,MAX,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,SNP
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5008339285850525,Stable,MAX,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.47756141424179077,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.4055383801460266,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.47756141424179077,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,274.0,CR,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5014009475708008,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,NS,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.5008339285850525,Stable,KIT,ONGOING,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,130.0,NE,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.5014009475708008,Stable,MAX,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,46.0,Non-Hispanic,17/21,Female,Abdomen,38.0,0.4055383801460266,Stable,KIT,NS,1.0,28.274,DECEASED,P-0004509,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,455.0,SD,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,11/21,Female,Abdomen,38.0,0.49379706382751465,Stable,KIT,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,INS
P-0004509-T01-IM5,689.0,60.0,45.0,47.0,Non-Hispanic,3/5,Female,Abdomen,38.0,0.49379706382751465,Stable,MAX,NS,2.0,28.274,DECEASED,P-0004509,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,2.344963550567627,OTHER,Medical Therapy,199.187710929975,UNKNOWN,12.0,INS
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Female,Spleen,42.52,0.12992897629737854,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Female,Spleen,42.52,0.12992897629737854,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Female,Spleen,42.95,0.2737216651439667,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Female,Spleen,42.95,0.2733381986618042,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Female,Spleen,42.95,0.2733381986618042,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Female,Spleen,42.95,0.2737216651439667,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Female,Spleen,42.52,0.12992897629737854,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Female,Spleen,42.95,0.2733381986618042,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Female,Spleen,42.95,0.2737216651439667,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Female,Spleen,15.1,0.12919193506240845,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707308769226074,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Female,Spleen,15.1,0.12919193506240845,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707308769226074,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Female,Spleen,15.1,0.12919193506240845,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707308769226074,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.13001444935798645,Stable,TP53,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.13001444935798645,Stable,TP53,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27404120564460754,Stable,TP53,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27370017766952515,Stable,TP53,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27370017766952515,Stable,TP53,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27404120564460754,Stable,TP53,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.13001444935798645,Stable,TP53,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27370017766952515,Stable,TP53,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27404120564460754,Stable,TP53,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,TP53,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.12915609776973724,Stable,TP53,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,TP53,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.13001444935798645,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.13001444935798645,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27404120564460754,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27370017766952515,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27370017766952515,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27404120564460754,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.13001444935798645,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27370017766952515,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27404120564460754,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.12915609776973724,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT;TP53,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT;TP53,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT;TP53,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT;TP53,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT;TP53,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27404120564460754,Stable,KIT;TP53,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.13001444935798645,Stable,KIT;TP53,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27370017766952515,Stable,KIT;TP53,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT;TP53,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT;TP53,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.12915609776973724,Stable,KIT;TP53,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT;TP53,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT;PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT;PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT;PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT;PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT;PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27404120564460754,Stable,KIT;PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.13001444935798645,Stable,KIT;PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27370017766952515,Stable,KIT;PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT;PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT;PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.12915609776973724,Stable,KIT;PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT;PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27404120564460754,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.13001444935798645,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27370017766952515,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,SUNITINIB,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.12915609776973724,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,SUNITINIB,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,SUNITINIB,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27404120564460754,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.13001444935798645,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27370017766952515,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,REGORAFENIB,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.12915609776973724,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,REGORAFENIB,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,REGORAFENIB,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27404120564460754,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.13001444935798645,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27370017766952515,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.12915609776973724,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27404120564460754,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.13001444935798645,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27370017766952515,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.12915609776973724,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27404120564460754,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.13001444935798645,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27370017766952515,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.12915609776973724,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.13001853227615356,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.13001853227615356,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.2743194103240967,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27405309677124023,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27405309677124023,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.2743194103240967,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.13001853227615356,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27405309677124023,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.2743194103240967,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12927769124507904,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.3707103729248047,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.12927769124507904,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.3707103729248047,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12927769124507904,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.3707103729248047,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,SNP
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,DEL
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,DEL
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,DEL
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,DEL
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,DEL
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27404120564460754,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,DEL
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.13001444935798645,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,DEL
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27370017766952515,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,DEL
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,DEL
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,DEL
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.12915609776973724,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,DEL
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,DEL
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,INS
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.52,0.13001444935798645,Stable,KIT,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,INS
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,INS
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,11/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,INS
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27370017766952515,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,INS
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27404120564460754,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,INS
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.52,0.13001444935798645,Stable,PDGFRA,ONGOING,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1317.0,SD,18.5,INS
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/23,Male,Spleen,42.95,0.27370017766952515,Stable,PDGFRA,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,18.5,INS
P-0004639-T01-IM5,756.0,40.0,71.0,74.0,Non-Hispanic,17/21,Male,Spleen,42.95,0.27404120564460754,Stable,KIT,NS,1.0,95.309,ALIVE,P-0004639,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,SD,18.5,INS
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,INS
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,18/23,Male,Spleen,15.1,0.12915609776973724,Stable,PDGFRA,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,INS
P-0004639-T01-IM5,756.0,40.0,71.0,75.0,Non-Hispanic,11/21,Male,Spleen,15.1,0.12915609776973724,Stable,KIT,ONGOING,2.0,89.326,ALIVE,P-0004639,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.3707115650177,OTHER,Medical Therapy,765.3320497835499,UNKNOWN,18.5,INS
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Female,Not Applicable,4.0,0.14491252601146698,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,CR,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Female,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,700.0,SD,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Female,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.383137583732605,OTHER,Medical Therapy,671.1577186147184,UNKNOWN,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.14524464309215546,Stable,KIT,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,CR,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,KIT,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,700.0,SD,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,KIT,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.3831418752670288,OTHER,Medical Therapy,671.1577186147184,UNKNOWN,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.14524464309215546,Stable,TP53,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,CR,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,TP53,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,700.0,SD,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,TP53,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.3831418752670288,OTHER,Medical Therapy,671.1577186147184,UNKNOWN,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.14524464309215546,Stable,KIT;TP53,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,CR,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,KIT;TP53,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,700.0,SD,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,KIT;TP53,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.3831418752670288,OTHER,Medical Therapy,671.1577186147184,UNKNOWN,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.14524464309215546,Stable,KIT;PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,CR,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,KIT;PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,700.0,SD,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,KIT;PDGFRA,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.3831418752670288,OTHER,Medical Therapy,671.1577186147184,UNKNOWN,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.14524464309215546,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,120.0,CR,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,700.0,SD,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.3831418752670288,IMATINIB,Medical Therapy,671.1577186147184,UNKNOWN,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.14524464309215546,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,120.0,CR,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,700.0,SD,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.3831418752670288,REGORAFENIB,Medical Therapy,671.1577186147184,UNKNOWN,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.14524464309215546,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,CR,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,700.0,SD,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.3831418752670288,OTHER,Medical Therapy,671.1577186147184,UNKNOWN,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.14524464309215546,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,CR,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,700.0,SD,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.3831418752670288,OTHER,Medical Therapy,671.1577186147184,UNKNOWN,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.14524464309215546,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,CR,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,700.0,SD,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.3831418752670288,OTHER,Medical Therapy,671.1577186147184,UNKNOWN,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.14486993849277496,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,CR,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,700.0,SD,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.38316136598587036,OTHER,Medical Therapy,671.1577186147184,UNKNOWN,24.0,SNP
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.14524464309215546,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,CR,24.0,DEL
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,700.0,SD,24.0,DEL
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.3831418752670288,OTHER,Medical Therapy,671.1577186147184,UNKNOWN,24.0,DEL
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.14524464309215546,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,CR,24.0,INS
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,97.03266000000002,ALIVE,P-0004651,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,700.0,SD,24.0,INS
P-0004651-T01-IM5,589.0,50.0,25.0,28.0,Non-Hispanic,18/23,Male,Not Applicable,4.0,0.0,Stable,PDGFRA,NS,1.0,96.83508,ALIVE,P-0004651,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.3831418752670288,OTHER,Medical Therapy,671.1577186147184,UNKNOWN,24.0,INS
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Female,Not Applicable,16.0,0.4689357876777649,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Female,Not Applicable,16.0,0.42011505365371704,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Female,Not Applicable,16.0,0.37868624925613403,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Female,Not Applicable,16.0,0.4158526659011841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,16.0,0.4689357876777649,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,16.0,0.42011505365371704,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,16.0,0.37868624925613403,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,16.0,0.4158526659011841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Female,Not Applicable,16.0,0.836554229259491,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205127716064453,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,SNP
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Female,Not Applicable,16.0,0.836554229259491,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205127716064453,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Female,Not Applicable,16.0,0.836554229259491,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205127716064453,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,TP53,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,SNP
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,TP53,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,TP53,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,PDGFRA,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,SNP
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,PDGFRA,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,PDGFRA,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT;TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT;TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT;TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT;TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT;TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT;TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT;TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT;TP53,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT;TP53,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,SNP
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT;TP53,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT;TP53,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT;PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT;PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT;PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT;PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT;PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT;PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT;PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT;PDGFRA,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT;PDGFRA,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,SNP
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT;PDGFRA,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT;PDGFRA,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,-650.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,1187.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,121.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,587.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,SUNITINIB,Medical Therapy,633.5924636271457,UNKNOWN,17.9,SNP
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,SUNITINIB,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,SUNITINIB,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,-650.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,1187.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,121.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,587.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,REGORAFENIB,Medical Therapy,633.5924636271457,UNKNOWN,17.9,SNP
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,REGORAFENIB,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,REGORAFENIB,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Small Intestine,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Small Intestine,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Small Intestine,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Small Intestine,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Small Intestine,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Small Intestine,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Small Intestine,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Small Intestine,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,SNP
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Colon,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Colon,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Colon,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Colon,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Colon,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Colon,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Colon,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Colon,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,SNP
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Rectum,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Rectum,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Rectum,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Rectum,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Rectum,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Rectum,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Rectum,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Rectum,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,SNP
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.46899765729904175,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4201168119907379,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.37860584259033203,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.41603589057922363,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,SNP
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.46899765729904175,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4201168119907379,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.37860584259033203,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.41603589057922363,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8365271687507629,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.8205212354660034,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,SNP
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8365271687507629,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.8205212354660034,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8365271687507629,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.8205212354660034,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,DEL
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,INS
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,INS
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,INS
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,17/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,INS
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4691384434700012,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,-650.0,SD,17.9,INS
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4201117157936096,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1187.0,SD,17.9,INS
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.3788653612136841,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,121.0,NR,17.9,INS
P-0004760-T01-IM5,182.0,60.0,71.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.4160933196544647,Stable,KIT,ONGOING,1.0,90.674,DECEASED,P-0004760,NS,Neoadjuvant,Stomach,Gastric,White,29.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,NR,17.9,INS
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,INS
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,INS
P-0004760-T03-IM7,468.0,90.0,71.0,81.0,Non-Hispanic,11/21,Male,Not Applicable,16.0,0.8366881608963013,Stable,KIT,ONGOING,2.0,89.096,ALIVE,P-0004760,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.8205111026763916,OTHER,Medical Therapy,633.5924636271457,UNKNOWN,17.9,INS
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Male,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,0.0,Stable,KIT,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Male,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498170375823975,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,15.0,0.0,Stable,KIT,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498170375823975,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,KIT,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,KIT,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,TP53,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,TP53,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,TP53,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,TP53,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,PDGFRA,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,PDGFRA,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,PDGFRA,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,PDGFRA,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,KIT;TP53,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT;TP53,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,KIT;TP53,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT;TP53,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,KIT;PDGFRA,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT;PDGFRA,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,SUNITINIB,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,SUNITINIB,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,REGORAFENIB,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,REGORAFENIB,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Small Intestine,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Small Intestine,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Colon,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Colon,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Colon,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Colon,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Rectum,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Rectum,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Rectum,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Rectum,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Metastasis,Localized,1.3498320579528809,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,SNP
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Metastasis,Localized,1.3498320579528809,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,DEL
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,3/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,INS
P-0004776-T01-IM5,705.0,60.0,65.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,ONGOING,1.0,95.145,ALIVE,P-0004776,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,587.0,SD,3.0,INS
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,22/25,Female,Not Applicable,15.0,0.0,Stable,JAK1,ONGOING,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,INS
P-0004776-T01-IM5,705.0,60.0,65.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,15.0,0.0,Stable,KIT,NS,2.0,89.162,ALIVE,P-0004776,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3498342037200928,OTHER,Medical Therapy,645.8756566776135,UNKNOWN,3.0,INS
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Female,Liver,2.0,1.9482355117797852,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Female,Liver,2.0,1.946114420890808,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Female,Liver,2.0,1.7767518758773804,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Female,Liver,2.0,1.9482355117797852,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Female,Liver,2.0,1.946114420890808,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Female,Liver,2.0,1.7767518758773804,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Female,Liver,2.0,1.9482355117797852,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Female,Liver,2.0,1.946114420890808,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Female,Liver,2.0,1.7767518758773804,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,2.0,1.9277695417404175,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403732776641846,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,2.0,1.9277695417404175,Stable,RB1,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403732776641846,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,2.0,1.8767808675765991,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340391159057617,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,TP53,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,TP53,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,TP53,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,PDGFRA,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,PDGFRA,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,PDGFRA,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT;TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT;TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,KIT;TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,KIT;TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,KIT;TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT;TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT;TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT;TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT;TP53,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT;TP53,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT;TP53,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,KIT;TP53,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT;PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT;PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,KIT;PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,KIT;PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,KIT;PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT;PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT;PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT;PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT;PDGFRA,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT;PDGFRA,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT;PDGFRA,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,KIT;PDGFRA,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,IMATINIB,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,RB1,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,IMATINIB,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,IMATINIB,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,SUNITINIB,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,RB1,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,SUNITINIB,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,SUNITINIB,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,REGORAFENIB,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,RB1,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,REGORAFENIB,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,REGORAFENIB,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Stomach,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Stomach,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Stomach,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Stomach,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Stomach,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Stomach,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Stomach,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Stomach,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Stomach,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,RB1,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Small Intestine,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Small Intestine,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Small Intestine,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Small Intestine,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Small Intestine,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Small Intestine,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Small Intestine,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Small Intestine,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Small Intestine,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,RB1,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Colon,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Colon,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Colon,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Colon,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Colon,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Colon,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Colon,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Colon,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Colon,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,RB1,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Rectum,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Rectum,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Rectum,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Rectum,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Rectum,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Rectum,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Rectum,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Rectum,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Rectum,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,RB1,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9486949443817139,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9467265605926514,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.776898741722107,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9486949443817139,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9467265605926514,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.776898741722107,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9486949443817139,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9467265605926514,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.776898741722107,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.92804753780365,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,2.3403594493865967,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,SNP
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.92804753780365,Stable,RB1,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Primary,Localized,2.3403594493865967,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8770527839660645,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Localized,2.340376615524292,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,RB1,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,DEL
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,INS
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,INS
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.7768727540969849,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,INS
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9484070539474487,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,INS
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,20/27,Male,Liver,2.0,1.9463967084884644,Stable,RB1,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,INS
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,INS
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9484070539474487,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,191.0,NE,6.5,INS
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9463967084884644,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,60.0,NR,6.5,INS
P-0004784-T01-IM5,732.0,60.0,42.0,47.0,Non-Hispanic,17/21,Male,Liver,2.0,1.7768727540969849,Stable,KIT,ONGOING,1.0,18.674,DECEASED,P-0004784,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,43.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,975.0,SD,6.5,INS
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,INS
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.9279005527496338,Stable,RB1,NS,2.0,18.674,DECEASED,P-0004784,No,NS,Abdomen/Intraabdominal,Gastric,Black or African American,0.0,Recurrence,Metastasis,Localized,2.340364456176758,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,INS
P-0004784-T01-IM5,732.0,60.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,2.0,1.8768975734710693,Stable,KIT,NS,2.0,18.674,DECEASED,P-0004784,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Localized,2.3403820991516113,OTHER,Medical Therapy,408.2205068530149,UNKNOWN,6.5,INS
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Female,Pancreas,1.0,0.3744266629219055,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Female,Pancreas,1.0,0.5118280649185181,Stable,PDGFRA,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,DASATINIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Female,Pancreas,1.0,0.38126081228256226,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513304591178894,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.374558687210083,Stable,KIT,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5121746063232422,Stable,KIT,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,DASATINIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3811950087547302,Stable,KIT,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513162136077881,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.374558687210083,Stable,TP53,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5121746063232422,Stable,TP53,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,DASATINIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3811950087547302,Stable,TP53,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513162136077881,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.374558687210083,Stable,KIT;TP53,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5121746063232422,Stable,KIT;TP53,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,DASATINIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3811950087547302,Stable,KIT;TP53,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513162136077881,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.374558687210083,Stable,KIT;PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5121746063232422,Stable,KIT;PDGFRA,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,DASATINIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3811950087547302,Stable,KIT;PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513162136077881,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.374558687210083,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5121746063232422,Stable,PDGFRA,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3811950087547302,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513162136077881,SUNITINIB,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.374558687210083,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5121746063232422,Stable,PDGFRA,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3811950087547302,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513162136077881,REGORAFENIB,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.374558687210083,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Stomach,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5121746063232422,Stable,PDGFRA,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Stomach,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,DASATINIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3811950087547302,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513162136077881,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.374558687210083,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Small Intestine,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5121746063232422,Stable,PDGFRA,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Small Intestine,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,DASATINIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3811950087547302,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513162136077881,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.374558687210083,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Colon,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5121746063232422,Stable,PDGFRA,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Colon,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,DASATINIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3811950087547302,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513162136077881,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.374558687210083,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Rectum,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5121746063232422,Stable,PDGFRA,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Rectum,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,DASATINIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3811950087547302,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513162136077881,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.37456488609313965,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1188.0,SD,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5126290917396545,Stable,PDGFRA,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Primary,Metastatic,0.0,DASATINIB,Medical Therapy,31.0,NR,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3813912272453308,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.35132473707199097,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,SNP
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.374558687210083,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1188.0,SD,21.0,DEL
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5121746063232422,Stable,PDGFRA,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,DASATINIB,Medical Therapy,31.0,NR,21.0,DEL
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3811950087547302,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513162136077881,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,DEL
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.374558687210083,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1188.0,SD,21.0,INS
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.5121746063232422,Stable,PDGFRA,ONGOING,1.0,11.112,DECEASED,P-0004828,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,7.0,Recurrence,Metastasis,Metastatic,0.0,DASATINIB,Medical Therapy,31.0,NR,21.0,INS
P-0004828-T02-IM5,625.0,80.0,75.0,80.0,Non-Hispanic,18/23,Male,Pancreas,1.0,0.3811950087547302,Stable,PDGFRA,NS,1.0,11.112,DECEASED,P-0004828,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.3513162136077881,OTHER,Medical Therapy,564.5330595238094,UNKNOWN,21.0,INS
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,75.0,2.1209497451782227,Stable,KIT,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,DEL
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Male,Not Applicable,75.0,2.1209497451782227,Stable,TBX3,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Male,Not Applicable,75.0,2.1209497451782227,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Male,Peritoneum,75.0,2.0679500102996826,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592151165008545,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,DEL
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Male,Peritoneum,75.0,2.0679500102996826,Stable,TBX3,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592151165008545,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Male,Peritoneum,75.0,2.0679500102996826,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592151165008545,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Male,Peritoneum,75.0,2.0679500102996826,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592151165008545,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Male,Peritoneum,75.0,2.0679500102996826,Stable,PMS2,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592151165008545,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Male,Peritoneum,75.0,2.0226492881774902,Stable,MALT1,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592149257659912,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.120783567428589,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,DEL
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.120783567428589,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.120783567428589,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,DEL
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.022545099258423,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592169284820557,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.120783567428589,Stable,PDGFRA,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,DEL
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.120783567428589,Stable,PDGFRA,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.120783567428589,Stable,PDGFRA,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,PDGFRA,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,DEL
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,PDGFRA,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,PDGFRA,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.067822217941284,Stable,PDGFRA,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,PDGFRA,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.022545099258423,Stable,PDGFRA,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592169284820557,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT;TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,DEL
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT;TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT;TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT;TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,DEL
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT;TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT;TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT;TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT;TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.022545099258423,Stable,KIT;TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592169284820557,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT;PDGFRA,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,DEL
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT;PDGFRA,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT;PDGFRA,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT;PDGFRA,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,DEL
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT;PDGFRA,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT;PDGFRA,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT;PDGFRA,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT;PDGFRA,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.022545099258423,Stable,KIT;PDGFRA,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592169284820557,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,618.0,SD,10.0,DEL
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.120783567428589,Stable,TBX3,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.120783567428589,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,SUNITINIB,Medical Therapy,452.3393186250667,UNKNOWN,10.0,DEL
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,TBX3,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,SUNITINIB,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,SUNITINIB,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,SUNITINIB,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,PMS2,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,SUNITINIB,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.022545099258423,Stable,MALT1,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592169284820557,SUNITINIB,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,618.0,SD,10.0,DEL
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.120783567428589,Stable,TBX3,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.120783567428589,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,REGORAFENIB,Medical Therapy,452.3393186250667,UNKNOWN,10.0,DEL
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,TBX3,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,REGORAFENIB,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,REGORAFENIB,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,REGORAFENIB,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,PMS2,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,REGORAFENIB,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.022545099258423,Stable,MALT1,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592169284820557,REGORAFENIB,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,DEL
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.120783567428589,Stable,TBX3,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.120783567428589,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,DEL
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,TBX3,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,PMS2,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.022545099258423,Stable,MALT1,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Stomach,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592169284820557,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,DEL
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.120783567428589,Stable,TBX3,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.120783567428589,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,DEL
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,TBX3,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,PMS2,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.022545099258423,Stable,MALT1,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Colon,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592169284820557,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,DEL
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.120783567428589,Stable,TBX3,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.120783567428589,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,DEL
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,TBX3,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,PMS2,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.022545099258423,Stable,MALT1,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Rectum,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592169284820557,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.120770215988159,Stable,KIT,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,DEL
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.120770215988159,Stable,TBX3,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.120770215988159,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,DEL
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,TBX3,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,PMS2,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.022545099258423,Stable,MALT1,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592169284820557,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.120783567428589,Stable,TBX3,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.120783567428589,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,TBX3,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,PMS2,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.022545099258423,Stable,MALT1,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592169284820557,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,SNP
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,75.0,2.120783567428589,Stable,KIT,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,INS
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/8,Female,Not Applicable,75.0,2.120783567428589,Stable,TBX3,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,INS
P-0004883-T01-IM5,205.0,80.0,48.0,48.0,Non-Hispanic,7/11,Female,Not Applicable,75.0,2.120783567428589,Stable,TP53,ONGOING,1.0,51.353,DECEASED,P-0004883,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,10.0,INS
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,INS
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,TBX3,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,INS
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,11/21,Female,Peritoneum,75.0,2.067822217941284,Stable,KIT,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,INS
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,6/11,Female,Peritoneum,75.0,2.067822217941284,Stable,TP53,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,INS
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.067822217941284,Stable,PMS2,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592170715332031,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,INS
P-0004883-T03-IM6,823.0,60.0,48.0,53.0,Non-Hispanic,7/8,Female,Peritoneum,75.0,2.022545099258423,Stable,MALT1,NS,2.0,51.353,DECEASED,P-0004883,No,Neoadjuvant,Small Intestine,Small Intestine,Black or African American,0.0,Recurrence,Metastasis,Metastatic,4.592169284820557,OTHER,Medical Therapy,452.3393186250667,UNKNOWN,10.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Female,Not Applicable,20.0,1.7087621688842773,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,1.7895417213439941,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Female,Not Applicable,20.0,1.7895417213439941,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Female,Not Applicable,20.0,1.8347914218902588,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Female,Not Applicable,20.0,1.8445485830307007,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Female,Not Applicable,20.0,1.708599328994751,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Female,Not Applicable,20.0,1.7036162614822388,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,1.8445485830307007,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,1.8347914218902588,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,1.7087621688842773,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Female,Not Applicable,20.0,1.708599328994751,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,1.708599328994751,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,1.7036162614822388,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Female,Not Applicable,20.0,1.7036162614822388,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Female,Not Applicable,20.0,1.7087621688842773,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Female,Not Applicable,20.0,1.8445485830307007,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Female,Not Applicable,20.0,1.8347914218902588,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Female,Not Applicable,20.0,1.7895417213439941,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,1.5161622762680054,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354942321777344,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Female,Not Applicable,20.0,1.5161622762680054,Stable,FBXW7,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354942321777344,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,TP53,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,TP53,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,TP53,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,TP53,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,TP53,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,TP53,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,PDGFRA,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,PDGFRA,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,PDGFRA,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,PDGFRA,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,PDGFRA,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,PDGFRA,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT;TP53,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT;TP53,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT;TP53,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT;TP53,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT;TP53,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT;TP53,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT;TP53,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT;PDGFRA,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT;PDGFRA,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT;PDGFRA,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT;PDGFRA,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT;PDGFRA,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT;PDGFRA,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT;PDGFRA,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,IMATINIB,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,FBXW7,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,IMATINIB,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,SUNITINIB,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,FBXW7,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,SUNITINIB,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,REGORAFENIB,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,FBXW7,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,REGORAFENIB,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Stomach,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,FBXW7,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Small Intestine,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,FBXW7,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Colon,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,FBXW7,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Rectum,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,FBXW7,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085809707641602,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.78964102268219,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.78964102268219,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8346025943756104,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.844480276107788,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.708417296409607,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7035843133926392,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.844480276107788,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8346025943756104,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085809707641602,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.708417296409607,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.708417296409607,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7035843133926392,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7035843133926392,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085809707641602,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.844480276107788,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8346025943756104,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.78964102268219,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,INS
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.5161852836608887,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1354889869689941,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.5161852836608887,Stable,FBXW7,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1354889869689941,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,INS
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,FBXW7,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,SNP
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7897156476974487,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.8448512554168701,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.834952473640442,Stable,KIT,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7087211608886719,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7085604667663574,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7085604667663574,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.7037168741226196,Stable,KIT,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7037168741226196,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,608.0,NR,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.7087211608886719,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,456.0,CR,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.8448512554168701,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,151.0,CR,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.834952473640442,Stable,FBXW7,ONGOING,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,NE,24.0,DEL
P-0004937-T01-IM5,470.0,60.0,57.0,62.0,Non-Hispanic,3/12,Male,Not Applicable,20.0,1.7897156476974487,Stable,FBXW7,NS,1.0,87.09,ALIVE,P-0004937,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,13.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,274.0,NE,24.0,DEL
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,1.516336441040039,Stable,KIT,NS,2.0,87.09,ALIVE,P-0004937,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,DEL
P-0004937-T03-IM6,677.0,60.0,57.0,66.0,Non-Hispanic,10/12,Male,Not Applicable,20.0,1.516336441040039,Stable,FBXW7,NS,2.0,87.09,ALIVE,P-0004937,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.1354773044586182,OTHER,Medical Therapy,361.5628534693193,UNKNOWN,24.0,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,0.0,1.0608896017074585,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.3317456245422363,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,0.0,1.073160171508789,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,0.0,1.1980615854263306,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Male,Not Applicable,0.0,1.210789680480957,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Male,Not Applicable,0.0,1.2096130847930908,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Male,Not Applicable,0.0,1.1980615854263306,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Male,Not Applicable,0.0,1.073160171508789,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Male,Not Applicable,0.0,1.2086637020111084,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,0.0,1.2096130847930908,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,0.0,1.210789680480957,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Male,Not Applicable,0.0,1.0608896017074585,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.3317456245422363,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Male,Not Applicable,0.0,1.2086637020111084,Stable,TRAF7,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,0.0,1.0608896017074585,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.3317456245422363,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Male,Not Applicable,0.0,1.210789680480957,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Male,Not Applicable,0.0,1.2096130847930908,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Male,Not Applicable,0.0,1.1980615854263306,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Male,Not Applicable,0.0,1.073160171508789,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,0.0,1.2086637020111084,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,TP53,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,TP53,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,TP53,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,PDGFRA,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,PDGFRA,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,PDGFRA,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT;TP53,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT;TP53,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT;TP53,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT;TP53,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT;PDGFRA,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT;PDGFRA,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT;PDGFRA,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT;PDGFRA,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,IMATINIB,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,IMATINIB,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,TRAF7,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,IMATINIB,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,SUNITINIB,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,SUNITINIB,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,TRAF7,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,SUNITINIB,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,REGORAFENIB,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,REGORAFENIB,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,TRAF7,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,REGORAFENIB,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,TRAF7,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,TRAF7,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,TRAF7,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0607985258102417,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.331760883331299,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0607985258102417,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.331760883331299,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,TRAF7,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0607985258102417,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,2.331760883331299,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,SNP
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,SNP
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,TRAF7,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,DEL
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,DEL
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,DEL
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,INS
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,INS
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,INS
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,INS
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,INS
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.197956919670105,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,INS
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.073179841041565,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,INS
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,INS
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,INS
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,INS
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,TRAF7,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,INS
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,21/21,Female,Not Applicable,0.0,1.208264708518982,Stable,TRAF7,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,INS
P-0005330-T02-IM5,682.0,57.8,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.0609585046768188,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,2.331763744354248,OTHER,Medical Therapy,617.264905505621,UNKNOWN,9.6,INS
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2105098962783813,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,120.0,NR,9.6,INS
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.2092804908752441,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,92.0,NE,9.6,INS
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.197956919670105,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,242.0,NR,9.6,INS
P-0005330-T02-IM5,682.0,57.9,46.0,53.0,Non-Hispanic,13/21,Female,Not Applicable,0.0,1.073179841041565,Stable,KIT,NS,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1735.0,SD,9.6,INS
P-0005330-T02-IM5,682.0,57.6,46.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.208264708518982,Stable,KIT,UNKNOWN,1.0,4.241,DECEASED,P-0005330,NS,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1.0,NE,9.6,INS
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Male,Not Applicable,2.0,0.0,Stable,SDHA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Male,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Male,Not Applicable,2.0,0.0,Stable,ARID2,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Male,Liver,2.0,0.0,Stable,SDHA,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21711421012878418,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,KIT,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,KIT,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,KIT,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,KIT,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,TP53,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,PDGFRA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,PDGFRA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,PDGFRA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,PDGFRA,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,KIT;TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,KIT;TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,KIT;TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,KIT;TP53,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,KIT;PDGFRA,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,SDHA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,ARID2,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,SDHA,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,SUNITINIB,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,SDHA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,ARID2,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,SDHA,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,REGORAFENIB,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,SDHA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Small Intestine,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Small Intestine,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,ARID2,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Small Intestine,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,SDHA,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,SDHA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Colon,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Colon,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,ARID2,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Colon,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,SDHA,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,SDHA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Rectum,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Rectum,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,ARID2,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Rectum,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,SDHA,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,SDHA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,ARID2,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,SNP
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,SDHA,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,SNP
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,SDHA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,DEL
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,DEL
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,ARID2,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,DEL
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,SDHA,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,DEL
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,8/15,Female,Not Applicable,2.0,0.0,Stable,SDHA,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,INS
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,3/11,Female,Not Applicable,2.0,0.0,Stable,TP53,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,INS
P-0005379-T01-IM5,554.0,80.0,27.0,34.0,Non-Hispanic,15/21,Female,Not Applicable,2.0,0.0,Stable,ARID2,ONGOING,1.0,94.159,ALIVE,P-0005379,NS,NS,Stomach,Gastric,White,46.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1134.0,SD,10.0,INS
P-0005379-T02-IM6,391.0,70.0,27.0,39.0,Non-Hispanic,2/15,Female,Liver,2.0,0.0,Stable,SDHA,NS,2.0,86.794,ALIVE,P-0005379,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.21712040901184082,OTHER,Medical Therapy,1700.379751276501,UNKNOWN,10.0,INS
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Female,Not Applicable,1.0,0.0,Stable,PDGFRA,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Stomach,Gastric,White,59.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Female,Not Applicable,1.0,0.0,Stable,PDGFRA,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3699532747268677,OTHER,Medical Therapy,428.5590000029211,UNKNOWN,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,KIT,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Stomach,Gastric,White,59.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,KIT,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.36994320154190063,OTHER,Medical Therapy,428.5590000029211,UNKNOWN,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,TP53,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Stomach,Gastric,White,59.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,TP53,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.36994320154190063,OTHER,Medical Therapy,428.5590000029211,UNKNOWN,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,KIT;TP53,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Stomach,Gastric,White,59.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,KIT;TP53,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.36994320154190063,OTHER,Medical Therapy,428.5590000029211,UNKNOWN,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Stomach,Gastric,White,59.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,KIT;PDGFRA,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.36994320154190063,OTHER,Medical Therapy,428.5590000029211,UNKNOWN,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Stomach,Gastric,White,59.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,31.0,NR,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.36994320154190063,SUNITINIB,Medical Therapy,428.5590000029211,UNKNOWN,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Stomach,Gastric,White,59.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,31.0,NR,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.36994320154190063,REGORAFENIB,Medical Therapy,428.5590000029211,UNKNOWN,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Small Intestine,Gastric,White,59.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,0.36994320154190063,OTHER,Medical Therapy,428.5590000029211,UNKNOWN,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Colon,Gastric,White,59.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,0.36994320154190063,OTHER,Medical Therapy,428.5590000029211,UNKNOWN,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Rectum,Gastric,White,59.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,0.36994320154190063,OTHER,Medical Therapy,428.5590000029211,UNKNOWN,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Stomach,Gastric,White,59.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.3699498176574707,OTHER,Medical Therapy,428.5590000029211,UNKNOWN,15.0,SNP
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Stomach,Gastric,White,59.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,15.0,DEL
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.36994320154190063,OTHER,Medical Therapy,428.5590000029211,UNKNOWN,15.0,DEL
P-0005481-T01-IM5,830.0,70.0,45.0,45.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,ONGOING,1.0,92.252,ALIVE,P-0005481,NS,Neoadjuvant,Stomach,Gastric,White,59.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,NR,15.0,INS
P-0005481-T01-IM5,830.0,70.0,45.0,46.0,Non-Hispanic,18/23,Male,Not Applicable,1.0,0.0,Stable,PDGFRA,NS,2.0,86.038,ALIVE,P-0005481,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.36994320154190063,OTHER,Medical Therapy,428.5590000029211,UNKNOWN,15.0,INS
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Female,Not Applicable,1.0,0.16031363606452942,Stable,MCL1,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.16031363606452942,Stable,KIT,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Female,Not Applicable,1.0,0.21277491748332977,Stable,MCL1,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649868965148926,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.21277491748332977,Stable,KIT,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649868965148926,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16041651368141174,Stable,TP53,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16041651368141174,Stable,TP53,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21284909546375275,Stable,TP53,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21284909546375275,Stable,TP53,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16041651368141174,Stable,PDGFRA,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16041651368141174,Stable,PDGFRA,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21284909546375275,Stable,PDGFRA,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21284909546375275,Stable,PDGFRA,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT;TP53,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT;TP53,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT;TP53,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT;TP53,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT;PDGFRA,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT;PDGFRA,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT;PDGFRA,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT;PDGFRA,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16041651368141174,Stable,MCL1,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21284909546375275,Stable,MCL1,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,SUNITINIB,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,SUNITINIB,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16041651368141174,Stable,MCL1,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21284909546375275,Stable,MCL1,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,REGORAFENIB,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,REGORAFENIB,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16041651368141174,Stable,MCL1,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Small Intestine,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Small Intestine,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21284909546375275,Stable,MCL1,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16041651368141174,Stable,MCL1,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Colon,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Colon,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21284909546375275,Stable,MCL1,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16041651368141174,Stable,MCL1,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Rectum,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Rectum,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21284909546375275,Stable,MCL1,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16018663346767426,Stable,MCL1,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16018663346767426,Stable,KIT,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21267978847026825,Stable,MCL1,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3649916648864746,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,DEL
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21267978847026825,Stable,KIT,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3649916648864746,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16041651368141174,Stable,MCL1,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21284909546375275,Stable,MCL1,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,SNP
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.16041651368141174,Stable,MCL1,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,INS
P-0005505-T01-IM5,1005.0,60.0,52.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.16041651368141174,Stable,KIT,ONGOING,1.0,4.175,ALIVE,P-0005505,NS,Neoadjuvant,Stomach,Gastric,White,40.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,SD,1.4,INS
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,1/3,Male,Not Applicable,1.0,0.21284909546375275,Stable,MCL1,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,INS
P-0005505-T01-IM5,1005.0,60.0,52.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.21284909546375275,Stable,KIT,ONGOING,2.0,4.175,ALIVE,P-0005505,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3649842739105225,OTHER,Medical Therapy,392.32186904761903,UNKNOWN,1.4,INS
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,0.264352023601532,Stable,KIT,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Male,Not Applicable,20.0,0.264352023601532,Stable,PIK3CA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,0.3703654408454895,Stable,PIK3CA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.358211874961853,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Male,Not Applicable,20.0,0.3703654408454895,Stable,KIT,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.358211874961853,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,TP53,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,TP53,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,TP53,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,TP53,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,PDGFRA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,PDGFRA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,PDGFRA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,PDGFRA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,KIT;TP53,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,KIT;TP53,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,KIT;TP53,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,KIT;TP53,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,KIT;PDGFRA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,KIT;PDGFRA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,KIT;PDGFRA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,KIT;PDGFRA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,KIT,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,1073.0,SD,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,PIK3CA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,PIK3CA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,SUNITINIB,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,KIT,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,SUNITINIB,Medical Therapy,650.6811879160043,UNKNOWN,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,KIT,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,1073.0,SD,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,PIK3CA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,PIK3CA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,REGORAFENIB,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,KIT,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,REGORAFENIB,Medical Therapy,650.6811879160043,UNKNOWN,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,KIT,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Small Intestine,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,PIK3CA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Small Intestine,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,PIK3CA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,KIT,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,KIT,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Colon,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,PIK3CA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Colon,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,PIK3CA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,KIT,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,KIT,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Rectum,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,PIK3CA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Rectum,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,PIK3CA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,KIT,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.2642800807952881,Stable,KIT,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.2642800807952881,Stable,PIK3CA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3702862858772278,Stable,PIK3CA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.35823392868042,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3702862858772278,Stable,KIT,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.35823392868042,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,DEL
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,KIT,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,PIK3CA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,PIK3CA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,KIT,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,SNP
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,KIT,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,INS
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,21/21,Female,Not Applicable,20.0,0.2643016576766968,Stable,PIK3CA,ONGOING,1.0,86.236,ALIVE,P-0005605,NS,Neoadjuvant,Stomach,Gastric,White,68.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1073.0,SD,3.6,INS
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,PIK3CA,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,INS
P-0005605-T01-IM5,1005.0,60.0,44.0,46.0,Non-Hispanic,11/21,Female,Not Applicable,20.0,0.3703513443470001,Stable,KIT,NS,1.0,86.236,ALIVE,P-0005605,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3582284450531006,OTHER,Medical Therapy,650.6811879160043,UNKNOWN,3.6,INS
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Female,Not Applicable,41.0,0.5680400133132935,Stable,KIT,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Female,Not Applicable,41.0,0.5680400133132935,Stable,SPEN,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Female,Not Applicable,41.0,0.602274477481842,Stable,KIT,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582227230072021,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Female,Not Applicable,41.0,0.602274477481842,Stable,SPEN,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582227230072021,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.5681519508361816,Stable,TP53,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.5681519508361816,Stable,TP53,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,TP53,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,TP53,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.5681519508361816,Stable,PDGFRA,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.5681519508361816,Stable,PDGFRA,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,PDGFRA,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,PDGFRA,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.5681519508361816,Stable,KIT;TP53,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.5681519508361816,Stable,KIT;TP53,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,KIT;TP53,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,KIT;TP53,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.5681519508361816,Stable,KIT;PDGFRA,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.5681519508361816,Stable,KIT;PDGFRA,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,KIT;PDGFRA,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,KIT;PDGFRA,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.5681519508361816,Stable,KIT,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,526.0,NE,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.5681519508361816,Stable,SPEN,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,KIT,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,SUNITINIB,Medical Therapy,566.6514901644359,UNKNOWN,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,SPEN,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,SUNITINIB,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.5681519508361816,Stable,KIT,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,526.0,NE,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.5681519508361816,Stable,SPEN,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,KIT,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,REGORAFENIB,Medical Therapy,566.6514901644359,UNKNOWN,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,SPEN,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,REGORAFENIB,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.5681519508361816,Stable,KIT,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Stomach,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.5681519508361816,Stable,SPEN,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Stomach,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,KIT,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,SPEN,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.5681519508361816,Stable,KIT,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Colon,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.5681519508361816,Stable,SPEN,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Colon,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,KIT,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,SPEN,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Colon,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.5681519508361816,Stable,KIT,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Rectum,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.5681519508361816,Stable,SPEN,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Rectum,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,KIT,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,SPEN,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.5680597424507141,Stable,KIT,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Small Intestine,Small Bowel,White,60.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.5680597424507141,Stable,SPEN,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Small Intestine,Small Bowel,White,60.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6021659970283508,Stable,KIT,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.358203411102295,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,DEL
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6021659970283508,Stable,SPEN,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,1.358203411102295,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.5681519508361816,Stable,KIT,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.5681519508361816,Stable,SPEN,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,KIT,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,SPEN,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,SNP
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.5681519508361816,Stable,KIT,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,Neoadjuvant,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,INS
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,4/15,Male,Not Applicable,41.0,0.5681519508361816,Stable,SPEN,ONGOING,1.0,92.022,ALIVE,P-0005626,NS,NS,Small Intestine,Small Bowel,White,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,10.5,INS
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,KIT,NS,1.0,84.92,ALIVE,P-0005626,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,INS
P-0005626-T02-IM5,846.0,60.0,61.0,62.0,Non-Hispanic,11/21,Male,Not Applicable,41.0,0.6022810339927673,Stable,SPEN,NS,1.0,84.92,ALIVE,P-0005626,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,1.3582038879394531,OTHER,Medical Therapy,566.6514901644359,UNKNOWN,10.5,INS
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Male,Not Applicable,47.0,0.8934526443481445,Stable,KIT,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Male,Not Applicable,47.0,0.8934526443481445,Stable,ARID1A,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Male,Not Applicable,47.0,0.8934526443481445,Stable,RECQL4,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Male,Not Applicable,47.0,0.934213399887085,Stable,RECQL4,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.304013252258301,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Male,Not Applicable,47.0,0.934213399887085,Stable,KIT,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.304013252258301,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Male,Not Applicable,47.0,0.934213399887085,Stable,ARID1A,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.304013252258301,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.8934789299964905,Stable,TP53,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,0.8934789299964905,Stable,TP53,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.8934789299964905,Stable,TP53,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.9342597723007202,Stable,TP53,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.9342597723007202,Stable,TP53,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,0.9342597723007202,Stable,TP53,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.8934789299964905,Stable,PDGFRA,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,0.8934789299964905,Stable,PDGFRA,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.8934789299964905,Stable,PDGFRA,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.9342597723007202,Stable,PDGFRA,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.9342597723007202,Stable,PDGFRA,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,0.9342597723007202,Stable,PDGFRA,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT;TP53,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT;TP53,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT;TP53,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT;TP53,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT;TP53,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT;TP53,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT;PDGFRA,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT;PDGFRA,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT;PDGFRA,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT;PDGFRA,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT;PDGFRA,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT;PDGFRA,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,0.8934789299964905,Stable,ARID1A,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.8934789299964905,Stable,RECQL4,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.9342597723007202,Stable,RECQL4,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,SUNITINIB,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,SUNITINIB,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,0.9342597723007202,Stable,ARID1A,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,SUNITINIB,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,0.8934789299964905,Stable,ARID1A,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.8934789299964905,Stable,RECQL4,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.9342597723007202,Stable,RECQL4,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,REGORAFENIB,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,REGORAFENIB,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,0.9342597723007202,Stable,ARID1A,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,REGORAFENIB,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Small Intestine,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,0.8934789299964905,Stable,ARID1A,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Small Intestine,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.8934789299964905,Stable,RECQL4,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Small Intestine,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.9342597723007202,Stable,RECQL4,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,0.9342597723007202,Stable,ARID1A,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Colon,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,0.8934789299964905,Stable,ARID1A,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Colon,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.8934789299964905,Stable,RECQL4,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Colon,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.9342597723007202,Stable,RECQL4,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,0.9342597723007202,Stable,ARID1A,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Rectum,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,0.8934789299964905,Stable,ARID1A,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Rectum,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.8934789299964905,Stable,RECQL4,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Rectum,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.9342597723007202,Stable,RECQL4,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,0.9342597723007202,Stable,ARID1A,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.8933209180831909,Stable,KIT,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,0.8933209180831909,Stable,ARID1A,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.8933209180831909,Stable,RECQL4,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.9341107606887817,Stable,RECQL4,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.304027795791626,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.9341107606887817,Stable,KIT,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.304027795791626,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,0.9341107606887817,Stable,ARID1A,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,2.304027795791626,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,DEL
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,0.8934789299964905,Stable,ARID1A,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.8934789299964905,Stable,RECQL4,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.9342597723007202,Stable,RECQL4,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,0.9342597723007202,Stable,ARID1A,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,SNP
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.8934789299964905,Stable,KIT,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,INS
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,11/20,Female,Not Applicable,47.0,0.8934789299964905,Stable,ARID1A,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,INS
P-0005737-T02-IM5,678.0,90.0,84.0,83.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.8934789299964905,Stable,RECQL4,ONGOING,1.0,82.257,ALIVE,P-0005737,NS,NS,Stomach,Gastric,White,53.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,6.0,INS
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,5/22,Female,Not Applicable,47.0,0.9342597723007202,Stable,RECQL4,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,INS
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,11/21,Female,Not Applicable,47.0,0.9342597723007202,Stable,KIT,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,INS
P-0005737-T02-IM5,678.0,90.0,84.0,84.0,Non-Hispanic,1/20,Female,Not Applicable,47.0,0.9342597723007202,Stable,ARID1A,ONGOING,2.0,82.257,ALIVE,P-0005737,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,2.3040294647216797,OTHER,Medical Therapy,537.9308723257419,UNKNOWN,6.0,INS
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Female,Not Applicable,6.0,0.06396742165088654,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Stomach,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Female,Not Applicable,6.0,0.1537870615720749,Stable,KIT,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.35915428400039673,OTHER,Medical Therapy,433.4452869075371,UNKNOWN,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.06406687200069427,Stable,TP53,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Stomach,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.15389922261238098,Stable,TP53,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.35914701223373413,OTHER,Medical Therapy,433.4452869075371,UNKNOWN,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.06406687200069427,Stable,PDGFRA,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Stomach,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.15389922261238098,Stable,PDGFRA,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.35914701223373413,OTHER,Medical Therapy,433.4452869075371,UNKNOWN,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.06406687200069427,Stable,KIT;TP53,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Stomach,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.15389922261238098,Stable,KIT;TP53,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.35914701223373413,OTHER,Medical Therapy,433.4452869075371,UNKNOWN,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.06406687200069427,Stable,KIT;PDGFRA,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Stomach,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.15389922261238098,Stable,KIT;PDGFRA,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.35914701223373413,OTHER,Medical Therapy,433.4452869075371,UNKNOWN,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.06406687200069427,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Stomach,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,526.0,NE,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.15389922261238098,Stable,KIT,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.35914701223373413,SUNITINIB,Medical Therapy,433.4452869075371,UNKNOWN,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.06406687200069427,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Stomach,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,526.0,NE,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.15389922261238098,Stable,KIT,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.35914701223373413,REGORAFENIB,Medical Therapy,433.4452869075371,UNKNOWN,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.06406687200069427,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Small Intestine,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.15389922261238098,Stable,KIT,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Small Intestine,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.35914701223373413,OTHER,Medical Therapy,433.4452869075371,UNKNOWN,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.06406687200069427,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Colon,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.15389922261238098,Stable,KIT,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Colon,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.35914701223373413,OTHER,Medical Therapy,433.4452869075371,UNKNOWN,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.06406687200069427,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Rectum,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.15389922261238098,Stable,KIT,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Rectum,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.35914701223373413,OTHER,Medical Therapy,433.4452869075371,UNKNOWN,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.06391580402851105,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Stomach,Gastric,Asian,58.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.1537562757730484,Stable,KIT,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Metastasis,Localized,0.3591521978378296,OTHER,Medical Therapy,433.4452869075371,UNKNOWN,7.0,DEL
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.06406687200069427,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Stomach,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,7.0,SNP
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.15389922261238098,Stable,KIT,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.35914701223373413,OTHER,Medical Therapy,433.4452869075371,UNKNOWN,7.0,SNP
P-0005780-T01-IM5,793.0,80.0,48.0,48.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.06406687200069427,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0005780,NS,NS,Stomach,Gastric,Asian,58.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,526.0,NE,7.0,INS
P-0005780-T01-IM5,793.0,80.0,48.0,49.0,Non-Hispanic,11/21,Male,Not Applicable,6.0,0.15389922261238098,Stable,KIT,NS,2.0,64.011,ALIVE,P-0005780,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.35914701223373413,OTHER,Medical Therapy,433.4452869075371,UNKNOWN,7.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Female,Liver,4.0,0.9026343822479248,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Female,Liver,4.0,0.7587850689888,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Female,Liver,4.0,0.8968833684921265,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Female,Liver,4.0,0.8968833684921265,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Female,Liver,4.0,0.7587850689888,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Female,Liver,4.0,0.9026343822479248,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Female,Liver,4.0,0.9042543172836304,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Female,Liver,4.0,0.9026343822479248,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Female,Liver,4.0,0.8968833684921265,Stable,MGA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Female,Liver,4.0,0.7587850689888,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Female,Liver,4.0,0.9042543172836304,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Female,Liver,4.0,0.9026343822479248,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Female,Liver,4.0,0.8968833684921265,Stable,PTEN,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Female,Liver,4.0,0.9042543172836304,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Female,Liver,4.0,0.7587850689888,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Female,Liver,4.0,0.9042543172836304,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Female,Liver,4.0,0.6896873116493225,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.7139532566070557,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Female,Liver,4.0,0.6896873116493225,Stable,PTEN,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.7139532566070557,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Female,Liver,4.0,0.6896873116493225,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.7139532566070557,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Female,Liver,4.0,0.6896873116493225,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.7139532566070557,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Female,Liver,4.0,0.6444875001907349,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.7139618396759033,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6445720195770264,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.713951587677002,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.90291428565979,Stable,TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7587270736694336,Stable,TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8969548344612122,Stable,TP53,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8969548344612122,Stable,TP53,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7587270736694336,Stable,TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.90291428565979,Stable,TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9044747948646545,Stable,TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.90291428565979,Stable,TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8969548344612122,Stable,TP53,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7587270736694336,Stable,TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9044747948646545,Stable,TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.90291428565979,Stable,TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8969548344612122,Stable,TP53,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9044747948646545,Stable,TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7587270736694336,Stable,TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9044747948646545,Stable,TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,TP53,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6897907257080078,Stable,TP53,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,TP53,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,TP53,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6445720195770264,Stable,TP53,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.713951587677002,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.90291428565979,Stable,PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7587270736694336,Stable,PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8969548344612122,Stable,PDGFRA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8969548344612122,Stable,PDGFRA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7587270736694336,Stable,PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.90291428565979,Stable,PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9044747948646545,Stable,PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.90291428565979,Stable,PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8969548344612122,Stable,PDGFRA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7587270736694336,Stable,PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9044747948646545,Stable,PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.90291428565979,Stable,PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8969548344612122,Stable,PDGFRA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9044747948646545,Stable,PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7587270736694336,Stable,PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9044747948646545,Stable,PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,PDGFRA,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6897907257080078,Stable,PDGFRA,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,PDGFRA,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,PDGFRA,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6445720195770264,Stable,PDGFRA,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.713951587677002,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.90291428565979,Stable,KIT;TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7587270736694336,Stable,KIT;TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT;TP53,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT;TP53,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT;TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.90291428565979,Stable,KIT;TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9044747948646545,Stable,KIT;TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.90291428565979,Stable,KIT;TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8969548344612122,Stable,KIT;TP53,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT;TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT;TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.90291428565979,Stable,KIT;TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8969548344612122,Stable,KIT;TP53,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9044747948646545,Stable,KIT;TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7587270736694336,Stable,KIT;TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT;TP53,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT;TP53,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6897907257080078,Stable,KIT;TP53,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT;TP53,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT;TP53,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6445720195770264,Stable,KIT;TP53,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.713951587677002,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.90291428565979,Stable,KIT;PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7587270736694336,Stable,KIT;PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT;PDGFRA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT;PDGFRA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT;PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.90291428565979,Stable,KIT;PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9044747948646545,Stable,KIT;PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.90291428565979,Stable,KIT;PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8969548344612122,Stable,KIT;PDGFRA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT;PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT;PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.90291428565979,Stable,KIT;PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8969548344612122,Stable,KIT;PDGFRA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9044747948646545,Stable,KIT;PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7587270736694336,Stable,KIT;PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT;PDGFRA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT;PDGFRA,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6897907257080078,Stable,KIT;PDGFRA,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT;PDGFRA,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT;PDGFRA,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6445720195770264,Stable,KIT;PDGFRA,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.713951587677002,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.90291428565979,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7587270736694336,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9044747948646545,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.90291428565979,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8969548344612122,Stable,MGA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8969548344612122,Stable,PTEN,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9044747948646545,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7587270736694336,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,SUNITINIB,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6897907257080078,Stable,PTEN,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,SUNITINIB,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,SUNITINIB,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,SUNITINIB,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6445720195770264,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.713951587677002,SUNITINIB,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.90291428565979,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7587270736694336,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9044747948646545,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.90291428565979,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8969548344612122,Stable,MGA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8969548344612122,Stable,PTEN,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9044747948646545,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7587270736694336,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,REGORAFENIB,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6897907257080078,Stable,PTEN,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,REGORAFENIB,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,REGORAFENIB,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,REGORAFENIB,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6445720195770264,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.713951587677002,REGORAFENIB,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.90291428565979,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7587270736694336,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9044747948646545,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.90291428565979,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8969548344612122,Stable,MGA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8969548344612122,Stable,PTEN,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9044747948646545,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7587270736694336,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6897907257080078,Stable,PTEN,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6445720195770264,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Stomach,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.713951587677002,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.90291428565979,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7587270736694336,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9044747948646545,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.90291428565979,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8969548344612122,Stable,MGA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8969548344612122,Stable,PTEN,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9044747948646545,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7587270736694336,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6897907257080078,Stable,PTEN,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6445720195770264,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Colon,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.713951587677002,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.90291428565979,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7587270736694336,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9044747948646545,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.90291428565979,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8969548344612122,Stable,MGA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8969548344612122,Stable,PTEN,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9044747948646545,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7587270736694336,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6897907257080078,Stable,PTEN,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6445720195770264,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Rectum,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.713951587677002,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9031409025192261,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7588670253753662,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8971037864685059,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8971037864685059,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7588670253753662,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9031409025192261,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9047231674194336,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9031409025192261,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8971037864685059,Stable,MGA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7588670253753662,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9047231674194336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9031409025192261,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8971037864685059,Stable,PTEN,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9047231674194336,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7588670253753662,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,SNP
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9047231674194336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6898812055587769,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,3.713942050933838,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6898812055587769,Stable,PTEN,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,3.713942050933838,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6898812055587769,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,3.713942050933838,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,SNP
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6898812055587769,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,3.713942050933838,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6446757316589355,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Primary,Metastatic,3.7139508724212646,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.90291428565979,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7587270736694336,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9044747948646545,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.90291428565979,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8969548344612122,Stable,MGA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8969548344612122,Stable,PTEN,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9044747948646545,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7587270736694336,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6897907257080078,Stable,PTEN,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6445720195770264,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.713951587677002,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,DEL
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.90291428565979,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.7587270736694336,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.8969548344612122,Stable,KIT,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.9044747948646545,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.90291428565979,Stable,MGA,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,16/24,Male,Liver,4.0,0.8969548344612122,Stable,MGA,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.7587270736694336,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,11/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.90291428565979,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,62.0,NE,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.8969548344612122,Stable,PTEN,ONGOING,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.9044747948646545,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,5/9,Male,Liver,4.0,0.7587270736694336,Stable,PTEN,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,819.0,CR,20.0,INS
P-0006104-T01-IM5,923.0,90.0,56.0,58.0,Non-Hispanic,17/21,Male,Liver,4.0,0.9044747948646545,Stable,KIT,NS,1.0,63.123,DECEASED,P-0006104,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,NILOTINIB,Medical Therapy,122.0,NR,20.0,INS
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,INS
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,5/9,Male,Liver,4.0,0.6897907257080078,Stable,PTEN,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,INS
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,INS
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6897907257080078,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.713942527770996,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,INS
P-0006104-T02-IM6,694.0,70.0,56.0,63.0,Non-Hispanic,11/21,Male,Liver,4.0,0.6445720195770264,Stable,KIT,NS,2.0,63.123,DECEASED,P-0006104,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,3.713951587677002,OTHER,Medical Therapy,398.0151544078519,UNKNOWN,20.0,INS
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Male,Not Applicable,40.0,0.2915342152118683,Stable,TRAF7,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.2915342152118683,Stable,KIT,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.2879255712032318,Stable,KIT,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067526817321777,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,40.0,0.2879255712032318,Stable,TRAF7,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067526817321777,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,TP53,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,TP53,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,TP53,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,TP53,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,PDGFRA,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,PDGFRA,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,PDGFRA,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,PDGFRA,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT;TP53,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT;TP53,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT;TP53,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT;TP53,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT;PDGFRA,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT;PDGFRA,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT;PDGFRA,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT;PDGFRA,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,TRAF7,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,SUNITINIB,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,TRAF7,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,SUNITINIB,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,TRAF7,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,REGORAFENIB,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,TRAF7,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,REGORAFENIB,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,TRAF7,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,TRAF7,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,TRAF7,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,TRAF7,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,TRAF7,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,TRAF7,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.2915467619895935,Stable,TRAF7,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2915467619895935,Stable,KIT,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879418432712555,Stable,KIT,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3067617416381836,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879418432712555,Stable,TRAF7,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3067617416381836,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,DEL
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,TRAF7,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,SNP
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,SNP
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,SNP
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,TRAF7,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,SNP
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,TRAF7,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,INS
P-0006120-T01-IM5,384.0,70.0,57.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.29154032468795776,Stable,KIT,ONGOING,1.0,88.175,ALIVE,P-0006120,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3568.0,UNKNOWN,12.0,INS
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,KIT,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,INS
P-0006120-T01-IM5,384.0,70.0,57.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,40.0,0.2879345118999481,Stable,TRAF7,NS,2.0,76.044,ALIVE,P-0006120,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3067562580108643,OTHER,Medical Therapy,2699.4276893390424,UNKNOWN,12.0,INS
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Male,Not Applicable,13.0,0.29451221227645874,Stable,RAD51,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Male,Not Applicable,13.0,0.29451221227645874,Stable,HLA-A,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,13.0,0.29451221227645874,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,13.0,0.2916335463523865,Stable,RAD51,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.2662739753723145,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Male,Not Applicable,13.0,0.29451221227645874,Stable,MAX,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,13.0,0.2916335463523865,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.2662739753723145,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,13.0,0.2916335463523865,Stable,MAX,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.2662739753723145,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,13.0,0.2916335463523865,Stable,MET,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.2662739753723145,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Male,Not Applicable,13.0,0.29451221227645874,Stable,MET,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,13.0,0.2916335463523865,Stable,HLA-A,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.2662739753723145,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.2945849895477295,Stable,TP53,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.2945849895477295,Stable,TP53,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,TP53,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,TP53,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.2945849895477295,Stable,TP53,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,TP53,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,TP53,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,TP53,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,TP53,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,TP53,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.2945849895477295,Stable,PDGFRA,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.2945849895477295,Stable,PDGFRA,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,PDGFRA,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,PDGFRA,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.2945849895477295,Stable,PDGFRA,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,PDGFRA,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,PDGFRA,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,PDGFRA,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,PDGFRA,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,PDGFRA,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT;TP53,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT;TP53,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT;TP53,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT;TP53,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT;TP53,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT;TP53,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT;TP53,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT;TP53,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT;TP53,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT;TP53,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT;PDGFRA,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT;PDGFRA,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT;PDGFRA,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT;PDGFRA,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT;PDGFRA,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT;PDGFRA,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT;PDGFRA,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT;PDGFRA,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT;PDGFRA,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT;PDGFRA,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.2945849895477295,Stable,RAD51,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.2945849895477295,Stable,HLA-A,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,RAD51,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,SUNITINIB,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.2945849895477295,Stable,MAX,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,SUNITINIB,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MAX,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,SUNITINIB,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MET,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,SUNITINIB,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,MET,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,HLA-A,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,SUNITINIB,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.2945849895477295,Stable,RAD51,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.2945849895477295,Stable,HLA-A,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,RAD51,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,REGORAFENIB,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.2945849895477295,Stable,MAX,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,REGORAFENIB,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MAX,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,REGORAFENIB,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MET,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,REGORAFENIB,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,MET,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,HLA-A,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,REGORAFENIB,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.2945849895477295,Stable,RAD51,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.2945849895477295,Stable,HLA-A,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,RAD51,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Stomach,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.2945849895477295,Stable,MAX,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MAX,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Stomach,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MET,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,MET,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,HLA-A,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Stomach,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.2945849895477295,Stable,RAD51,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.2945849895477295,Stable,HLA-A,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,RAD51,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Colon,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.2945849895477295,Stable,MAX,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MAX,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Colon,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MET,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,MET,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,HLA-A,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Colon,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.2945849895477295,Stable,RAD51,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.2945849895477295,Stable,HLA-A,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,RAD51,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Rectum,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.2945849895477295,Stable,MAX,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MAX,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Rectum,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MET,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,MET,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,HLA-A,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Rectum,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.29433679580688477,Stable,RAD51,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.29433679580688477,Stable,HLA-A,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29433679580688477,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.291440486907959,Stable,RAD51,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,4.266279220581055,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.29433679580688477,Stable,MAX,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.291440486907959,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,4.266279220581055,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.291440486907959,Stable,MAX,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,4.266279220581055,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.291440486907959,Stable,MET,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,4.266279220581055,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.29433679580688477,Stable,MET,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.291440486907959,Stable,HLA-A,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Metastatic,4.266279220581055,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,SNP
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.2945849895477295,Stable,RAD51,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.2945849895477295,Stable,HLA-A,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,RAD51,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.2945849895477295,Stable,MAX,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MAX,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MET,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,MET,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,HLA-A,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,DEL
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,10/10,Female,Not Applicable,13.0,0.2945849895477295,Stable,RAD51,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,INS
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/8,Female,Not Applicable,13.0,0.2945849895477295,Stable,HLA-A,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,INS
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,KIT,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,INS
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,RAD51,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,INS
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,4/5,Female,Not Applicable,13.0,0.2945849895477295,Stable,MAX,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,INS
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,KIT,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,INS
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MAX,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,INS
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,MET,NS,1.0,84.888,ALIVE,P-0006293,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,INS
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,2/21,Female,Not Applicable,13.0,0.2945849895477295,Stable,MET,ONGOING,1.0,90.871,ALIVE,P-0006293,NS,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,465.0,NE,15.0,INS
P-0006293-T01-IM5,517.0,80.0,64.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,13.0,0.29168933629989624,Stable,HLA-A,NS,1.0,84.888,ALIVE,P-0006293,No,NS,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Metastatic,4.266290664672852,OTHER,Medical Therapy,462.809585447909,UNKNOWN,15.0,INS
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Male,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Male,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.4718400239944458,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.4718400239944458,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,TP53,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,TP53,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,TP53,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,TP53,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,PDGFRA,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,PDGFRA,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,PDGFRA,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,PDGFRA,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT;TP53,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT;TP53,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT;TP53,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT;TP53,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT;PDGFRA,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT;PDGFRA,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT;PDGFRA,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT;PDGFRA,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,IMATINIB,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,IMATINIB,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,SUNITINIB,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,SUNITINIB,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,REGORAFENIB,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,REGORAFENIB,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Stomach,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Stomach,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Small Intestine,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Small Intestine,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Colon,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Colon,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Rectum,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Rectum,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.471771478652954,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,SNP
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.471771478652954,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,DEL
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,13/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,INS
P-0006343-T02-IM6,738.0,10.0,59.0,65.0,Non-Hispanic,11/21,Female,Not Applicable,34.95,0.0,Stable,KIT,NS,1.0,86.203,DECEASED,P-0006343,NS,Palliative,Soft Tissue,Small Bowel,White,91.0,No recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,1107.9272794150295,UNKNOWN,12.8,INS
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,INS
P-0006343-T02-IM6,738.0,10.0,59.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,32.11,0.0,Stable,KIT,NS,2.0,86.301,ALIVE,P-0006343,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Localized,1.471726417541504,OTHER,Medical Therapy,1104.8612280758457,UNKNOWN,12.8,INS
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Female,Not Applicable,10.0,0.31060314178466797,Stable,KIT,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387998580932617,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Female,Not Applicable,10.0,0.31060314178466797,Stable,PTEN,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387998580932617,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Female,Not Applicable,10.0,0.31036317348480225,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Female,Not Applicable,10.0,0.31036317348480225,Stable,PTEN,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.31054896116256714,Stable,TP53,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.31054896116256714,Stable,TP53,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3103092908859253,Stable,TP53,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3103092908859253,Stable,TP53,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.31054896116256714,Stable,PDGFRA,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.31054896116256714,Stable,PDGFRA,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3103092908859253,Stable,PDGFRA,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3103092908859253,Stable,PDGFRA,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.31054896116256714,Stable,KIT;TP53,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.31054896116256714,Stable,KIT;TP53,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3103092908859253,Stable,KIT;TP53,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3103092908859253,Stable,KIT;TP53,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.31054896116256714,Stable,KIT;PDGFRA,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.31054896116256714,Stable,KIT;PDGFRA,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3103092908859253,Stable,KIT;PDGFRA,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3103092908859253,Stable,KIT;PDGFRA,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.31054896116256714,Stable,KIT,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,IMATINIB,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.31054896116256714,Stable,PTEN,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,IMATINIB,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3103092908859253,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3103092908859253,Stable,PTEN,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.31054896116256714,Stable,KIT,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,SUNITINIB,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.31054896116256714,Stable,PTEN,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,SUNITINIB,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3103092908859253,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3103092908859253,Stable,PTEN,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.31054896116256714,Stable,KIT,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,REGORAFENIB,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.31054896116256714,Stable,PTEN,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,REGORAFENIB,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3103092908859253,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3103092908859253,Stable,PTEN,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.31054896116256714,Stable,KIT,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.31054896116256714,Stable,PTEN,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3103092908859253,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3103092908859253,Stable,PTEN,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.31054896116256714,Stable,KIT,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.31054896116256714,Stable,PTEN,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3103092908859253,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3103092908859253,Stable,PTEN,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.31054896116256714,Stable,KIT,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.31054896116256714,Stable,PTEN,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3103092908859253,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3103092908859253,Stable,PTEN,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3104158937931061,Stable,KIT,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.4387669563293457,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.3104158937931061,Stable,PTEN,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.4387669563293457,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3101744055747986,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3101744055747986,Stable,PTEN,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,SNP
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.31054896116256714,Stable,KIT,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,DEL
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.31054896116256714,Stable,PTEN,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,DEL
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3103092908859253,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,DEL
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3103092908859253,Stable,PTEN,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,DEL
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.31054896116256714,Stable,KIT,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,INS
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,5/9,Male,Not Applicable,10.0,0.31054896116256714,Stable,PTEN,NS,1.0,64.011,ALIVE,P-0006473,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.4387736320495605,OTHER,Medical Therapy,608.0418596264848,UNKNOWN,8.0,INS
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,11/21,Male,Not Applicable,10.0,0.3103092908859253,Stable,KIT,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,INS
P-0006473-T01-IM5,616.0,30.0,56.0,57.0,Non-Hispanic,2/9,Male,Not Applicable,10.0,0.3103092908859253,Stable,PTEN,ONGOING,1.0,64.011,ALIVE,P-0006473,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,618.0,SD,8.0,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Female,Liver,26.0,0.0,Stable,KIT,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Female,Liver,26.0,0.03489364683628082,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Female,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Female,Liver,26.0,0.0,Stable,PHOX2B,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Female,Liver,26.0,0.03489364683628082,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Female,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Female,Liver,26.0,0.03489364683628082,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Female,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Female,Liver,26.0,0.0,Stable,AR,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Female,Liver,26.0,0.7936510443687439,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889274835586548,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Female,Liver,26.0,0.7936510443687439,Stable,FLT3,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889274835586548,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Female,Liver,26.0,0.7936510443687439,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889274835586548,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,TP53,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,TP53,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,TP53,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,TP53,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,TP53,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,TP53,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,TP53,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,TP53,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,TP53,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,TP53,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,TP53,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,TP53,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,PDGFRA,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,PDGFRA,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,PDGFRA,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PDGFRA,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,PDGFRA,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PDGFRA,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,PDGFRA,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,PDGFRA,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,PDGFRA,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,PDGFRA,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,PDGFRA,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,PDGFRA,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT;TP53,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,KIT;TP53,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT;TP53,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,KIT;TP53,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,KIT;TP53,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,KIT;TP53,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,KIT;TP53,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,KIT;TP53,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,KIT;TP53,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT;TP53,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT;TP53,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT;TP53,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,KIT;PDGFRA,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT;PDGFRA,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,KIT;PDGFRA,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,KIT;PDGFRA,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,KIT;PDGFRA,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,KIT;PDGFRA,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT;PDGFRA,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT;PDGFRA,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT;PDGFRA,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,IMATINIB,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,FLT3,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,IMATINIB,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,IMATINIB,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,SUNITINIB,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,FLT3,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,SUNITINIB,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,SUNITINIB,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,REGORAFENIB,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,FLT3,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,REGORAFENIB,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,REGORAFENIB,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,FLT3,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,FLT3,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,FLT3,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,FLT3,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03539419174194336,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03539419174194336,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03539419174194336,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7937639951705933,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.9889097213745117,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7937639951705933,Stable,FLT3,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.9889097213745117,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7937639951705933,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,1.9889097213745117,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,INS
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,FLT3,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,SNP
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,DEL
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.03516623377799988,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,DEL
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,11/21,Male,Liver,26.0,0.0,Stable,KIT,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,DEL
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,DEL
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.03516623377799988,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,DEL
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,2/3,Male,Liver,26.0,0.0,Stable,PHOX2B,NS,1.0,56.581,DECEASED,P-0006664,NS,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,DEL
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.03516623377799988,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,153.0,NR,5.5,DEL
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,NS,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3256.0,SD,5.5,DEL
P-0006664-T01-IM5,887.0,10.0,51.0,65.0,Non-Hispanic,1/8,Male,Liver,26.0,0.0,Stable,AR,ONGOING,1.0,56.581,DECEASED,P-0006664,NS,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,404.0,CR,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,FLT3,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006664-T02-IM6,787.0,60.0,51.0,68.0,Non-Hispanic,11/21,Male,Liver,26.0,0.7935963869094849,Stable,KIT,NS,2.0,56.581,DECEASED,P-0006664,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.9889063835144043,OTHER,Medical Therapy,650.4379278655758,UNKNOWN,5.5,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Female,Liver,20.0,0.09295326471328735,Stable,KIT,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1560.0,NE,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Female,Liver,20.0,0.05611352622509003,Stable,KIT,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438648223876953,OTHER,Medical Therapy,658.5003208338328,UNKNOWN,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.0929335504770279,Stable,TP53,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1560.0,NE,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.05622735619544983,Stable,TP53,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438475370407104,OTHER,Medical Therapy,658.5003208338328,UNKNOWN,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.0929335504770279,Stable,PDGFRA,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1560.0,NE,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.05622735619544983,Stable,PDGFRA,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438475370407104,OTHER,Medical Therapy,658.5003208338328,UNKNOWN,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.0929335504770279,Stable,KIT;TP53,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1560.0,NE,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.05622735619544983,Stable,KIT;TP53,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438475370407104,OTHER,Medical Therapy,658.5003208338328,UNKNOWN,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.0929335504770279,Stable,KIT;PDGFRA,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1560.0,NE,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.05622735619544983,Stable,KIT;PDGFRA,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438475370407104,OTHER,Medical Therapy,658.5003208338328,UNKNOWN,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.0929335504770279,Stable,KIT,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,1560.0,NE,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.05622735619544983,Stable,KIT,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438475370407104,SUNITINIB,Medical Therapy,658.5003208338328,UNKNOWN,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.0929335504770279,Stable,KIT,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,1560.0,NE,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.05622735619544983,Stable,KIT,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438475370407104,REGORAFENIB,Medical Therapy,658.5003208338328,UNKNOWN,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.0929335504770279,Stable,KIT,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1560.0,NE,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.05622735619544983,Stable,KIT,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438475370407104,OTHER,Medical Therapy,658.5003208338328,UNKNOWN,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.0929335504770279,Stable,KIT,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1560.0,NE,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.05622735619544983,Stable,KIT,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438475370407104,OTHER,Medical Therapy,658.5003208338328,UNKNOWN,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.0929335504770279,Stable,KIT,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1560.0,NE,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.05622735619544983,Stable,KIT,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438475370407104,OTHER,Medical Therapy,658.5003208338328,UNKNOWN,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.09292297065258026,Stable,KIT,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1560.0,NE,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.05622735619544983,Stable,KIT,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438475370407104,OTHER,Medical Therapy,658.5003208338328,UNKNOWN,9.8,DEL
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.0929335504770279,Stable,KIT,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1560.0,NE,9.8,SNP
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.05622735619544983,Stable,KIT,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438475370407104,OTHER,Medical Therapy,658.5003208338328,UNKNOWN,9.8,SNP
P-0006712-T02-IM7,504.0,70.0,67.0,66.0,Non-Hispanic,11/21,Male,Liver,20.0,0.0929335504770279,Stable,KIT,ONGOING,1.0,91.463,ALIVE,P-0006712,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1560.0,NE,9.8,INS
P-0006712-T02-IM7,504.0,70.0,67.0,67.0,Non-Hispanic,11/21,Male,Liver,20.0,0.05622735619544983,Stable,KIT,ONGOING,2.0,85.183,ALIVE,P-0006712,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.19438475370407104,OTHER,Medical Therapy,658.5003208338328,UNKNOWN,9.8,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Female,Liver,20.0,0.4419671297073364,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Female,Liver,20.0,0.2957186996936798,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Female,Liver,20.0,0.3641889691352844,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Female,Liver,20.0,0.44098982214927673,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Female,Liver,20.0,0.2957186996936798,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Female,Liver,20.0,0.3641889691352844,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Female,Liver,20.0,0.34876763820648193,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340901374816895,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Female,Liver,20.0,0.34876763820648193,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340901374816895,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Female,Liver,20.0,0.2957186996936798,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Female,Liver,20.0,0.44098982214927673,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Female,Liver,20.0,0.34876763820648193,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340901374816895,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Female,Liver,20.0,0.3641889691352844,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Female,Liver,20.0,0.44098982214927673,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Female,Liver,20.0,0.4419671297073364,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Female,Liver,20.0,0.4419671297073364,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44218674302101135,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.295774906873703,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.36422955989837646,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44128406047821045,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.295774906873703,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.36422955989837646,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.295774906873703,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44128406047821045,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.36422955989837646,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44128406047821045,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44218674302101135,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44218674302101135,Stable,TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44218674302101135,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.295774906873703,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.36422955989837646,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44128406047821045,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.295774906873703,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.36422955989837646,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.295774906873703,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44128406047821045,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.36422955989837646,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44128406047821045,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44218674302101135,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44218674302101135,Stable,PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.295774906873703,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.295774906873703,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.295774906873703,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT;TP53,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.295774906873703,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.295774906873703,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.295774906873703,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT;PDGFRA,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,213.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,518.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,61.0,NR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,IMATINIB,Medical Therapy,557.0416222605828,UNKNOWN,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,IMATINIB,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,IMATINIB,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,213.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1553.0,SD,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,SUNITINIB,Medical Therapy,557.0416222605828,UNKNOWN,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,SUNITINIB,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,SUNITINIB,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.4424036145210266,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.295785516500473,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.36427953839302063,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.4415624141693115,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.295785516500473,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.36427953839302063,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34892019629478455,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,2.4340739250183105,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,INS
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34892019629478455,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,2.4340739250183105,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.295785516500473,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.4415624141693115,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34892019629478455,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,2.4340739250183105,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.36427953839302063,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.4415624141693115,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.4424036145210266,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.4424036145210266,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,SNP
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,9/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.295774906873703,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1553.0,SD,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,11/21,Male,Liver,20.0,0.34877294301986694,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,2.4340600967407227,OTHER,Medical Therapy,557.0416222605828,UNKNOWN,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.36422955989837646,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,518.0,CR,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44128406047821045,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,61.0,NR,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,17/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,DEL
P-0006901-T01-IM5,813.0,30.0,55.0,61.0,Non-Hispanic,13/21,Male,Liver,20.0,0.44218674302101135,Stable,KIT,NS,1.0,25.151,ALIVE,P-0006901,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,213.0,CR,11.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Female,Pelvis,12.0,0.4524419903755188,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Female,Pelvis,12.0,0.4524419903755188,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Female,Pelvis,12.0,0.4524419903755188,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Female,Pelvis,12.0,0.4506899416446686,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009166717529297,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Female,Pelvis,12.0,0.4506899416446686,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009166717529297,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Female,Pelvis,12.0,0.4506899416446686,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009166717529297,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Female,Pelvis,12.0,0.4506899416446686,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009166717529297,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Female,Pelvis,12.0,0.4524419903755188,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT;TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT;TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT;TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT;TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT;TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT;TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT;TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT;TP53,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT;PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT;PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT;PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT;PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT;PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT;PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT;PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT;PDGFRA,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,SUNITINIB,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,SUNITINIB,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,SUNITINIB,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,SUNITINIB,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,REGORAFENIB,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,REGORAFENIB,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,REGORAFENIB,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,REGORAFENIB,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.45251500606536865,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.45251500606536865,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.45251500606536865,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,TNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507642686367035,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,3.300915002822876,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,SNP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507642686367035,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,3.300915002822876,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507642686367035,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,3.300915002822876,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507642686367035,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,3.300915002822876,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,ONP
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.45251500606536865,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,DEL
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4524892568588257,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,INS
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,36/57,Male,Pelvis,12.0,0.4524892568588257,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,INS
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,14/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,INS
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,21/29,Male,Pelvis,12.0,0.4507386386394501,Stable,ALK,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,INS
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,28/57,Male,Pelvis,12.0,0.4507386386394501,Stable,NF1,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,INS
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,INS
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4507386386394501,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,No,NS,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.3009281158447266,OTHER,Medical Therapy,1779.64,UNKNOWN,26.0,INS
P-0006932-T01-IM5,835.0,50.0,63.0,73.0,Non-Hispanic,11/21,Male,Pelvis,12.0,0.4524892568588257,Stable,KIT,ONGOING,1.0,73.414,DECEASED,P-0006932,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1804.0,SD,26.0,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Female,Omentum,12.0,0.5265642404556274,Stable,KIT,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Female,Omentum,12.0,0.52811598777771,Stable,KIT,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3314439058303833,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Female,Omentum,12.0,0.52811598777771,Stable,MAX,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3314439058303833,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Female,Omentum,12.0,0.5265642404556274,Stable,MAX,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5265989899635315,Stable,TP53,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5281510949134827,Stable,TP53,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5281510949134827,Stable,TP53,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5265989899635315,Stable,TP53,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5265989899635315,Stable,PDGFRA,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5281510949134827,Stable,PDGFRA,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5281510949134827,Stable,PDGFRA,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5265989899635315,Stable,PDGFRA,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5265989899635315,Stable,KIT;TP53,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5281510949134827,Stable,KIT;TP53,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5281510949134827,Stable,KIT;TP53,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5265989899635315,Stable,KIT;TP53,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5265989899635315,Stable,KIT;PDGFRA,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5281510949134827,Stable,KIT;PDGFRA,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5281510949134827,Stable,KIT;PDGFRA,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5265989899635315,Stable,KIT;PDGFRA,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5265989899635315,Stable,KIT,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5281510949134827,Stable,KIT,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,SUNITINIB,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5281510949134827,Stable,MAX,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,SUNITINIB,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5265989899635315,Stable,MAX,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5265989899635315,Stable,KIT,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5281510949134827,Stable,KIT,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,REGORAFENIB,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5281510949134827,Stable,MAX,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,REGORAFENIB,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5265989899635315,Stable,MAX,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5265989899635315,Stable,KIT,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5281510949134827,Stable,KIT,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5281510949134827,Stable,MAX,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5265989899635315,Stable,MAX,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5265989899635315,Stable,KIT,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5281510949134827,Stable,KIT,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5281510949134827,Stable,MAX,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5265989899635315,Stable,MAX,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5265989899635315,Stable,KIT,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5281510949134827,Stable,KIT,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5281510949134827,Stable,MAX,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5265989899635315,Stable,MAX,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5265989899635315,Stable,KIT,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5281510949134827,Stable,KIT,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5281510949134827,Stable,MAX,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5265989899635315,Stable,MAX,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5267897844314575,Stable,KIT,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5283417105674744,Stable,KIT,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3314343690872192,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,INS
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5283417105674744,Stable,MAX,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3314343690872192,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5267897844314575,Stable,MAX,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5265989899635315,Stable,KIT,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,SNP
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5281510949134827,Stable,KIT,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,SNP
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5281510949134827,Stable,MAX,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,SNP
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5265989899635315,Stable,MAX,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,SNP
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,9/21,Male,Omentum,12.0,0.5265989899635315,Stable,KIT,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,11/21,Male,Omentum,12.0,0.5281510949134827,Stable,KIT,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,3/5,Male,Omentum,12.0,0.5281510949134827,Stable,MAX,NS,1.0,20.679,DECEASED,P-0007230,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.331437587738037,OTHER,Medical Therapy,426.8662925628464,UNKNOWN,7.4,DEL
P-0007230-T01-IM5,882.0,90.0,69.0,69.0,Non-Hispanic,4/5,Male,Omentum,12.0,0.5265989899635315,Stable,MAX,ONGOING,1.0,20.679,DECEASED,P-0007230,NS,Palliative,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,434.0,NE,7.4,DEL
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Female,Not Applicable,40.0,0.14952564239501953,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Female,Not Applicable,40.0,0.1495577096939087,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Female,Not Applicable,40.0,0.1492917537689209,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Female,Not Applicable,40.0,0.14952564239501953,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Female,Not Applicable,40.0,0.1492917537689209,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Female,Liver,40.0,0.015405379235744476,Stable,TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163334131240845,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Female,Liver,40.0,0.015405379235744476,Stable,CARD11,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163334131240845,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,KIT,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14982539415359497,Stable,KIT,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,KIT,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,KIT,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,KIT,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,KIT,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,KIT,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,TP53,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14982539415359497,Stable,TP53,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,TP53,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,TP53,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,TP53,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,PDGFRA,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14982539415359497,Stable,PDGFRA,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,PDGFRA,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,PDGFRA,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,PDGFRA,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,PDGFRA,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,PDGFRA,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,KIT;TP53,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14982539415359497,Stable,KIT;TP53,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,KIT;TP53,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,KIT;TP53,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,KIT;TP53,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,KIT;TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,KIT;TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,KIT;PDGFRA,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14982539415359497,Stable,KIT;PDGFRA,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,KIT;PDGFRA,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,KIT;PDGFRA,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,KIT;PDGFRA,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,KIT;PDGFRA,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,KIT;PDGFRA,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14982539415359497,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,IMATINIB,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,CARD11,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,IMATINIB,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14982539415359497,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,REGORAFENIB,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,CARD11,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,REGORAFENIB,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Small Intestine,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14982539415359497,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Small Intestine,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Small Intestine,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Small Intestine,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Small Intestine,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,CARD11,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Colon,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14982539415359497,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Colon,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Colon,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Colon,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Colon,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,CARD11,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Rectum,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14982539415359497,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Rectum,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Rectum,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Rectum,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Rectum,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,CARD11,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14961624145507812,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.149644672870636,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14939239621162415,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14961624145507812,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14939239621162415,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,CARD11,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,SNP
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,DEL
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14982539415359497,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,DEL
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,DEL
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,DEL
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,DEL
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,DEL
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,CARD11,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,DEL
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,INS
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.14982539415359497,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,15.0,INS
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,INS
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1497977077960968,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,INS
P-0007268-T01-IM5,1085.0,80.0,48.0,49.0,Non-Hispanic,7/25,Male,Not Applicable,40.0,0.1495719850063324,Stable,CARD11,NS,1.0,12.164,DECEASED,P-0007268,NS,Neoadjuvant,Stomach,Gastric,White,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,43.0,NR,15.0,INS
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,6/11,Male,Liver,40.0,0.01539851725101471,Stable,TP53,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,INS
P-0007268-T02-IM5,294.0,60.0,48.0,50.0,Non-Hispanic,7/25,Male,Liver,40.0,0.01539851725101471,Stable,CARD11,NS,2.0,12.164,DECEASED,P-0007268,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,1.3163269758224487,OTHER,Medical Therapy,1646.6849411446394,UNKNOWN,15.0,INS
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Male,Not Applicable,0.0,0.5171111226081848,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Male,Not Applicable,0.0,0.5171111226081848,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Male,Not Applicable,0.0,0.5199569463729858,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,154.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Male,Not Applicable,0.0,0.46224021911621094,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Male,Not Applicable,0.0,0.5190964341163635,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Male,Not Applicable,0.0,0.5195620059967041,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,142.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Male,Not Applicable,0.0,0.46224021911621094,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Male,Not Applicable,0.0,0.5190964341163635,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Male,Not Applicable,0.0,0.4607895016670227,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.38391780853271484,OTHER,Medical Therapy,406.45734014937034,UNKNOWN,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,TP53,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,TP53,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5197052359580994,Stable,TP53,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,154.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,TP53,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,TP53,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.519341230392456,Stable,TP53,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,142.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,TP53,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,TP53,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.4606717824935913,Stable,TP53,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.3839247226715088,OTHER,Medical Therapy,406.45734014937034,UNKNOWN,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5197052359580994,Stable,PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,154.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,PDGFRA,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.519341230392456,Stable,PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,142.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,PDGFRA,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.4606717824935913,Stable,PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.3839247226715088,OTHER,Medical Therapy,406.45734014937034,UNKNOWN,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT;TP53,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT;TP53,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5197052359580994,Stable,KIT;TP53,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,154.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT;TP53,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT;TP53,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.519341230392456,Stable,KIT;TP53,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,142.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT;TP53,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT;TP53,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.4606717824935913,Stable,KIT;TP53,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.3839247226715088,OTHER,Medical Therapy,406.45734014937034,UNKNOWN,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT;PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT;PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5197052359580994,Stable,KIT;PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,154.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT;PDGFRA,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT;PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.519341230392456,Stable,KIT;PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,142.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT;PDGFRA,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT;PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.4606717824935913,Stable,KIT;PDGFRA,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.3839247226715088,OTHER,Medical Therapy,406.45734014937034,UNKNOWN,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5197052359580994,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,154.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.519341230392456,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,142.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.4606717824935913,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.3839247226715088,IMATINIB,Medical Therapy,406.45734014937034,UNKNOWN,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5197052359580994,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,154.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.519341230392456,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,142.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.4606717824935913,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.3839247226715088,REGORAFENIB,Medical Therapy,406.45734014937034,UNKNOWN,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5197052359580994,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,154.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.519341230392456,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,142.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.4606717824935913,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.3839247226715088,OTHER,Medical Therapy,406.45734014937034,UNKNOWN,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5197052359580994,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,154.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.519341230392456,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,142.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.4606717824935913,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.3839247226715088,OTHER,Medical Therapy,406.45734014937034,UNKNOWN,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5197052359580994,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,154.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.519341230392456,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,142.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.4606717824935913,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.3839247226715088,OTHER,Medical Therapy,406.45734014937034,UNKNOWN,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5165098309516907,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5165098309516907,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5194085240364075,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,154.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46197086572647095,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5185302495956421,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5190032124519348,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,142.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46197086572647095,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5185302495956421,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.4605165123939514,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.38393092155456543,OTHER,Medical Therapy,406.45734014937034,UNKNOWN,2.8,DEL
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.8,SNP
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,2.8,SNP
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5197052359580994,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,154.0,NR,2.8,SNP
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,SNP
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,SNP
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.519341230392456,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,142.0,NR,2.8,SNP
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,SNP
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,SNP
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.4606717824935913,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.3839247226715088,OTHER,Medical Therapy,406.45734014937034,UNKNOWN,2.8,SNP
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.8,INS
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5168181657791138,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,61.0,NR,2.8,INS
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5197052359580994,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,154.0,NR,2.8,INS
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,INS
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,INS
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.519341230392456,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,142.0,NR,2.8,INS
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.46212542057037354,Stable,KIT,ONGOING,1.0,34.751,DECEASED,P-0007513,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,404.0,NR,2.8,INS
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.5188719034194946,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,2.8,INS
P-0007513-T03-IM5,747.0,60.0,52.0,60.0,Hispanic/Latino,11/21,Female,Not Applicable,0.0,0.4606717824935913,Stable,KIT,NS,1.0,34.751,DECEASED,P-0007513,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.3839247226715088,OTHER,Medical Therapy,406.45734014937034,UNKNOWN,2.8,INS
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Male,Liver,0.0,2.6187708377838135,Stable,ANKRD11,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Male,Liver,0.0,2.6187708377838135,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Male,Not Applicable,0.0,1.5023499727249146,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995268821716309,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Male,Not Applicable,0.0,1.5023499727249146,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995268821716309,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,TP53,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,TP53,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,TP53,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,TP53,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,PDGFRA,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,PDGFRA,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,PDGFRA,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,PDGFRA,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,KIT;TP53,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,KIT;TP53,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT;TP53,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT;TP53,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,KIT;PDGFRA,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,KIT;PDGFRA,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT;PDGFRA,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT;PDGFRA,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,ANKRD11,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,IMATINIB,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,IMATINIB,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,ANKRD11,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,SUNITINIB,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,SUNITINIB,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,ANKRD11,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,REGORAFENIB,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,REGORAFENIB,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,ANKRD11,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,ANKRD11,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Colon,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Colon,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,ANKRD11,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Rectum,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Rectum,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.618868589401245,Stable,ANKRD11,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,SNP
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.618868589401245,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,SNP
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,ANKRD11,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,DEL
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,9/13,Female,Liver,0.0,2.6186978816986084,Stable,ANKRD11,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,INS
P-0007702-T01-IM5,1031.0,90.0,54.0,54.0,Non-Hispanic,11/21,Female,Liver,0.0,2.6186978816986084,Stable,KIT,ONGOING,1.0,89.589,ALIVE,P-0007702,NS,Neoadjuvant,Stomach,Gastric,Black or African American,45.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,375.0,CR,7.3,INS
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,INS
P-0007702-T02-IM6,677.0,80.0,54.0,59.0,Non-Hispanic,11/21,Female,Not Applicable,0.0,1.5023868083953857,Stable,KIT,NS,2.0,83.375,ALIVE,P-0007702,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,1.0995378494262695,OTHER,Medical Therapy,673.2446682048721,UNKNOWN,7.3,INS
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Female,Pelvic Nodule,5.0,2.6363816261291504,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Female,Pelvic Nodule,5.0,2.474956512451172,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Female,Pelvic Nodule,5.0,2.474956512451172,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Female,Pelvic Nodule,5.0,2.6363816261291504,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Female,Pelvic Nodule,5.0,2.474956512451172,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Female,Pelvic Nodule,5.0,2.6363816261291504,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Female,Pelvic Nodule,5.0,2.6363816261291504,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Female,Pelvic Nodule,5.0,2.474956512451172,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Female,Pelvic Nodule,5.0,2.4683291912078857,Stable,RNF43,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.2772679328918457,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Female,Pelvic Nodule,5.0,2.4683291912078857,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.2772679328918457,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Female,Pelvic Nodule,5.0,2.4683291912078857,Stable,PPP2R1A,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.2772679328918457,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Female,Pelvic Nodule,5.0,2.4683291912078857,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.2772679328918457,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,TP53,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,TP53,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,TP53,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,TP53,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,PDGFRA,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,PDGFRA,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,PDGFRA,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,PDGFRA,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT;TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT;TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT;TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT;TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT;TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT;TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT;TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT;TP53,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT;TP53,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT;TP53,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT;TP53,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT;TP53,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT;PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT;PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT;PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT;PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT;PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT;PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT;PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT;PDGFRA,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT;PDGFRA,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT;PDGFRA,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT;PDGFRA,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT;PDGFRA,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,RNF43,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,IMATINIB,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,IMATINIB,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,PPP2R1A,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,IMATINIB,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,IMATINIB,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,RNF43,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,REGORAFENIB,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,REGORAFENIB,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,PPP2R1A,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,REGORAFENIB,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,REGORAFENIB,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,RNF43,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,PPP2R1A,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,RNF43,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,PPP2R1A,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,RNF43,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,PPP2R1A,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.636923313140869,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750444889068604,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750444889068604,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.636923313140869,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750444889068604,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.636923313140869,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.636923313140869,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750444889068604,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.468400001525879,Stable,RNF43,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,3.277256727218628,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.468400001525879,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,3.277256727218628,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.468400001525879,Stable,PPP2R1A,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,3.277256727218628,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,SNP
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.468400001525879,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,3.277256727218628,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,RNF43,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,PPP2R1A,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,DEL
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,INS
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,RNF43,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,INS
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,INS
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,INS
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,PPP2R1A,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,INS
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,INS
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,17/21,Male,Pelvic Nodule,5.0,2.6366512775421143,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,NR,2.3,INS
P-0007910-T01-IM5,810.0,90.0,49.0,54.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4750165939331055,Stable,KIT,NS,1.0,6.378,DECEASED,P-0007910,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1651.0,SD,2.3,INS
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,9/10,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,RNF43,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,INS
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,INS
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,5/15,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,PPP2R1A,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,INS
P-0007910-T01-IM5,810.0,90.0,49.0,55.0,Non-Hispanic,11/21,Male,Pelvic Nodule,5.0,2.4683005809783936,Stable,KIT,NS,2.0,6.378,DECEASED,P-0007910,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.27725887298584,OTHER,Medical Therapy,848.7793001475643,UNKNOWN,2.3,INS
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Female,Not Applicable,14.0,0.0,Stable,KIT,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Female,Not Applicable,14.0,0.0,Stable,MGA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Female,Not Applicable,14.0,0.0,Stable,MGA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.328223466873169,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Female,Not Applicable,14.0,0.0,Stable,KIT,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.3282454013824463,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,TP53,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.0,Stable,TP53,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.0,Stable,TP53,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.3282067775726318,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,TP53,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.3282287120819092,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,PDGFRA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.0,Stable,PDGFRA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.0,Stable,PDGFRA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.3282067775726318,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,PDGFRA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.3282287120819092,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT;TP53,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.0,Stable,KIT;TP53,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.0,Stable,KIT;TP53,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.3282067775726318,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT;TP53,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.3282287120819092,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.0,Stable,KIT;PDGFRA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.0,Stable,KIT;PDGFRA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.3282067775726318,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT;PDGFRA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.3282287120819092,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,373.0,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.0,Stable,MGA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.0,Stable,MGA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.3282067775726318,SUNITINIB,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.3282287120819092,SUNITINIB,Medical Therapy,463.30907875553567,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,373.0,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.0,Stable,MGA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.0,Stable,MGA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.3282067775726318,REGORAFENIB,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.3282287120819092,REGORAFENIB,Medical Therapy,463.30907875553567,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.0,Stable,MGA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Stomach,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.0,Stable,MGA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Stomach,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.3282067775726318,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Stomach,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.3282287120819092,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Colon,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.0,Stable,MGA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Colon,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.0,Stable,MGA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Colon,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.3282067775726318,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Colon,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.3282287120819092,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Rectum,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.0,Stable,MGA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Rectum,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.0,Stable,MGA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Rectum,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.3282067775726318,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Rectum,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.3282287120819092,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.0,Stable,MGA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.0,Stable,MGA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Metastasis,Localized,1.3281974792480469,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Intestine,Asian,0.0,Recurrence,Metastasis,Localized,1.3282196521759033,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,SNP
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.0,Stable,MGA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.0,Stable,MGA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.3282067775726318,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.3282287120819092,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,DEL
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,INS
P-0007985-T01-IM5,569.0,85.0,66.0,71.0,Non-Hispanic,22/24,Male,Not Applicable,14.0,0.0,Stable,MGA,ONGOING,1.0,87.353,ALIVE,P-0007985,NS,Neoadjuvant,Small Intestine,Gastric,Asian,60.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,373.0,UNKNOWN,6.1,INS
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,17/24,Male,Not Applicable,14.0,0.0,Stable,MGA,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Bowel,Asian,0.0,Recurrence,Primary,Localized,1.3282067775726318,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,INS
P-0007985-T01-IM5,569.0,85.0,66.0,72.0,Non-Hispanic,11/21,Male,Not Applicable,14.0,0.0,Stable,KIT,NS,2.0,83.079,ALIVE,P-0007985,No,Neoadjuvant,Small Intestine,Small Intestine,Asian,0.0,Recurrence,Primary,Localized,1.3282287120819092,OTHER,Medical Therapy,463.30907875553567,UNKNOWN,6.1,INS
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Male,Not Applicable,8.0,0.0,Stable,SDHA,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Stomach,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Male,Not Applicable,8.0,0.0,Stable,SDHA,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.35851919651031494,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,KIT,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Stomach,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,KIT,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.35853642225265503,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,TP53,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Stomach,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,TP53,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.35853642225265503,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,PDGFRA,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Stomach,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,PDGFRA,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.35853642225265503,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,KIT;TP53,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Stomach,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,KIT;TP53,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.35853642225265503,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,KIT;PDGFRA,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Stomach,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,KIT;PDGFRA,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.35853642225265503,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Stomach,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.35853642225265503,SUNITINIB,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Stomach,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.35853642225265503,REGORAFENIB,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Small Intestine,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,0.35853642225265503,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Colon,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,0.35853642225265503,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Rectum,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,0.35853642225265503,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Stomach,Gastric,White,144.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.3585357069969177,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,SNP
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Stomach,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,DEL
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.35853642225265503,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,DEL
P-0008247-T01-IM5,469.0,70.0,56.0,63.0,Non-Hispanic,11/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,1.0,82.915,ALIVE,P-0008247,NS,NS,Stomach,Gastric,White,144.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,31.0,UNKNOWN,2.1,INS
P-0008247-T01-IM5,469.0,70.0,56.0,64.0,Non-Hispanic,2/15,Female,Not Applicable,8.0,0.0,Stable,SDHA,NS,2.0,79.66,ALIVE,P-0008247,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.35853642225265503,OTHER,Medical Therapy,463.73959262959266,UNKNOWN,2.1,INS
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,50.0,1.9569613933563232,Stable,KIT,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,50.0,1.9560118913650513,Stable,KIT,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.3492392897605896,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9569087028503418,Stable,TP53,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559972286224365,Stable,TP53,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.34922683238983154,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9569087028503418,Stable,PDGFRA,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559972286224365,Stable,PDGFRA,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.34922683238983154,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9569087028503418,Stable,KIT;TP53,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559972286224365,Stable,KIT;TP53,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.34922683238983154,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9569087028503418,Stable,KIT;PDGFRA,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559972286224365,Stable,KIT;PDGFRA,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.34922683238983154,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9569087028503418,Stable,KIT,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559972286224365,Stable,KIT,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.34922683238983154,SUNITINIB,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9569087028503418,Stable,KIT,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559972286224365,Stable,KIT,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.34922683238983154,REGORAFENIB,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9569087028503418,Stable,KIT,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559972286224365,Stable,KIT,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.34922683238983154,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9569087028503418,Stable,KIT,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559972286224365,Stable,KIT,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.34922683238983154,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9569087028503418,Stable,KIT,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559972286224365,Stable,KIT,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.34922683238983154,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9569087028503418,Stable,KIT,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559972286224365,Stable,KIT,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.34922683238983154,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9567703008651733,Stable,KIT,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,830.0,SD,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559102058410645,Stable,KIT,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.3492312431335449,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,DEL
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9569087028503418,Stable,KIT,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,830.0,SD,10.1,SNP
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559972286224365,Stable,KIT,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.34922683238983154,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,SNP
P-0008468-T01-IM5,986.0,90.0,30.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9569087028503418,Stable,KIT,ONGOING,1.0,5.458,DECEASED,P-0008468,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,830.0,SD,10.1,INS
P-0008468-T01-IM5,986.0,90.0,30.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9559972286224365,Stable,KIT,NS,2.0,5.458,DECEASED,P-0008468,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.34922683238983154,OTHER,Medical Therapy,627.4335691285839,UNKNOWN,10.1,INS
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Female,Not available,0.0,0.8170250654220581,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Female,Not available,0.0,0.8170250654220581,Stable,RB1,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Female,Not available,0.0,0.8170250654220581,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Female,Not available,0.0,0.8170250654220581,Stable,PTEN,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Female,Liver,0.0,0.25603193044662476,Stable,PTEN,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700408458709717,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Female,Liver,0.0,0.2060437649488449,Stable,CTCF,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.6700334548950195,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Female,Liver,0.0,0.25603193044662476,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700408458709717,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Female,Liver,0.0,0.25603193044662476,Stable,RB1,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700408458709717,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Female,Liver,0.0,0.25603193044662476,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700408458709717,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.8170108795166016,Stable,TP53,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.8170108795166016,Stable,TP53,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.8170108795166016,Stable,TP53,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.8170108795166016,Stable,TP53,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.25600892305374146,Stable,TP53,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20601674914360046,Stable,TP53,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.670030355453491,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,TP53,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,TP53,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,TP53,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.8170108795166016,Stable,PDGFRA,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.8170108795166016,Stable,PDGFRA,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.8170108795166016,Stable,PDGFRA,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.8170108795166016,Stable,PDGFRA,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.25600892305374146,Stable,PDGFRA,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20601674914360046,Stable,PDGFRA,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.670030355453491,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,PDGFRA,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,PDGFRA,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,PDGFRA,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT;TP53,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.8170108795166016,Stable,KIT;TP53,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT;TP53,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.8170108795166016,Stable,KIT;TP53,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.25600892305374146,Stable,KIT;TP53,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20601674914360046,Stable,KIT;TP53,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.670030355453491,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT;TP53,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT;TP53,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT;TP53,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT;PDGFRA,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.8170108795166016,Stable,KIT;PDGFRA,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT;PDGFRA,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.8170108795166016,Stable,KIT;PDGFRA,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.25600892305374146,Stable,KIT;PDGFRA,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20601674914360046,Stable,KIT;PDGFRA,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.670030355453491,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT;PDGFRA,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT;PDGFRA,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT;PDGFRA,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.8170108795166016,Stable,RB1,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.8170108795166016,Stable,PTEN,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.25600892305374146,Stable,PTEN,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,SUNITINIB,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20601674914360046,Stable,CTCF,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.670030355453491,SUNITINIB,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,SUNITINIB,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,RB1,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,SUNITINIB,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,SUNITINIB,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.8170108795166016,Stable,RB1,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.8170108795166016,Stable,PTEN,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.25600892305374146,Stable,PTEN,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,REGORAFENIB,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20601674914360046,Stable,CTCF,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.670030355453491,REGORAFENIB,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,REGORAFENIB,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,RB1,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,REGORAFENIB,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,REGORAFENIB,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.8170108795166016,Stable,RB1,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.8170108795166016,Stable,PTEN,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.25600892305374146,Stable,PTEN,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20601674914360046,Stable,CTCF,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.670030355453491,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,RB1,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.8170108795166016,Stable,RB1,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.8170108795166016,Stable,PTEN,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.25600892305374146,Stable,PTEN,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20601674914360046,Stable,CTCF,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.670030355453491,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,RB1,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.8170108795166016,Stable,RB1,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.8170108795166016,Stable,PTEN,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.25600892305374146,Stable,PTEN,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20601674914360046,Stable,CTCF,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.670030355453491,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,RB1,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Colon,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.8170108795166016,Stable,RB1,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.8170108795166016,Stable,PTEN,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.25600892305374146,Stable,PTEN,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20601674914360046,Stable,CTCF,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.670030355453491,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,RB1,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.817012369632721,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.817012369632721,Stable,RB1,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.817012369632721,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.817012369632721,Stable,PTEN,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.2559957504272461,Stable,PTEN,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,3.6700220108032227,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20599587261676788,Stable,CTCF,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,3.6700146198272705,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.2559957504272461,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,3.6700220108032227,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.2559957504272461,Stable,RB1,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,3.6700220108032227,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.2559957504272461,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Primary,Metastatic,3.6700220108032227,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,DEL
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.8170108795166016,Stable,RB1,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.8170108795166016,Stable,PTEN,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.25600892305374146,Stable,PTEN,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20601674914360046,Stable,CTCF,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.670030355453491,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,RB1,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,SNP
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,11/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,INS
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,16/27,Male,Not available,0.0,0.8170108795166016,Stable,RB1,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,INS
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,17/21,Male,Not available,0.0,0.8170108795166016,Stable,KIT,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,INS
P-0008548-T01-IM5,1050.0,80.0,36.0,44.0,Non-Hispanic,2/9,Male,Not available,0.0,0.8170108795166016,Stable,PTEN,ONGOING,1.0,88.471,ALIVE,P-0008548,NS,Neoadjuvant,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,3052.0,SD,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,5/9,Male,Liver,0.0,0.25600892305374146,Stable,PTEN,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.20601674914360046,Stable,CTCF,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.670030355453491,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,RB1,NS,2.0,82.093,ALIVE,P-0008548,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008548-T03-IM6,616.0,90.0,36.0,49.0,Non-Hispanic,11/21,Male,Liver,0.0,0.25600892305374146,Stable,KIT,NS,2.0,82.093,ALIVE,P-0008548,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,3.6700377464294434,OTHER,Medical Therapy,1732.3472339086352,UNKNOWN,14.0,INS
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Female,Not Applicable,14.79,0.04287600517272949,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,14.79,0.04287600517272949,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Female,Not Applicable,14.79,0.04287600517272949,Stable,ARID2,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,15.03,0.14224056899547577,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.3169612884521484,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Female,Not Applicable,15.03,0.14224056899547577,Stable,ARID2,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.3169612884521484,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Female,Not Applicable,15.03,0.14224056899547577,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.3169612884521484,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,TP53,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,TP53,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,TP53,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,TP53,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,TP53,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,TP53,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,PDGFRA,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,PDGFRA,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,PDGFRA,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,PDGFRA,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,PDGFRA,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,PDGFRA,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT;TP53,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT;TP53,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT;TP53,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT;TP53,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT;TP53,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT;TP53,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT;PDGFRA,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT;PDGFRA,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT;PDGFRA,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT;PDGFRA,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT;PDGFRA,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT;PDGFRA,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,ARID2,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,SUNITINIB,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,ARID2,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,SUNITINIB,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,SUNITINIB,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,ARID2,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,REGORAFENIB,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,ARID2,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,REGORAFENIB,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,REGORAFENIB,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,ARID2,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,ARID2,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,ARID2,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,ARID2,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,ARID2,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,ARID2,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.04266422986984253,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04266422986984253,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04266422986984253,Stable,ARID2,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.142316073179245,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.316953420639038,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.142316073179245,Stable,ARID2,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.316953420639038,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,SNP
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.142316073179245,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,2.316953420639038,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,ARID2,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,ARID2,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,DEL
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,11/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,INS
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,KIT,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,INS
P-0008865-T01-IM5,721.0,80.0,70.0,66.0,Non-Hispanic,21/21,Male,Not Applicable,14.79,0.04285000264644623,Stable,ARID2,ONGOING,1.0,80.39200000000005,ALIVE,P-0008865,NS,Palliative,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,526.0,SD,9.0,INS
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,INS
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,15/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,ARID2,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,INS
P-0008865-T01-IM5,721.0,80.0,70.0,67.0,Non-Hispanic,11/21,Male,Not Applicable,15.03,0.14237050712108612,Stable,KIT,NS,2.0,68.82865000000001,ALIVE,P-0008865,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,2.31695294380188,OTHER,Medical Therapy,405.39093542664233,UNKNOWN,9.0,INS
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Male,Not Applicable,5.0,0.037348031997680664,Stable,KIT,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Stomach,Gastric,White,54.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,404.0,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Male,Not Applicable,5.0,0.04492916166782379,Stable,KIT,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.4300767779350281,OTHER,Medical Therapy,693.319845127095,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.03727796673774719,Stable,TP53,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Stomach,Gastric,White,54.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,404.0,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.044892147183418274,Stable,TP53,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.43008965253829956,OTHER,Medical Therapy,693.319845127095,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.03727796673774719,Stable,PDGFRA,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Stomach,Gastric,White,54.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,404.0,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.044892147183418274,Stable,PDGFRA,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.43008965253829956,OTHER,Medical Therapy,693.319845127095,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.03727796673774719,Stable,KIT;TP53,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Stomach,Gastric,White,54.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,404.0,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.044892147183418274,Stable,KIT;TP53,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.43008965253829956,OTHER,Medical Therapy,693.319845127095,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.03727796673774719,Stable,KIT;PDGFRA,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Stomach,Gastric,White,54.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,404.0,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.044892147183418274,Stable,KIT;PDGFRA,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.43008965253829956,OTHER,Medical Therapy,693.319845127095,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.03727796673774719,Stable,KIT,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Stomach,Gastric,White,54.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,404.0,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.044892147183418274,Stable,KIT,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.43008965253829956,SUNITINIB,Medical Therapy,693.319845127095,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.03727796673774719,Stable,KIT,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Stomach,Gastric,White,54.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,404.0,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.044892147183418274,Stable,KIT,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.43008965253829956,REGORAFENIB,Medical Therapy,693.319845127095,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.03727796673774719,Stable,KIT,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Small Intestine,Gastric,White,54.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,404.0,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.044892147183418274,Stable,KIT,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,0.43008965253829956,OTHER,Medical Therapy,693.319845127095,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.03727796673774719,Stable,KIT,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Colon,Gastric,White,54.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,404.0,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.044892147183418274,Stable,KIT,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,0.43008965253829956,OTHER,Medical Therapy,693.319845127095,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.03727796673774719,Stable,KIT,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Rectum,Gastric,White,54.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,404.0,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.044892147183418274,Stable,KIT,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,0.43008965253829956,OTHER,Medical Therapy,693.319845127095,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.03709685802459717,Stable,KIT,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Stomach,Gastric,White,54.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,404.0,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.04483771324157715,Stable,KIT,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.43009859323501587,OTHER,Medical Therapy,693.319845127095,UNKNOWN,5.0,SNP
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.03727796673774719,Stable,KIT,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Stomach,Gastric,White,54.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,404.0,UNKNOWN,5.0,DEL
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.044892147183418274,Stable,KIT,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.43008965253829956,OTHER,Medical Therapy,693.319845127095,UNKNOWN,5.0,DEL
P-0009156-T01-IM5,1135.0,40.0,45.0,45.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.03727796673774719,Stable,KIT,ONGOING,1.0,84.657,ALIVE,P-0009156,NS,Neoadjuvant,Stomach,Gastric,White,54.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,404.0,UNKNOWN,5.0,INS
P-0009156-T01-IM5,1135.0,40.0,45.0,46.0,Hispanic/Latino,11/21,Female,Not Applicable,5.0,0.044892147183418274,Stable,KIT,NS,2.0,78.444,ALIVE,P-0009156,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.43008965253829956,OTHER,Medical Therapy,693.319845127095,UNKNOWN,5.0,INS
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Female,Not Applicable,38.0,0.04392142593860626,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Female,Not Applicable,38.0,0.0,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Female,Not Applicable,38.0,0.0,Stable,TP63,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.34402984380722046,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04411099851131439,Stable,KIT,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,KIT,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,KIT,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.34403377771377563,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04411099851131439,Stable,TP53,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP53,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP53,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.34403377771377563,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04411099851131439,Stable,PDGFRA,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,PDGFRA,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,PDGFRA,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.34403377771377563,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04411099851131439,Stable,KIT;TP53,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,KIT;TP53,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,KIT;TP53,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.34403377771377563,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04411099851131439,Stable,KIT;PDGFRA,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,KIT;PDGFRA,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,KIT;PDGFRA,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.34403377771377563,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04411099851131439,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.34403377771377563,IMATINIB,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04411099851131439,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.34403377771377563,REGORAFENIB,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04411099851131439,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Small Intestine,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Small Intestine,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,0.34403377771377563,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04411099851131439,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Colon,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Colon,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,0.34403377771377563,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04411099851131439,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Rectum,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Rectum,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,0.34403377771377563,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04388922452926636,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,214.0,NR,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.3440477252006531,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,SNP
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04411099851131439,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,NR,5.5,DEL
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,DEL
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.34403377771377563,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,DEL
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.04411099851131439,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,214.0,NR,5.5,INS
P-0009195-T01-IM5,551.0,80.0,27.0,31.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,1.0,85.775,ALIVE,P-0009195,NS,NS,Stomach,Gastric,White,39.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1216.0,SD,5.5,INS
P-0009195-T01-IM5,551.0,80.0,27.0,32.0,Non-Hispanic,11/14,Male,Not Applicable,38.0,0.0,Stable,TP63,NS,2.0,80.745,ALIVE,P-0009195,No,NS,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.34403377771377563,OTHER,Medical Therapy,739.80197069923,UNKNOWN,5.5,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Male,Mesentery,2.0,1.9294285774230957,Stable,KMT2B,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.328951835632324,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Male,Mesentery,2.0,1.9294285774230957,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.328951835632324,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Male,Mesentery,2.0,1.979575753211975,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289542198181152,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Male,Mesentery,2.0,1.9801691770553589,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Male,Mesentery,2.0,2.000492572784424,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Male,Mesentery,2.0,2.0109426975250244,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Male,Mesentery,2.0,1.9801691770553589,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Male,Mesentery,2.0,1.9458287954330444,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Male,Mesentery,2.0,2.000492572784424,Stable,KMT2D,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Male,Mesentery,2.0,2.0109426975250244,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Male,Mesentery,2.0,1.9458287954330444,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Male,Mesentery,2.0,2.0109426975250244,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Male,Mesentery,2.0,1.9801691770553589,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Male,Mesentery,2.0,1.9458287954330444,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Male,Mesentery,2.0,2.000492572784424,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,TP53,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,TP53,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,TP53,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,TP53,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,TP53,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,TP53,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,TP53,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,PDGFRA,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,PDGFRA,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,PDGFRA,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,PDGFRA,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KIT;TP53,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KIT;TP53,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,KIT;TP53,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,KIT;TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,KIT;TP53,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT;TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,KIT;TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT;TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,KIT;TP53,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT;TP53,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT;TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT;TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,KIT;TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT;TP53,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,KIT;TP53,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KIT;PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KIT;PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,KIT;PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,KIT;PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,KIT;PDGFRA,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT;PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,KIT;PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT;PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,KIT;PDGFRA,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT;PDGFRA,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT;PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT;PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,KIT;PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT;PDGFRA,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,KIT;PDGFRA,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KMT2B,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,IMATINIB,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,IMATINIB,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,IMATINIB,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,KMT2D,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KMT2B,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,SUNITINIB,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,SUNITINIB,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,SUNITINIB,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,KMT2D,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KMT2B,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,REGORAFENIB,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,REGORAFENIB,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,REGORAFENIB,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,KMT2D,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KMT2B,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Stomach,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Stomach,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Stomach,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Stomach,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Stomach,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Stomach,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Stomach,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Stomach,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,KMT2D,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Stomach,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Stomach,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Stomach,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Stomach,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Stomach,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Stomach,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Stomach,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KMT2B,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Colon,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Colon,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Colon,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Colon,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Colon,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Colon,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Colon,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Colon,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,KMT2D,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Colon,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Colon,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Colon,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Colon,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Colon,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Colon,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Colon,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KMT2B,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Rectum,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Rectum,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Rectum,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Rectum,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Rectum,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Rectum,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Rectum,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Rectum,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,KMT2D,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Rectum,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Rectum,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Rectum,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Rectum,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Rectum,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Rectum,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Rectum,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.929593801498413,Stable,KMT2B,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Primary,Localized,2.32894229888916,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.929593801498413,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Primary,Localized,2.32894229888916,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9797416925430298,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,2.328944683074951,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.980299711227417,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0006043910980225,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0110466480255127,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.980299711227417,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.945833444595337,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0006043910980225,Stable,KMT2D,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0110466480255127,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.945833444595337,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,SNP
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0110466480255127,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.980299711227417,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.945833444595337,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0006043910980225,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KMT2B,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,KMT2D,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,DEL
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,KMT2B,NS,1.0,12.986,ALIVE,P-0009615,No,Neoadjuvant,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9293936491012573,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Intestine,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289525508880615,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/21,Female,Mesentery,2.0,1.9795308113098145,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,No,NS,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,2.3289546966552734,OTHER,Medical Therapy,346.77258608474403,UNKNOWN,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.98012375831604,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.000385046005249,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.0107977390289307,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.98012375831604,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,1.9457725286483765,Stable,KMT2D,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,11/54,Female,Mesentery,2.0,2.000385046005249,Stable,KMT2D,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,2.0107977390289307,Stable,PPP2R1A,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,5/15,Female,Mesentery,2.0,1.9457725286483765,Stable,PPP2R1A,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.0107977390289307,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,212.0,SD,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.98012375831604,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,396.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,1.9457725286483765,Stable,KIT,NS,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,487.0,CR,17.0,INS
P-0009615-T01-IM5,856.0,70.0,46.0,54.0,Hispanic/Latino,9/21,Female,Mesentery,2.0,2.000385046005249,Stable,KIT,ONGOING,1.0,12.986,ALIVE,P-0009615,NS,NS,Small Intestine,Small Bowel,Unknown,49.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,284.0,CR,17.0,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Male,Peritoneum,3.0,0.07719023525714874,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Male,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504297733306885,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Male,Peritoneum,3.0,0.07721984386444092,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Male,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Male,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Male,Peritoneum,3.0,0.07806406915187836,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Male,Peritoneum,3.0,0.07721984386444092,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Male,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504297733306885,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Male,Peritoneum,3.0,0.07719023525714874,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Male,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Male,Peritoneum,3.0,0.07806406915187836,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Male,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,TP53,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,TP53,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,TP53,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,TP53,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,PDGFRA,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,PDGFRA,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT;TP53,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT;TP53,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT;TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT;TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT;TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT;TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT;TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT;TP53,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT;TP53,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT;TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT;TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT;TP53,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT;PDGFRA,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT;PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT;PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT;PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT;PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT;PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT;PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT;PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT;PDGFRA,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT;PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT;PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT;PDGFRA,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,191.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,IMATINIB,Medical Therapy,722.89340034965,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1278.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,184.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,92.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,IMATINIB,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,191.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,SUNITINIB,Medical Therapy,722.89340034965,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1278.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,184.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,SUNITINIB,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,2252.0,SD,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07724803686141968,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.350450873374939,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07724647223949432,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07811759412288666,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07724647223949432,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.350450873374939,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07724803686141968,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07811759412288666,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,DEL
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,SNP
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.07696503400802612,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,92.0,UNKNOWN,6.5,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3504459857940674,OTHER,Medical Therapy,722.89340034965,UNKNOWN,6.5,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07709337770938873,Stable,KIT,ONGOING,1.0,66.871,ALIVE,P-0009938,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,6.5,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,1278.0,UNKNOWN,6.5,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,17/21,Female,Peritoneum,3.0,0.07796522974967957,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,184.0,UNKNOWN,6.5,INS
P-0009938-T01-IM5,832.0,60.0,37.0,50.0,Non-Hispanic,11/21,Female,Peritoneum,3.0,0.0,Stable,KIT,NS,1.0,66.871,ALIVE,P-0009938,NS,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,2252.0,SD,6.5,INS
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Female,Not Applicable,44.0,0.5697147846221924,Stable,EPHA7,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.6319611072540283,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Female,Not Applicable,44.0,0.5636336803436279,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Female,Not Applicable,44.0,0.651531994342804,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Female,Not Applicable,44.0,0.5636336803436279,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Female,Not Applicable,44.0,0.651531994342804,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Female,Not Applicable,44.0,0.5697147846221924,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.6319611072540283,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,KIT,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,KIT,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,KIT,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,KIT,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,KIT,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,KIT,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,TP53,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,TP53,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,TP53,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,TP53,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,TP53,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,TP53,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,KIT;TP53,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,KIT;TP53,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,KIT;TP53,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,KIT;TP53,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,KIT;TP53,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,KIT;TP53,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,KIT;PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,KIT;PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,KIT;PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,KIT;PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,KIT;PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,KIT;PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,EPHA7,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,IMATINIB,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,IMATINIB,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,EPHA7,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,SUNITINIB,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,SUNITINIB,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,EPHA7,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,REGORAFENIB,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,REGORAFENIB,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,EPHA7,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Small Intestine,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Small Intestine,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Small Intestine,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Small Intestine,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Small Intestine,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Small Intestine,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,EPHA7,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Colon,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Colon,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Colon,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Colon,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Colon,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Colon,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,EPHA7,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Rectum,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Rectum,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Rectum,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Rectum,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Rectum,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Rectum,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5695593357086182,Stable,EPHA7,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Metastasis,Localized,1.6317715644836426,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5635826587677002,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.651391863822937,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5635826587677002,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.651391863822937,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5695593357086182,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Metastasis,Localized,1.6317715644836426,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,SNP
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,EPHA7,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,DEL
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,DEL
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,DEL
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,DEL
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,DEL
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,DEL
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5696753859519958,Stable,EPHA7,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,INS
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.5636182427406311,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,INS
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,14/23,Male,Not Applicable,44.0,0.6517476439476013,Stable,PDGFRA,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,INS
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.5636182427406311,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,365.0,SD,18.0,INS
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,10/17,Male,Not Applicable,44.0,0.6517476439476013,Stable,EPHA7,ONGOING,1.0,13.907,DECEASED,P-0010175,NS,Neoadjuvant,Stomach,Gastric,Unknown,26.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,191.0,UNKNOWN,18.0,INS
P-0010175-T02-IM5,392.0,15.0,65.0,69.0,Non-Hispanic,18/23,Male,Not Applicable,44.0,0.5696753859519958,Stable,PDGFRA,NS,1.0,13.907,DECEASED,P-0010175,No,Neoadjuvant,Stomach,Gastric,Unknown,0.0,Recurrence,Primary,Localized,1.631903052330017,OTHER,Medical Therapy,323.9911143181133,UNKNOWN,18.0,INS
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Male,Pelvis,1.0,1.5460078716278076,Stable,ARID2,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Male,Pelvis,1.0,1.5460078716278076,Stable,ANKRD11,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Male,Pelvis,1.0,1.5460078716278076,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Male,Pelvis,1.0,1.5460078716278076,Stable,ARID1A,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Male,Not Applicable,1.0,0.7253377437591553,Stable,ARID2,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554783821105957,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Male,Not Applicable,1.0,0.7253377437591553,Stable,ANKRD11,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554783821105957,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.7253377437591553,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554783821105957,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Male,Not Applicable,1.0,0.7253377437591553,Stable,FYN,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554783821105957,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Male,Not Applicable,1.0,0.7253377437591553,Stable,CALR,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554783821105957,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,1.0,0.7253377437591553,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554783821105957,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,TP53,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,TP53,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,TP53,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,TP53,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,TP53,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,TP53,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,TP53,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,TP53,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,TP53,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,TP53,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,PDGFRA,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,PDGFRA,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,PDGFRA,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,PDGFRA,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,PDGFRA,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,PDGFRA,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,PDGFRA,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,PDGFRA,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,PDGFRA,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,PDGFRA,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT;TP53,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,KIT;TP53,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT;TP53,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,KIT;TP53,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT;TP53,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT;TP53,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT;TP53,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT;TP53,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT;TP53,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT;TP53,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT;PDGFRA,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,KIT;PDGFRA,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT;PDGFRA,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,KIT;PDGFRA,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT;PDGFRA,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT;PDGFRA,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT;PDGFRA,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT;PDGFRA,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT;PDGFRA,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT;PDGFRA,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,ARID2,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,ANKRD11,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,ARID1A,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,ARID2,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,SUNITINIB,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,ANKRD11,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,SUNITINIB,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,SUNITINIB,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,FYN,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,SUNITINIB,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,CALR,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,SUNITINIB,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,SUNITINIB,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,ARID2,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,ANKRD11,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,ARID1A,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,ARID2,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,REGORAFENIB,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,ANKRD11,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,REGORAFENIB,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,REGORAFENIB,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,FYN,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,REGORAFENIB,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,CALR,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,REGORAFENIB,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,REGORAFENIB,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,ARID2,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Stomach,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,ANKRD11,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Stomach,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Stomach,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,ARID1A,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Stomach,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,ARID2,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,ANKRD11,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,FYN,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,CALR,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,ARID2,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Small Intestine,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,ANKRD11,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Small Intestine,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Small Intestine,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,ARID1A,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Small Intestine,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,ARID2,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,ANKRD11,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,FYN,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,CALR,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,ARID2,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Colon,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,ANKRD11,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Colon,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Colon,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,ARID1A,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Colon,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,ARID2,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,ANKRD11,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,FYN,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,CALR,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,ARID2,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Rectum,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,ANKRD11,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Rectum,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Rectum,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,ARID1A,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Rectum,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,ARID2,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,ANKRD11,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,FYN,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,CALR,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.5460695028305054,Stable,ARID2,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.5460695028305054,Stable,ANKRD11,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.5460695028305054,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.5460695028305054,Stable,ARID1A,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,ARID2,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,ANKRD11,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,FYN,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,CALR,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,SNP
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,ARID2,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,ANKRD11,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,ARID1A,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,ARID2,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,ANKRD11,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,FYN,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,CALR,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,DEL
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,15/21,Female,Pelvis,1.0,1.545892357826233,Stable,ARID2,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,INS
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,10/13,Female,Pelvis,1.0,1.545892357826233,Stable,ANKRD11,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,INS
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,11/21,Female,Pelvis,1.0,1.545892357826233,Stable,KIT,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,INS
P-0010183-T01-IM5,1107.0,60.0,37.0,73.0,Non-Hispanic,1/20,Female,Pelvis,1.0,1.545892357826233,Stable,ARID1A,ONGOING,1.0,84.92,ALIVE,P-0010183,NS,NS,Abdomen/Intraabdominal,Gastric,White,54.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,281.0,UNKNOWN,21.0,INS
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,ARID2,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,INS
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,10/13,Female,Not Applicable,1.0,0.7252839207649231,Stable,ANKRD11,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,INS
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,INS
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,FYN,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,INS
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,15/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,CALR,ONGOING,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,INS
P-0010183-T02-IM6,649.0,80.0,37.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,1.0,0.7252839207649231,Stable,KIT,NS,2.0,79.2,ALIVE,P-0010183,No,Neoadjuvant,Abdomen/Intraabdominal,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.554786205291748,OTHER,Medical Therapy,771.8999973544808,UNKNOWN,21.0,INS
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Male,Pancreas,10.0,1.4692249298095703,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Male,Pancreas,10.0,1.6401094198226929,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Male,Pancreas,10.0,1.5105280876159668,Stable,KIT,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.3543129563331604,OTHER,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4690964221954346,Stable,TP53,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6398547887802124,Stable,TP53,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5104671716690063,Stable,TP53,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.35433030128479004,OTHER,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4690964221954346,Stable,PDGFRA,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6398547887802124,Stable,PDGFRA,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5104671716690063,Stable,PDGFRA,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.35433030128479004,OTHER,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4690964221954346,Stable,KIT;TP53,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6398547887802124,Stable,KIT;TP53,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5104671716690063,Stable,KIT;TP53,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.35433030128479004,OTHER,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4690964221954346,Stable,KIT;PDGFRA,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6398547887802124,Stable,KIT;PDGFRA,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5104671716690063,Stable,KIT;PDGFRA,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.35433030128479004,OTHER,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4690964221954346,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6398547887802124,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5104671716690063,Stable,KIT,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.35433030128479004,IMATINIB,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4690964221954346,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6398547887802124,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5104671716690063,Stable,KIT,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.35433030128479004,SUNITINIB,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4690964221954346,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6398547887802124,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5104671716690063,Stable,KIT,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.35433030128479004,REGORAFENIB,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4690964221954346,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Stomach,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6398547887802124,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Stomach,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5104671716690063,Stable,KIT,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Stomach,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.35433030128479004,OTHER,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4690964221954346,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Colon,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6398547887802124,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Colon,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5104671716690063,Stable,KIT,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Colon,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.35433030128479004,OTHER,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4690964221954346,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Rectum,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6398547887802124,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Rectum,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5104671716690063,Stable,KIT,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Rectum,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.35433030128479004,OTHER,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4691238403320312,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Primary,Localized,0.0,NILOTINIB,Medical Therapy,943.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6401660442352295,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5105847120285034,Stable,KIT,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Primary,Localized,0.35432296991348267,OTHER,Medical Therapy,446.7855712152603,UNKNOWN,5.0,DEL
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4690964221954346,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,943.0,UNKNOWN,5.0,SNP
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6398547887802124,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,SNP
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5104671716690063,Stable,KIT,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.35433030128479004,OTHER,Medical Therapy,446.7855712152603,UNKNOWN,5.0,SNP
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.4690964221954346,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,943.0,UNKNOWN,5.0,INS
P-0010949-T01-IM5,755.0,85.0,48.0,54.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.6398547887802124,Stable,KIT,NS,1.0,83.573,ALIVE,P-0010949,NS,NS,Small Intestine,Small Bowel,White,42.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,89.0,UNKNOWN,5.0,INS
P-0010949-T01-IM5,755.0,85.0,48.0,55.0,Non-Hispanic,11/21,Female,Pancreas,10.0,1.5104671716690063,Stable,KIT,NS,2.0,78.279,ALIVE,P-0010949,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,0.35433030128479004,OTHER,Medical Therapy,446.7855712152603,UNKNOWN,5.0,INS
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Female,Not Applicable,2.0,1.3494081497192383,Stable,KDM6A,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Female,Not Applicable,2.0,1.3494081497192383,Stable,KIT,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Female,Not Applicable,2.0,1.2893656492233276,Stable,KIT,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823528289794922,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Female,Not Applicable,2.0,1.2893656492233276,Stable,KDM6A,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823528289794922,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3497443199157715,Stable,TP53,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3497443199157715,Stable,TP53,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.289446473121643,Stable,TP53,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.289446473121643,Stable,TP53,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3497443199157715,Stable,PDGFRA,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3497443199157715,Stable,PDGFRA,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.289446473121643,Stable,PDGFRA,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.289446473121643,Stable,PDGFRA,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT;TP53,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT;TP53,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT;TP53,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT;TP53,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT;PDGFRA,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT;PDGFRA,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT;PDGFRA,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT;PDGFRA,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3497443199157715,Stable,KDM6A,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,SUNITINIB,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.289446473121643,Stable,KDM6A,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,SUNITINIB,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3497443199157715,Stable,KDM6A,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,REGORAFENIB,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.289446473121643,Stable,KDM6A,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,REGORAFENIB,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3497443199157715,Stable,KDM6A,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Stomach,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Stomach,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Stomach,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.289446473121643,Stable,KDM6A,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Stomach,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3497443199157715,Stable,KDM6A,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Colon,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Colon,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Colon,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.289446473121643,Stable,KDM6A,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Colon,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3497443199157715,Stable,KDM6A,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Rectum,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Rectum,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Rectum,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.289446473121643,Stable,KDM6A,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Rectum,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3493901491165161,Stable,KDM6A,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3493901491165161,Stable,KIT,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.2893867492675781,Stable,KIT,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Small Intestine,Small Bowel,Other,0.0,Recurrence,Metastasis,Metastatic,1.382343053817749,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.2893867492675781,Stable,KDM6A,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Small Intestine,Small Bowel,Other,0.0,Recurrence,Metastasis,Metastatic,1.382343053817749,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,SNP
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3497443199157715,Stable,KDM6A,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.289446473121643,Stable,KDM6A,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,DEL
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,7/29,Male,Not Applicable,2.0,1.3497443199157715,Stable,KDM6A,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,INS
P-0012007-T01-IM5,776.0,50.0,63.0,63.0,Not Provided,11/21,Male,Not Applicable,2.0,1.3497443199157715,Stable,KIT,NS,1.0,67.62248000000001,ALIVE,P-0012007,NS,NS,Small Intestine,Small Bowel,Other,2.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,UNKNOWN,20.0,INS
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,11/21,Male,Not Applicable,2.0,1.289446473121643,Stable,KIT,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,NS,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,INS
P-0012007-T01-IM5,776.0,50.0,63.0,64.0,Not Provided,7/29,Male,Not Applicable,2.0,1.289446473121643,Stable,KDM6A,NS,2.0,71.46250000000003,ALIVE,P-0012007,No,Neoadjuvant,Small Intestine,Small Bowel,Other,0.0,Recurrence,Primary,Metastatic,1.3823416233062744,OTHER,Medical Therapy,444.92777022977026,UNKNOWN,20.0,INS
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Male,Not Applicable,46.0,0.7764867544174194,Stable,IRS2,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,46.0,0.8522224426269531,Stable,KIT,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331170082092285,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Male,Not Applicable,46.0,0.8522224426269531,Stable,IRS2,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331170082092285,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,46.0,0.7764867544174194,Stable,KIT,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7763338088989258,Stable,TP53,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8521290421485901,Stable,TP53,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8521290421485901,Stable,TP53,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7763338088989258,Stable,TP53,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7763338088989258,Stable,PDGFRA,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8521290421485901,Stable,PDGFRA,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8521290421485901,Stable,PDGFRA,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7763338088989258,Stable,PDGFRA,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT;TP53,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT;TP53,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT;TP53,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT;TP53,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT;PDGFRA,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT;PDGFRA,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT;PDGFRA,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT;PDGFRA,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7763338088989258,Stable,IRS2,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,SUNITINIB,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8521290421485901,Stable,IRS2,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,SUNITINIB,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7763338088989258,Stable,IRS2,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,REGORAFENIB,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8521290421485901,Stable,IRS2,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,REGORAFENIB,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7763338088989258,Stable,IRS2,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Small Intestine,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Small Intestine,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8521290421485901,Stable,IRS2,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Small Intestine,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Small Intestine,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7763338088989258,Stable,IRS2,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Colon,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Colon,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8521290421485901,Stable,IRS2,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Colon,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Colon,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7763338088989258,Stable,IRS2,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Rectum,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Rectum,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8521290421485901,Stable,IRS2,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Rectum,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Rectum,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7760002017021179,Stable,IRS2,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8520164489746094,Stable,KIT,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Metastasis,Localized,1.3331224918365479,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8520164489746094,Stable,IRS2,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Metastasis,Localized,1.3331224918365479,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,SNP
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7760002017021179,Stable,KIT,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7763338088989258,Stable,IRS2,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8521290421485901,Stable,IRS2,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,DEL
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.7763338088989258,Stable,IRS2,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,INS
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.8521290421485901,Stable,KIT,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,INS
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,1/2,Female,Not Applicable,46.0,0.8521290421485901,Stable,IRS2,NS,1.0,56.252,ALIVE,P-0012411,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,1.3331165313720703,OTHER,Medical Therapy,224.0685712777315,UNKNOWN,8.5,INS
P-0012411-T01-IM5,860.0,90.0,58.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,46.0,0.7763338088989258,Stable,KIT,ONGOING,1.0,56.252,ALIVE,P-0012411,NS,Neoadjuvant,Stomach,Gastric,Asian,6.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,160.0,NE,8.5,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Female,Abdominal Mass,26.43,5.328864574432373,Indeterminate,KIT,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Female,Abdominal Mass,26.93,5.504982948303223,Indeterminate,KIT,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Female,Abdominal Mass,26.43,5.328864574432373,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Female,Abdominal Mass,26.93,5.504982948303223,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Female,Abdominal Mass,26.93,5.504982948303223,Indeterminate,MGA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Female,Abdominal Mass,26.43,5.328864574432373,Indeterminate,MGA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Female,Renal Pelvis,51.38,4.266592025756836,Do not report,MGA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.9773101806640625,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Female,Renal Pelvis,51.38,4.266592025756836,Do not report,PIK3C2G,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.9773101806640625,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Female,Renal Pelvis,51.38,4.266592025756836,Do not report,KIT,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.9773101806640625,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,TP53,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,TP53,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,TP53,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,TP53,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,TP53,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,TP53,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,TP53,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,TP53,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,TP53,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,PDGFRA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,PDGFRA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,PDGFRA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,PDGFRA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,PDGFRA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,PDGFRA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,PDGFRA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,PDGFRA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,PDGFRA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT;TP53,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT;TP53,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT;TP53,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT;TP53,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT;TP53,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT;TP53,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT;TP53,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT;TP53,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT;TP53,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT;PDGFRA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT;PDGFRA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT;PDGFRA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT;PDGFRA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT;PDGFRA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT;PDGFRA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT;PDGFRA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT;PDGFRA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT;PDGFRA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1187.0,NE,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,373.0,CR,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,MGA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,MGA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,MGA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,SUNITINIB,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,PIK3C2G,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,SUNITINIB,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,SUNITINIB,Medical Therapy,305.0956224812253,UNKNOWN,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1187.0,NE,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,373.0,CR,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,MGA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,MGA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,MGA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,REGORAFENIB,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,PIK3C2G,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,REGORAFENIB,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,REGORAFENIB,Medical Therapy,305.0956224812253,UNKNOWN,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Stomach,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Stomach,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Stomach,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Stomach,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,MGA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Stomach,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,MGA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Stomach,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,MGA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Stomach,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,PIK3C2G,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Stomach,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Stomach,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Colon,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Colon,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Colon,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Colon,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,MGA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Colon,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,MGA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Colon,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,MGA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Colon,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,PIK3C2G,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Colon,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Colon,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Rectum,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Rectum,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Rectum,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Rectum,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,MGA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Rectum,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,MGA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Rectum,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,MGA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Rectum,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,PIK3C2G,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Rectum,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Rectum,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.329007148742676,Indeterminate,KIT,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.505205154418945,Indeterminate,KIT,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.329007148742676,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.505205154418945,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.505205154418945,Indeterminate,MGA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.329007148742676,Indeterminate,MGA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.266769886016846,Do not report,MGA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Primary,Metastatic,1.9773046970367432,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.266769886016846,Do not report,PIK3C2G,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Primary,Metastatic,1.9773046970367432,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.266769886016846,Do not report,KIT,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Primary,Metastatic,1.9773046970367432,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,INS
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,MGA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,MGA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,MGA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,PIK3C2G,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,SNP
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,KIT,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,9/21,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,KIT,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,1/31,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,PIK3C2G,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,17/24,Male,Abdominal Mass,26.93,5.505081653594971,Indeterminate,MGA,ONGOING,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,373.0,CR,12.0,DEL
P-0012459-T01-IM5,1031.0,90.0,58.0,72.0,Non-Hispanic,11/21,Male,Abdominal Mass,26.43,5.328950881958008,Indeterminate,MGA,NS,1.0,20.614,DECEASED,P-0012459,NS,Palliative,Small Intestine,Small Bowel,White,40.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1187.0,NE,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,17/24,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,MGA,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/31,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,PIK3C2G,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012459-T02-IM6,1079.0,80.0,58.0,73.0,Non-Hispanic,11/21,Male,Renal Pelvis,51.38,4.266706943511963,Do not report,KIT,NS,2.0,20.614,DECEASED,P-0012459,No,Neoadjuvant,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Metastatic,1.977308988571167,OTHER,Medical Therapy,305.0956224812253,UNKNOWN,12.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Female,Liver,55.0,1.283807396888733,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Female,Liver,55.0,1.2691586017608643,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Female,Liver,55.0,1.2822704315185547,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Female,Liver,55.0,1.1476492881774902,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Female,Liver,55.0,1.1476492881774902,Stable,PTPRS,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Female,Liver,55.0,1.1678903102874756,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.290745973587036,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Female,Liver,55.0,1.2822704315185547,Stable,PTPRS,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Female,Liver,55.0,1.2691586017608643,Stable,PTPRS,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Female,Liver,55.0,1.1476492881774902,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Female,Liver,55.0,1.2822704315185547,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Female,Liver,55.0,1.283807396888733,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Female,Liver,55.0,1.2691586017608643,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Female,Liver,55.0,1.1476492881774902,Stable,MAX,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Female,Liver,55.0,1.2822704315185547,Stable,MAX,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Female,Liver,55.0,1.283807396888733,Stable,MAX,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Female,Liver,55.0,1.2691586017608643,Stable,MAX,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Female,Liver,55.0,1.1678903102874756,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.290745973587036,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Female,Liver,55.0,1.1678903102874756,Stable,PTPRS,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.290745973587036,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Female,Liver,55.0,1.1678903102874756,Stable,MAX,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.290745973587036,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Female,Liver,55.0,1.283807396888733,Stable,PTPRS,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,TP53,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,TP53,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,TP53,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,TP53,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,TP53,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,TP53,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,TP53,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,TP53,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,TP53,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,TP53,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,TP53,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,TP53,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,TP53,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,TP53,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,TP53,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,TP53,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,TP53,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,TP53,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,TP53,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,TP53,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,PDGFRA,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,PDGFRA,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,PDGFRA,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,PDGFRA,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,PDGFRA,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,PDGFRA,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,PDGFRA,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,PDGFRA,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,PDGFRA,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,PDGFRA,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,PDGFRA,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,PDGFRA,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,PDGFRA,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,PDGFRA,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,PDGFRA,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,PDGFRA,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,PDGFRA,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,PDGFRA,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,PDGFRA,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,PDGFRA,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT;TP53,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT;TP53,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT;TP53,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,KIT;TP53,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,KIT;TP53,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT;TP53,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,KIT;TP53,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,KIT;TP53,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,KIT;TP53,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT;TP53,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT;TP53,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT;TP53,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,KIT;TP53,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,KIT;TP53,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,KIT;TP53,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,KIT;TP53,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT;TP53,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,KIT;TP53,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT;TP53,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,KIT;TP53,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT;PDGFRA,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT;PDGFRA,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT;PDGFRA,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,KIT;PDGFRA,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,KIT;PDGFRA,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT;PDGFRA,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,KIT;PDGFRA,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,KIT;PDGFRA,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,KIT;PDGFRA,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT;PDGFRA,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT;PDGFRA,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT;PDGFRA,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,KIT;PDGFRA,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,KIT;PDGFRA,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,KIT;PDGFRA,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,KIT;PDGFRA,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT;PDGFRA,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,KIT;PDGFRA,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT;PDGFRA,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,KIT;PDGFRA,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,PTPRS,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,IMATINIB,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,PTPRS,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,PTPRS,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,MAX,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,MAX,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,MAX,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,MAX,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,IMATINIB,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,PTPRS,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,IMATINIB,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,MAX,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,IMATINIB,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,PTPRS,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,PTPRS,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,SUNITINIB,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,PTPRS,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,PTPRS,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,MAX,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,MAX,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,MAX,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,MAX,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,SUNITINIB,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,PTPRS,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,SUNITINIB,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,MAX,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,SUNITINIB,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,PTPRS,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,PTPRS,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,REGORAFENIB,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,PTPRS,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,PTPRS,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,MAX,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,MAX,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,MAX,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,MAX,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,REGORAFENIB,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,PTPRS,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,REGORAFENIB,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,MAX,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,REGORAFENIB,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,PTPRS,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,PTPRS,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,PTPRS,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,PTPRS,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,MAX,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,MAX,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,MAX,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,MAX,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,PTPRS,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,MAX,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,PTPRS,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Stomach,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,PTPRS,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,PTPRS,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,PTPRS,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,MAX,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,MAX,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,MAX,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,MAX,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,PTPRS,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,MAX,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,PTPRS,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Small Intestine,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,PTPRS,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,PTPRS,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,PTPRS,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,MAX,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,MAX,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,MAX,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,MAX,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,PTPRS,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,MAX,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,PTPRS,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Colon,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,PTPRS,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,PTPRS,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,PTPRS,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,MAX,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,MAX,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,MAX,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,MAX,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,PTPRS,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,MAX,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,PTPRS,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Rectum,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2843706607818604,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2693690061569214,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2826757431030273,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147727131843567,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147727131843567,Stable,PTPRS,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1680070161819458,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,3.290731906890869,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2826757431030273,Stable,PTPRS,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2693690061569214,Stable,PTPRS,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147727131843567,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2826757431030273,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2843706607818604,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2693690061569214,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147727131843567,Stable,MAX,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2826757431030273,Stable,MAX,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2843706607818604,Stable,MAX,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2693690061569214,Stable,MAX,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1680070161819458,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,3.290731906890869,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1680070161819458,Stable,PTPRS,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,3.290731906890869,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1680070161819458,Stable,MAX,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,3.290731906890869,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2843706607818604,Stable,PTPRS,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Primary,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,SNP
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,PTPRS,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,PTPRS,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,PTPRS,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,MAX,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,MAX,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,MAX,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,MAX,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,PTPRS,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,MAX,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,PTPRS,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,DEL
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,17/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.147601842880249,Stable,PTPRS,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2824342250823975,Stable,PTPRS,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2692394256591797,Stable,PTPRS,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.147601842880249,Stable,KIT,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2824342250823975,Stable,KIT,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2840914726257324,Stable,KIT,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.2692394256591797,Stable,KIT,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.147601842880249,Stable,MAX,NS,1.0,37.29266999999999,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,791.0,UNKNOWN,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2824342250823975,Stable,MAX,NS,1.0,27.480920000000005,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,183.0,UNKNOWN,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2840914726257324,Stable,MAX,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,1/5,Male,Liver,55.0,1.2692394256591797,Stable,MAX,NS,1.0,27.628850000000007,ALIVE,P-0012564,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,310.0,NE,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,KIT,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.1678699254989624,Stable,PTPRS,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,11/21,Male,Liver,55.0,1.1678699254989624,Stable,MAX,NS,1.0,47.56136999999999,ALIVE,P-0012564,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,3.2907297611236572,OTHER,Medical Therapy,689.8732600041334,UNKNOWN,10.0,INS
P-0012564-T01-IM5,952.0,80.0,60.0,64.0,Non-Hispanic,36/38,Male,Liver,55.0,1.2840914726257324,Stable,PTPRS,NO END DATE,1.0,27.480920000000005,ALIVE,P-0012564,NS,NS,Abdomen/Intraabdominal,Small Bowel,Black or African American,0.0,Recurrence,Metastasis,Metastatic,0.0,SORAFENIB,Medical Therapy,1.0,NE,10.0,INS
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Male,Mesentery,7.0,0.8640521168708801,Stable,CDK12,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Male,Mesentery,7.0,0.8640521168708801,Stable,PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Male,Mesentery,7.0,0.9874027967453003,Stable,CDK12,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3528711795806885,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Male,Mesentery,7.0,0.9874027967453003,Stable,PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.3528711795806885,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Male,Mesentery,7.0,0.9877706170082092,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Male,Mesentery,7.0,0.9903894066810608,Stable,PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Male,Mesentery,7.0,0.9877706170082092,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Male,Mesentery,7.0,0.9457617998123169,Stable,PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Male,Mesentery,7.0,0.9877706170082092,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Male,Mesentery,7.0,0.9903894066810608,Stable,CDK12,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Male,Mesentery,7.0,0.9877706170082092,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Male,Mesentery,7.0,0.9457617998123169,Stable,CDK12,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8640803098678589,Stable,KIT,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8640803098678589,Stable,KIT,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9871340990066528,Stable,KIT,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9871340990066528,Stable,KIT,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,KIT,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9900949001312256,Stable,KIT,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,KIT,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9457202553749084,Stable,KIT,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,KIT,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9900949001312256,Stable,KIT,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,KIT,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9457202553749084,Stable,KIT,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8640803098678589,Stable,TP53,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8640803098678589,Stable,TP53,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9871340990066528,Stable,TP53,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9871340990066528,Stable,TP53,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,TP53,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9900949001312256,Stable,TP53,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,TP53,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9457202553749084,Stable,TP53,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,TP53,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9900949001312256,Stable,TP53,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,TP53,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9457202553749084,Stable,TP53,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8640803098678589,Stable,PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8640803098678589,Stable,PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9871340990066528,Stable,PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9871340990066528,Stable,PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9900949001312256,Stable,PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9457202553749084,Stable,PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9900949001312256,Stable,PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9457202553749084,Stable,PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8640803098678589,Stable,KIT;TP53,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8640803098678589,Stable,KIT;TP53,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9871340990066528,Stable,KIT;TP53,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9871340990066528,Stable,KIT;TP53,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,KIT;TP53,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9900949001312256,Stable,KIT;TP53,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,KIT;TP53,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9457202553749084,Stable,KIT;TP53,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,KIT;TP53,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9900949001312256,Stable,KIT;TP53,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,KIT;TP53,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9457202553749084,Stable,KIT;TP53,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8640803098678589,Stable,KIT;PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8640803098678589,Stable,KIT;PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9871340990066528,Stable,KIT;PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9871340990066528,Stable,KIT;PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,KIT;PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9900949001312256,Stable,KIT;PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,KIT;PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9457202553749084,Stable,KIT;PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,KIT;PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9900949001312256,Stable,KIT;PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,KIT;PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9457202553749084,Stable,KIT;PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8640803098678589,Stable,CDK12,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8640803098678589,Stable,PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9871340990066528,Stable,CDK12,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,SUNITINIB,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9871340990066528,Stable,PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,SUNITINIB,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9900949001312256,Stable,PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9457202553749084,Stable,PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9900949001312256,Stable,CDK12,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9457202553749084,Stable,CDK12,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8640803098678589,Stable,CDK12,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8640803098678589,Stable,PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9871340990066528,Stable,CDK12,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,REGORAFENIB,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9871340990066528,Stable,PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,REGORAFENIB,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9900949001312256,Stable,PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9457202553749084,Stable,PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9900949001312256,Stable,CDK12,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9457202553749084,Stable,CDK12,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8640803098678589,Stable,CDK12,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Small Intestine,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8640803098678589,Stable,PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Small Intestine,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9871340990066528,Stable,CDK12,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9871340990066528,Stable,PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Small Intestine,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9900949001312256,Stable,PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Small Intestine,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Small Intestine,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9457202553749084,Stable,PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Small Intestine,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Small Intestine,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9900949001312256,Stable,CDK12,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Small Intestine,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Small Intestine,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9457202553749084,Stable,CDK12,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Small Intestine,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8640803098678589,Stable,CDK12,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Colon,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8640803098678589,Stable,PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Colon,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9871340990066528,Stable,CDK12,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9871340990066528,Stable,PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Colon,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9900949001312256,Stable,PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Colon,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Colon,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9457202553749084,Stable,PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Colon,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Colon,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9900949001312256,Stable,CDK12,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Colon,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Colon,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9457202553749084,Stable,CDK12,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Colon,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8640803098678589,Stable,CDK12,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Rectum,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8640803098678589,Stable,PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Rectum,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9871340990066528,Stable,CDK12,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9871340990066528,Stable,PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Rectum,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9900949001312256,Stable,PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Rectum,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Rectum,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9457202553749084,Stable,PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Rectum,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Rectum,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9900949001312256,Stable,CDK12,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Rectum,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Rectum,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9457202553749084,Stable,CDK12,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Rectum,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8642757534980774,Stable,CDK12,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8642757534980774,Stable,PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9874304533004761,Stable,CDK12,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3528518676757812,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9874304533004761,Stable,PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.3528518676757812,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987755298614502,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9903393983840942,Stable,PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987755298614502,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9459190964698792,Stable,PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987755298614502,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9903393983840942,Stable,CDK12,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987755298614502,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9459190964698792,Stable,CDK12,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,SNP
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8640803098678589,Stable,CDK12,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,DEL
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8640803098678589,Stable,PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,DEL
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9871340990066528,Stable,CDK12,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,DEL
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9871340990066528,Stable,PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,DEL
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,DEL
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9900949001312256,Stable,PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,DEL
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,DEL
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9457202553749084,Stable,PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,DEL
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,DEL
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9900949001312256,Stable,CDK12,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,DEL
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,DEL
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9457202553749084,Stable,CDK12,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,DEL
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.8640803098678589,Stable,CDK12,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,INS
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.8640803098678589,Stable,PDGFRA,ONGOING,1.0,73.99513999999998,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,639.0,UNKNOWN,15.0,INS
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9871340990066528,Stable,CDK12,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,INS
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9871340990066528,Stable,PDGFRA,NS,1.0,41.01129000000001,ALIVE,P-0013017,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.352860450744629,OTHER,Medical Therapy,133.5083523028947,UNKNOWN,15.0,INS
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,INS
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9900949001312256,Stable,PDGFRA,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,INS
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.987476110458374,Stable,PDGFRA,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,INS
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,18/23,Female,Mesentery,7.0,0.9457202553749084,Stable,PDGFRA,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,INS
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,15.0,INS
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9900949001312256,Stable,CDK12,ONGOING,1.0,42.20768000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,120.0,CR,15.0,INS
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.987476110458374,Stable,CDK12,ONGOING,1.0,42.07782000000002,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,CR,15.0,INS
P-0013017-T01-IM5,812.0,70.0,59.0,65.0,Non-Hispanic,2/14,Female,Mesentery,7.0,0.9457202553749084,Stable,CDK12,ONGOING,1.0,45.96578,ALIVE,P-0013017,NS,Neoadjuvant,Stomach,Gastric,White,19.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,427.0,CR,15.0,INS
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,42.0,0.8267953395843506,Stable,KIT,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697308301925659,OTHER,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,42.0,0.8649628758430481,Stable,KIT,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,42.0,0.8081057071685791,Stable,KIT,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Female,Not Applicable,42.0,0.8908652067184448,Stable,KIT,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8269350528717041,Stable,TP53,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697160482406616,OTHER,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8650237321853638,Stable,TP53,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.808210015296936,Stable,TP53,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8911305665969849,Stable,TP53,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8269350528717041,Stable,PDGFRA,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697160482406616,OTHER,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8650237321853638,Stable,PDGFRA,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.808210015296936,Stable,PDGFRA,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8911305665969849,Stable,PDGFRA,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8269350528717041,Stable,KIT;TP53,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697160482406616,OTHER,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8650237321853638,Stable,KIT;TP53,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.808210015296936,Stable,KIT;TP53,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8911305665969849,Stable,KIT;TP53,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8269350528717041,Stable,KIT;PDGFRA,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697160482406616,OTHER,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8650237321853638,Stable,KIT;PDGFRA,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.808210015296936,Stable,KIT;PDGFRA,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8911305665969849,Stable,KIT;PDGFRA,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8269350528717041,Stable,KIT,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697160482406616,IMATINIB,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8650237321853638,Stable,KIT,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.808210015296936,Stable,KIT,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8911305665969849,Stable,KIT,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8269350528717041,Stable,KIT,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697160482406616,SUNITINIB,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8650237321853638,Stable,KIT,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.808210015296936,Stable,KIT,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8911305665969849,Stable,KIT,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8269350528717041,Stable,KIT,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697160482406616,REGORAFENIB,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8650237321853638,Stable,KIT,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.808210015296936,Stable,KIT,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8911305665969849,Stable,KIT,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8269350528717041,Stable,KIT,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Stomach,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697160482406616,OTHER,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8650237321853638,Stable,KIT,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.808210015296936,Stable,KIT,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8911305665969849,Stable,KIT,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Stomach,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8269350528717041,Stable,KIT,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Colon,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697160482406616,OTHER,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8650237321853638,Stable,KIT,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Colon,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.808210015296936,Stable,KIT,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Colon,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8911305665969849,Stable,KIT,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Colon,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8269350528717041,Stable,KIT,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Rectum,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697160482406616,OTHER,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8650237321853638,Stable,KIT,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.808210015296936,Stable,KIT,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8911305665969849,Stable,KIT,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Rectum,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8268002271652222,Stable,KIT,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Metastasis,Localized,0.36972373723983765,OTHER,Medical Therapy,406.52642534152625,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8648396730422974,Stable,KIT,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,312.0,CR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8081679940223694,Stable,KIT,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8908858895301819,Stable,KIT,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,12.0,SNP
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8269350528717041,Stable,KIT,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697160482406616,OTHER,Medical Therapy,406.52642534152625,UNKNOWN,12.0,DEL
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8650237321853638,Stable,KIT,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,312.0,CR,12.0,DEL
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.808210015296936,Stable,KIT,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,DEL
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8911305665969849,Stable,KIT,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,12.0,DEL
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8269350528717041,Stable,KIT,NS,1.0,46.27881,ALIVE,P-0013024,No,Neoadjuvant,Small Intestine,Small Bowel,Unknown,0.0,Recurrence,Primary,Localized,0.3697160482406616,OTHER,Medical Therapy,406.52642534152625,UNKNOWN,12.0,INS
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8650237321853638,Stable,KIT,ONGOING,1.0,37.59843000000001,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,312.0,CR,12.0,INS
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.808210015296936,Stable,KIT,ONGOING,1.0,48.44211000000002,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,457.0,UNKNOWN,12.0,INS
P-0013024-T01-IM5,736.0,70.0,56.0,58.0,Non-Hispanic,11/21,Male,Not Applicable,42.0,0.8911305665969849,Stable,KIT,ONGOING,1.0,38.38222,ALIVE,P-0013024,NS,Neoadjuvant,Small Intestine,Small Bowel,Unknown,16.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,153.0,NR,12.0,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Female,Not Applicable,50.0,2.053816318511963,Stable,PIK3CA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,1.9145078659057617,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Female,Not Applicable,50.0,2.05415940284729,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,2.053816318511963,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,1.8991016149520874,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,2.05415940284729,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,2.053816318511963,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,1.9145078659057617,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,1.8991016149520874,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Female,Not Applicable,50.0,2.053816318511963,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Female,Not Applicable,50.0,1.8991016149520874,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Female,Not Applicable,50.0,1.9145078659057617,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,50.0,2.05415940284729,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Female,Not Applicable,50.0,1.8991016149520874,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Female,Not Applicable,50.0,2.05415940284729,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Female,Not Applicable,50.0,1.9145078659057617,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Female,Not Applicable,50.0,1.8991016149520874,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Female,Not Applicable,50.0,2.053816318511963,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Female,Not Applicable,50.0,1.9145078659057617,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Female,Not Applicable,50.0,2.05415940284729,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Female,Not Applicable,50.0,2.05415940284729,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,50.0,1.9145078659057617,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,50.0,1.8991016149520874,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Female,Not Applicable,50.0,2.053816318511963,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Female,Not Applicable,50.0,2.0023138523101807,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253415107727051,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Female,Not Applicable,50.0,2.0023138523101807,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253415107727051,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Female,Not Applicable,50.0,2.0023138523101807,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253415107727051,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Female,Not Applicable,50.0,2.0023138523101807,Stable,PIK3CA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253415107727051,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Female,Not Applicable,50.0,2.0023138523101807,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253415107727051,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Female,Not Applicable,50.0,2.0023138523101807,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253415107727051,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,TP53,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,TP53,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,TP53,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,TP53,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,TP53,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,TP53,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,TP53,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,TP53,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,TP53,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,TP53,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,TP53,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,TP53,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PDGFRA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PDGFRA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PDGFRA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PDGFRA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PDGFRA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PDGFRA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PDGFRA,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PDGFRA,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PDGFRA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PDGFRA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PDGFRA,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PDGFRA,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT;TP53,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT;TP53,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT;TP53,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT;TP53,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT;TP53,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT;TP53,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT;TP53,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT;TP53,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT;TP53,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT;TP53,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT;TP53,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT;TP53,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT;TP53,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT;PDGFRA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT;PDGFRA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT;PDGFRA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT;PDGFRA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT;PDGFRA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT;PDGFRA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT;PDGFRA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT;PDGFRA,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT;PDGFRA,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT;PDGFRA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT;PDGFRA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT;PDGFRA,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT;PDGFRA,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PIK3CA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,IMATINIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,IMATINIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,IMATINIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PIK3CA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,IMATINIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,IMATINIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,IMATINIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PIK3CA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,SUNITINIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,SUNITINIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,SUNITINIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PIK3CA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,SUNITINIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,SUNITINIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,SUNITINIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PIK3CA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,REGORAFENIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,REGORAFENIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,REGORAFENIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PIK3CA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,REGORAFENIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,REGORAFENIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,REGORAFENIB,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PIK3CA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Small Intestine,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PIK3CA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Small Intestine,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PIK3CA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Colon,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PIK3CA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Colon,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PIK3CA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Rectum,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PIK3CA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Rectum,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0538408756256104,Stable,PIK3CA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9143158197402954,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054178237915039,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0538408756256104,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8989967107772827,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054178237915039,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0538408756256104,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9143158197402954,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8989967107772827,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0538408756256104,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8989967107772827,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9143158197402954,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054178237915039,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8989967107772827,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054178237915039,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9143158197402954,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8989967107772827,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0538408756256104,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9143158197402954,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054178237915039,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054178237915039,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9143158197402954,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8989967107772827,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0538408756256104,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Metastasis,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0023653507232666,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,5.253406524658203,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0023653507232666,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,5.253406524658203,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0023653507232666,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,5.253406524658203,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0023653507232666,Stable,PIK3CA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,5.253406524658203,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0023653507232666,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,5.253406524658203,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0023653507232666,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Metastasis,Metastatic,5.253406524658203,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,SNP
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PIK3CA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PIK3CA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,DEL
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.054147720336914,Stable,PIK3CA,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,PIK3CA,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,14/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,17/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,13/21,Male,Not Applicable,50.0,2.0544331073760986,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,NR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.9144670963287354,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,731.0,SD,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,1.8990851640701294,Stable,KIT,NS,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,851.0,CR,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,77.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.054147720336914,Stable,KIT,ONGOING,1.0,27.781,DECEASED,P-0013110,NS,Neoadjuvant,Stomach,Gastric,Black or African American,1.0,Recurrence,Primary,Metastatic,0.0,OTHER,Medical Therapy,38.0,NE,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,2/21,Male,Not Applicable,50.0,2.002462863922119,Stable,PIK3CA,ONGOING,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013110-T01-IM5,821.0,80.0,72.0,78.0,Non-Hispanic,11/21,Male,Not Applicable,50.0,2.002462863922119,Stable,KIT,NS,2.0,27.781,DECEASED,P-0013110,No,Neoadjuvant,Stomach,Gastric,Black or African American,0.0,Recurrence,Primary,Metastatic,5.253401279449463,OTHER,Medical Therapy,434.29994627238506,UNKNOWN,14.6,INS
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Female,Not Applicable,40.0,0.6965161561965942,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Female,Not Applicable,40.0,0.7471388578414917,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.7471388578414917,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Female,Not Applicable,40.0,0.6965161561965942,Stable,CDKN1B,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Female,Not Applicable,40.0,0.7471388578414917,Stable,CDKN1B,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.6965161561965942,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.30499303340911865,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.9659817218780518,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Female,Not Applicable,40.0,0.30499303340911865,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.9659817218780518,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Female,Not Applicable,40.0,0.30499303340911865,Stable,PTEN,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.9659817218780518,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,TP53,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,TP53,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,TP53,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966156363487244,Stable,TP53,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7471143007278442,Stable,TP53,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,TP53,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,TP53,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,TP53,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30493152141571045,Stable,TP53,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,PDGFRA,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,PDGFRA,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,PDGFRA,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966156363487244,Stable,PDGFRA,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7471143007278442,Stable,PDGFRA,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,PDGFRA,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,PDGFRA,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,PDGFRA,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30493152141571045,Stable,PDGFRA,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT;TP53,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT;TP53,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT;TP53,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT;TP53,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT;TP53,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT;TP53,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT;TP53,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT;TP53,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT;TP53,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT;PDGFRA,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT;PDGFRA,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT;PDGFRA,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT;PDGFRA,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT;PDGFRA,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT;PDGFRA,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT;PDGFRA,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT;PDGFRA,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT;PDGFRA,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966156363487244,Stable,CDKN1B,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7471143007278442,Stable,CDKN1B,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,SUNITINIB,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,SUNITINIB,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30493152141571045,Stable,PTEN,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,SUNITINIB,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966156363487244,Stable,CDKN1B,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7471143007278442,Stable,CDKN1B,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,REGORAFENIB,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,REGORAFENIB,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30493152141571045,Stable,PTEN,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,REGORAFENIB,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966156363487244,Stable,CDKN1B,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7471143007278442,Stable,CDKN1B,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30493152141571045,Stable,PTEN,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966156363487244,Stable,CDKN1B,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7471143007278442,Stable,CDKN1B,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30493152141571045,Stable,PTEN,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966156363487244,Stable,CDKN1B,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7471143007278442,Stable,CDKN1B,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30493152141571045,Stable,PTEN,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966156363487244,Stable,CDKN1B,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7471143007278442,Stable,CDKN1B,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30493152141571045,Stable,PTEN,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966264843940735,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7472570538520813,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7472570538520813,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,SNP
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966264843940735,Stable,CDKN1B,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7472570538520813,Stable,CDKN1B,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966264843940735,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30510392785072327,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.9659669399261475,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30510392785072327,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.9659669399261475,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,SNP
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30510392785072327,Stable,PTEN,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.9659669399261475,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966156363487244,Stable,CDKN1B,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7471143007278442,Stable,CDKN1B,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,DEL
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30493152141571045,Stable,PTEN,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,DEL
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,INS
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,17/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,INS
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.7471143007278442,Stable,KIT,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,INS
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.6966156363487244,Stable,CDKN1B,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,INS
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,1/3,Male,Not Applicable,40.0,0.7471143007278442,Stable,CDKN1B,ONGOING,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,738.0,CR,10.0,INS
P-0013114-T01-IM5,996.0,70.0,51.0,56.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.6966156363487244,Stable,KIT,NS,1.0,52.997,DECEASED,P-0013114,NS,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1338.0,SD,10.0,INS
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,INS
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,11/21,Male,Not Applicable,40.0,0.30493152141571045,Stable,KIT,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,INS
P-0013114-T05-IM6,711.0,80.0,51.0,60.0,Non-Hispanic,5/9,Male,Not Applicable,40.0,0.30493152141571045,Stable,PTEN,NS,2.0,52.997,DECEASED,P-0013114,No,Neoadjuvant,Abdomen/Intraabdominal,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.965965747833252,OTHER,Medical Therapy,646.2801081558738,UNKNOWN,10.0,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Male,Spleen,10.0,1.2604578733444214,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Male,Spleen,10.0,1.106516718864441,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Male,Spleen,10.0,1.1166940927505493,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Male,Spleen,10.0,1.2630255222320557,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Male,Spleen,10.0,1.1166940927505493,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Male,Spleen,10.0,1.106516718864441,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Male,Spleen,10.0,1.266903042793274,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Male,Spleen,10.0,1.2630255222320557,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Male,Spleen,10.0,1.1360028982162476,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Male,Spleen,10.0,1.2604578733444214,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Male,Spleen,10.0,1.266903042793274,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Male,Spleen,10.0,1.1360028982162476,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Male,Spleen,10.0,1.0944290161132812,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328795433044434,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Male,Spleen,10.0,1.0944290161132812,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328795433044434,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2602312564849854,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1065552234649658,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116600751876831,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.262681245803833,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116600751876831,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1065552234649658,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2667185068130493,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.262681245803833,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.136061668395996,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2602312564849854,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2667185068130493,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.136061668395996,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.094503402709961,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.094503402709961,Stable,TP53,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2602312564849854,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1065552234649658,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116600751876831,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.262681245803833,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116600751876831,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1065552234649658,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2667185068130493,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.262681245803833,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.136061668395996,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2602312564849854,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2667185068130493,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.136061668395996,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.094503402709961,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.094503402709961,Stable,PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2602312564849854,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1065552234649658,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116600751876831,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.262681245803833,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116600751876831,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1065552234649658,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2667185068130493,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.262681245803833,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.136061668395996,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2602312564849854,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2667185068130493,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.136061668395996,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.094503402709961,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.094503402709961,Stable,KIT;TP53,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2602312564849854,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1065552234649658,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116600751876831,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.262681245803833,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116600751876831,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1065552234649658,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2667185068130493,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.262681245803833,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.136061668395996,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2602312564849854,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2667185068130493,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.136061668395996,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.094503402709961,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.094503402709961,Stable,KIT;PDGFRA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2602312564849854,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1065552234649658,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116600751876831,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.262681245803833,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116600751876831,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1065552234649658,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2667185068130493,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.262681245803833,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.136061668395996,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2602312564849854,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2667185068130493,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.136061668395996,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.094503402709961,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,IMATINIB,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.094503402709961,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,IMATINIB,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2602312564849854,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1065552234649658,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116600751876831,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.262681245803833,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116600751876831,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1065552234649658,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2667185068130493,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.262681245803833,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.136061668395996,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2602312564849854,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2667185068130493,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.136061668395996,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.094503402709961,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,SUNITINIB,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.094503402709961,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,SUNITINIB,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2602312564849854,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1065552234649658,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116600751876831,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.262681245803833,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116600751876831,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1065552234649658,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2667185068130493,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.262681245803833,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.136061668395996,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2602312564849854,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2667185068130493,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.136061668395996,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.094503402709961,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,REGORAFENIB,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.094503402709961,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,REGORAFENIB,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2602312564849854,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Stomach,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1065552234649658,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Stomach,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116600751876831,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Stomach,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.262681245803833,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Stomach,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116600751876831,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Stomach,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1065552234649658,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Stomach,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2667185068130493,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Stomach,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.262681245803833,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Stomach,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.136061668395996,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Stomach,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2602312564849854,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Stomach,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2667185068130493,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Stomach,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.136061668395996,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Stomach,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.094503402709961,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Stomach,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.094503402709961,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Stomach,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2602312564849854,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Colon,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1065552234649658,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Colon,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116600751876831,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Colon,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.262681245803833,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Colon,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116600751876831,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Colon,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1065552234649658,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Colon,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2667185068130493,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Colon,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.262681245803833,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Colon,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.136061668395996,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Colon,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2602312564849854,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Colon,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2667185068130493,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Colon,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.136061668395996,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Colon,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.094503402709961,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Colon,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.094503402709961,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Colon,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2602312564849854,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Rectum,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1065552234649658,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Rectum,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116600751876831,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Rectum,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.262681245803833,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Rectum,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116600751876831,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Rectum,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1065552234649658,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Rectum,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2667185068130493,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Rectum,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.262681245803833,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Rectum,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.136061668395996,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Rectum,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2602312564849854,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Rectum,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2667185068130493,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Rectum,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.136061668395996,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Rectum,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.094503402709961,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Rectum,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.094503402709961,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Rectum,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2605645656585693,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.106671929359436,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116621494293213,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2630558013916016,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116621494293213,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.106671929359436,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.267025351524353,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2630558013916016,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1362335681915283,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2605645656585693,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Primary,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.267025351524353,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Primary,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1362335681915283,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.0947281122207642,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Primary,Localized,1.332906723022461,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,SNP
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.0947281122207642,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Primary,Localized,1.332906723022461,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2602312564849854,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1065552234649658,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116600751876831,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.262681245803833,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116600751876831,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1065552234649658,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2667185068130493,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.262681245803833,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.136061668395996,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2602312564849854,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2667185068130493,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.136061668395996,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.094503402709961,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.094503402709961,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,DEL
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2602312564849854,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.1065552234649658,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.116600751876831,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.262681245803833,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.116600751876831,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1339.0,UNKNOWN,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.1065552234649658,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,579.0,UNKNOWN,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.2667185068130493,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.262681245803833,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,61.0,NR,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.136061668395996,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2602312564849854,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,PAZOPANIB,Medical Therapy,183.0,NR,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.2667185068130493,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,CLINICAL_TRIAL,Medical Therapy,122.0,CR,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.136061668395996,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,NS,NS,Small Intestine,Small Bowel,White,41.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,457.0,CR,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,11/21,Female,Spleen,10.0,1.094503402709961,Stable,KIT,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,INS
P-0013235-T01-IM5,583.0,80.0,53.0,64.0,Non-Hispanic,17/24,Female,Spleen,10.0,1.094503402709961,Stable,MGA,NS,1.0,1.874,DECEASED,P-0013235,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,1.3328986167907715,OTHER,Medical Therapy,442.8944237508633,UNKNOWN,3.5,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Male,Liver,12.0,0.010612666606903076,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,12.0,0.1836705505847931,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,12.0,0.18547014892101288,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,12.0,0.1805972009897232,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Male,Liver,12.0,0.010612666606903076,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Male,Liver,12.0,0.1836705505847931,Stable,RB1,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Male,Liver,12.0,0.18547014892101288,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Male,Liver,12.0,0.010612666606903076,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Male,Liver,12.0,0.1805972009897232,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Male,Liver,12.0,0.18547014892101288,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Male,Liver,12.0,0.1805972009897232,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Male,Liver,12.0,0.010612666606903076,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Male,Liver,12.0,0.1836705505847931,Stable,NTRK3,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Male,Liver,12.0,0.18547014892101288,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Male,Liver,12.0,0.1805972009897232,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Male,Liver,12.0,0.1836705505847931,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Male,Liver,12.0,0.0699276477098465,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.4214401245117188,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Male,Liver,12.0,0.0699276477098465,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.4214401245117188,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Male,Liver,12.0,0.0699276477098465,Stable,NTRK3,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.4214401245117188,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Male,Liver,12.0,0.0699276477098465,Stable,RB1,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.4214401245117188,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010515958070755005,Stable,TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18340304493904114,Stable,TP53,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18520881235599518,Stable,TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18029551208019257,Stable,TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010515958070755005,Stable,TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18340304493904114,Stable,TP53,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18520881235599518,Stable,TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010515958070755005,Stable,TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18029551208019257,Stable,TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18520881235599518,Stable,TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18029551208019257,Stable,TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010515958070755005,Stable,TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18340304493904114,Stable,TP53,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18520881235599518,Stable,TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18029551208019257,Stable,TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18340304493904114,Stable,TP53,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,TP53,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,TP53,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.06990832090377808,Stable,TP53,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,TP53,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010515958070755005,Stable,PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18340304493904114,Stable,PDGFRA,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18520881235599518,Stable,PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18029551208019257,Stable,PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010515958070755005,Stable,PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18340304493904114,Stable,PDGFRA,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18520881235599518,Stable,PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010515958070755005,Stable,PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18029551208019257,Stable,PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18520881235599518,Stable,PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18029551208019257,Stable,PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010515958070755005,Stable,PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18340304493904114,Stable,PDGFRA,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18520881235599518,Stable,PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18029551208019257,Stable,PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18340304493904114,Stable,PDGFRA,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,PDGFRA,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,PDGFRA,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.06990832090377808,Stable,PDGFRA,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,PDGFRA,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010515958070755005,Stable,KIT;TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT;TP53,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT;TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT;TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT;TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18340304493904114,Stable,KIT;TP53,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18520881235599518,Stable,KIT;TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010515958070755005,Stable,KIT;TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18029551208019257,Stable,KIT;TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT;TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT;TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT;TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18340304493904114,Stable,KIT;TP53,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18520881235599518,Stable,KIT;TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18029551208019257,Stable,KIT;TP53,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT;TP53,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT;TP53,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT;TP53,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.06990832090377808,Stable,KIT;TP53,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT;TP53,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010515958070755005,Stable,KIT;PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT;PDGFRA,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT;PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT;PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT;PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18340304493904114,Stable,KIT;PDGFRA,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18520881235599518,Stable,KIT;PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010515958070755005,Stable,KIT;PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18029551208019257,Stable,KIT;PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT;PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT;PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT;PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18340304493904114,Stable,KIT;PDGFRA,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18520881235599518,Stable,KIT;PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18029551208019257,Stable,KIT;PDGFRA,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT;PDGFRA,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT;PDGFRA,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT;PDGFRA,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.06990832090377808,Stable,KIT;PDGFRA,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT;PDGFRA,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010515958070755005,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18340304493904114,Stable,RB1,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18520881235599518,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010515958070755005,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18029551208019257,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18340304493904114,Stable,NTRK3,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18520881235599518,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18029551208019257,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,SUNITINIB,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,SUNITINIB,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.06990832090377808,Stable,NTRK3,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,SUNITINIB,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,RB1,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,SUNITINIB,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010515958070755005,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18340304493904114,Stable,RB1,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18520881235599518,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010515958070755005,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18029551208019257,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18340304493904114,Stable,NTRK3,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18520881235599518,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18029551208019257,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,REGORAFENIB,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,REGORAFENIB,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.06990832090377808,Stable,NTRK3,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,REGORAFENIB,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,RB1,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,REGORAFENIB,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010515958070755005,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18340304493904114,Stable,RB1,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18520881235599518,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010515958070755005,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18029551208019257,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18340304493904114,Stable,NTRK3,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18520881235599518,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18029551208019257,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Stomach,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.06990832090377808,Stable,NTRK3,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,RB1,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010515958070755005,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18340304493904114,Stable,RB1,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18520881235599518,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010515958070755005,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18029551208019257,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18340304493904114,Stable,NTRK3,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18520881235599518,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18029551208019257,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Colon,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.06990832090377808,Stable,NTRK3,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,RB1,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010515958070755005,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18340304493904114,Stable,RB1,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18520881235599518,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010515958070755005,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18029551208019257,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18340304493904114,Stable,NTRK3,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18520881235599518,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18029551208019257,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Rectum,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.06990832090377808,Stable,NTRK3,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,RB1,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010525345802307129,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18367119133472443,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.1854759156703949,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18059132993221283,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010525345802307129,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18367119133472443,Stable,RB1,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.1854759156703949,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010525345802307129,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18059132993221283,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.1854759156703949,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18059132993221283,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010525345802307129,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18367119133472443,Stable,NTRK3,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.1854759156703949,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18059132993221283,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18367119133472443,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Primary,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.07006505131721497,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,3.421435832977295,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.07006505131721497,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,3.421435832977295,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.07006505131721497,Stable,NTRK3,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,3.421435832977295,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.07006505131721497,Stable,RB1,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,3.421435832977295,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,SNP
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010515958070755005,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18340304493904114,Stable,RB1,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18520881235599518,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010515958070755005,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18029551208019257,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18340304493904114,Stable,NTRK3,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18520881235599518,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18029551208019257,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.06990832090377808,Stable,NTRK3,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,RB1,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,DEL
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.010515958070755005,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,11/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18340304493904114,Stable,RB1,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18520881235599518,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.010515958070755005,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,3/27,Female,Liver,12.0,0.18029551208019257,Stable,RB1,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18520881235599518,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18029551208019257,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.010515958070755005,Stable,KIT,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,1309.0,SD,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18340304493904114,Stable,NTRK3,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18520881235599518,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,REGORAFENIB,Medical Therapy,151.0,NR,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,9/19,Female,Liver,12.0,0.18029551208019257,Stable,NTRK3,NS,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,SUNITINIB,Medical Therapy,61.0,NR,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,48.0,Non-Hispanic,13/21,Female,Liver,12.0,0.18340304493904114,Stable,KIT,ONGOING,1.0,10.784,DECEASED,P-0013393,NS,NS,Small Intestine,Gastric,White,24.0,Recurrence,Metastasis,Metastatic,0.0,PAZOPANIB,Medical Therapy,130.0,NE,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,KIT,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,9/19,Female,Liver,12.0,0.06990832090377808,Stable,NTRK3,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,INS
P-0013393-T01-IM5,808.0,30.0,42.0,49.0,Non-Hispanic,11/21,Female,Liver,12.0,0.06990832090377808,Stable,RB1,NS,2.0,10.784,DECEASED,P-0013393,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,3.421440362930298,OTHER,Medical Therapy,440.3030765648179,UNKNOWN,2.4,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Female,Liver,50.0,1.218448519706726,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,395.0,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Female,Liver,50.0,1.2283762693405151,Stable,KIT,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,343.0,CR,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Female,Liver,50.0,1.2170469760894775,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5872277021408081,OTHER,Medical Therapy,388.4093757703769,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.218519687652588,Stable,TP53,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,395.0,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2284653186798096,Stable,TP53,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,343.0,CR,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.2171096801757812,Stable,TP53,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5872306227684021,OTHER,Medical Therapy,388.4093757703769,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.218519687652588,Stable,PDGFRA,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,395.0,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2284653186798096,Stable,PDGFRA,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,343.0,CR,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.2171096801757812,Stable,PDGFRA,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5872306227684021,OTHER,Medical Therapy,388.4093757703769,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.218519687652588,Stable,KIT;TP53,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,395.0,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2284653186798096,Stable,KIT;TP53,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,343.0,CR,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.2171096801757812,Stable,KIT;TP53,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5872306227684021,OTHER,Medical Therapy,388.4093757703769,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.218519687652588,Stable,KIT;PDGFRA,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,395.0,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2284653186798096,Stable,KIT;PDGFRA,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,343.0,CR,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.2171096801757812,Stable,KIT;PDGFRA,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5872306227684021,OTHER,Medical Therapy,388.4093757703769,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.218519687652588,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,395.0,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2284653186798096,Stable,KIT,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,343.0,CR,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.2171096801757812,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5872306227684021,SUNITINIB,Medical Therapy,388.4093757703769,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.218519687652588,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,395.0,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2284653186798096,Stable,KIT,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,343.0,CR,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.2171096801757812,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5872306227684021,REGORAFENIB,Medical Therapy,388.4093757703769,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.218519687652588,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Stomach,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,395.0,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2284653186798096,Stable,KIT,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Stomach,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,343.0,CR,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.2171096801757812,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5872306227684021,OTHER,Medical Therapy,388.4093757703769,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.218519687652588,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Colon,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,395.0,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2284653186798096,Stable,KIT,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Colon,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,343.0,CR,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.2171096801757812,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5872306227684021,OTHER,Medical Therapy,388.4093757703769,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.218519687652588,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Rectum,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,395.0,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2284653186798096,Stable,KIT,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Rectum,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,343.0,CR,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.2171096801757812,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5872306227684021,OTHER,Medical Therapy,388.4093757703769,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2186795473098755,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,395.0,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2286043167114258,Stable,KIT,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,343.0,CR,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.217268705368042,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.5872493982315063,OTHER,Medical Therapy,388.4093757703769,UNKNOWN,7.0,INS
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.218519687652588,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,395.0,UNKNOWN,7.0,SNP
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2284653186798096,Stable,KIT,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,343.0,CR,7.0,SNP
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.2171096801757812,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5872306227684021,OTHER,Medical Therapy,388.4093757703769,UNKNOWN,7.0,SNP
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.218519687652588,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,395.0,UNKNOWN,7.0,DEL
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,9/21,Male,Liver,50.0,1.2284653186798096,Stable,KIT,ONGOING,1.0,0.921,ALIVE,P-0013410,NS,Neoadjuvant,Small Intestine,Small Bowel,White,12.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,343.0,CR,7.0,DEL
P-0013410-T01-IM5,952.0,20.0,52.0,54.0,Non-Hispanic,11/21,Male,Liver,50.0,1.2171096801757812,Stable,KIT,NS,1.0,0.921,ALIVE,P-0013410,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.5872306227684021,OTHER,Medical Therapy,388.4093757703769,UNKNOWN,7.0,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Female,Not Applicable,2.0,0.15581488609313965,Stable,KIT,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Female,Not Applicable,2.0,0.15581488609313965,Stable,PIK3C3,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Female,Not Applicable,2.0,0.15062008798122406,Stable,PIK3C3,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306093215942383,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,2.0,0.15062008798122406,Stable,KIT,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306093215942383,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15580417215824127,Stable,TP53,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15580417215824127,Stable,TP53,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.1506045013666153,Stable,TP53,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.1506045013666153,Stable,TP53,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15580417215824127,Stable,PDGFRA,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15580417215824127,Stable,PDGFRA,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.1506045013666153,Stable,PDGFRA,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.1506045013666153,Stable,PDGFRA,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15580417215824127,Stable,KIT;TP53,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15580417215824127,Stable,KIT;TP53,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.1506045013666153,Stable,KIT;TP53,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.1506045013666153,Stable,KIT;TP53,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15580417215824127,Stable,KIT;PDGFRA,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15580417215824127,Stable,KIT;PDGFRA,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.1506045013666153,Stable,KIT;PDGFRA,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.1506045013666153,Stable,KIT;PDGFRA,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15580417215824127,Stable,KIT,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,4202.0,SD,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15580417215824127,Stable,PIK3C3,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.1506045013666153,Stable,PIK3C3,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,SUNITINIB,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.1506045013666153,Stable,KIT,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,SUNITINIB,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15580417215824127,Stable,KIT,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,4202.0,SD,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15580417215824127,Stable,PIK3C3,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.1506045013666153,Stable,PIK3C3,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,REGORAFENIB,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.1506045013666153,Stable,KIT,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,REGORAFENIB,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15580417215824127,Stable,KIT,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15580417215824127,Stable,PIK3C3,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.1506045013666153,Stable,PIK3C3,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.1506045013666153,Stable,KIT,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15580417215824127,Stable,KIT,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15580417215824127,Stable,PIK3C3,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.1506045013666153,Stable,PIK3C3,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.1506045013666153,Stable,KIT,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Colon,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15580417215824127,Stable,KIT,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15580417215824127,Stable,PIK3C3,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.1506045013666153,Stable,PIK3C3,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.1506045013666153,Stable,KIT,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15580983459949493,Stable,KIT,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15580983459949493,Stable,PIK3C3,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15061458945274353,Stable,PIK3C3,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3306111097335815,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15061458945274353,Stable,KIT,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Metastatic,1.3306111097335815,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,DEL
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15580417215824127,Stable,KIT,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15580417215824127,Stable,PIK3C3,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.1506045013666153,Stable,PIK3C3,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.1506045013666153,Stable,KIT,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,SNP
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.15580417215824127,Stable,KIT,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,INS
P-0013447-T01-IM5,694.0,50.0,41.0,52.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.15580417215824127,Stable,PIK3C3,ONGOING,1.0,36.164,ALIVE,P-0013447,NS,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,4202.0,SD,3.8,INS
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/25,Male,Not Applicable,2.0,0.1506045013666153,Stable,PIK3C3,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,INS
P-0013447-T01-IM5,694.0,50.0,41.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,2.0,0.1506045013666153,Stable,KIT,NS,2.0,36.164,ALIVE,P-0013447,No,NS,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Metastatic,1.3306059837341309,OTHER,Medical Therapy,3226.6347535797536,UNKNOWN,3.8,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Male,Abdominal Wall,10.0,1.7266840934753418,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Male,Abdominal Wall,10.0,1.7266840934753418,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Male,Abdominal Wall,10.0,1.8101569414138794,Do not report,KIT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Male,Abdominal Wall,10.0,1.9071910381317139,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Male,Abdominal Wall,10.0,1.9121376276016235,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Male,Abdominal Wall,10.0,1.8101569414138794,Do not report,PIK3C2G,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Male,Abdominal Wall,10.0,1.7727760076522827,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387434959411621,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Male,Abdominal Wall,10.0,1.7727760076522827,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387434959411621,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Male,Abdominal Wall,10.0,1.9121376276016235,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Male,Abdominal Wall,10.0,1.7727760076522827,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387434959411621,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Male,Abdominal Wall,10.0,1.7266840934753418,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Male,Abdominal Wall,10.0,1.9121376276016235,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Male,Abdominal Wall,10.0,1.9071910381317139,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Male,Abdominal Wall,10.0,1.8101569414138794,Do not report,PTPRT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Male,Abdominal Wall,10.0,1.9071910381317139,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,TP53,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,TP53,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,TP53,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,TP53,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,TP53,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,TP53,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PDGFRA,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PDGFRA,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PDGFRA,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT;TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT;TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT;TP53,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT;TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT;TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT;TP53,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT;TP53,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT;TP53,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT;TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT;TP53,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT;TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT;TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT;TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT;TP53,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT;TP53,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT;PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT;PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT;PDGFRA,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT;PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT;PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT;PDGFRA,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT;PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT;PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT;PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT;PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT;PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT;PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT;PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT;PDGFRA,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT;PDGFRA,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1096.0,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,677.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,365.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,335.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PIK3C2G,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,SUNITINIB,Medical Therapy,634.1590760940126,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,SUNITINIB,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,SUNITINIB,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PTPRT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,SUNITINIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1096.0,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,677.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,335.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PIK3C2G,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,REGORAFENIB,Medical Therapy,634.1590760940126,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,REGORAFENIB,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,REGORAFENIB,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PTPRT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Stomach,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Stomach,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Stomach,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Stomach,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Stomach,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PIK3C2G,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Stomach,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Stomach,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Stomach,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Stomach,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Stomach,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Stomach,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Stomach,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Stomach,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PTPRT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Stomach,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Stomach,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Colon,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Colon,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Colon,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Colon,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Colon,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PIK3C2G,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Colon,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Colon,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Colon,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Colon,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Colon,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Colon,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Colon,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Colon,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PTPRT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Colon,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Colon,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Rectum,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Rectum,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Rectum,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Rectum,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Rectum,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PIK3C2G,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Rectum,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Rectum,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Rectum,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Rectum,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Rectum,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Rectum,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Rectum,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Rectum,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PTPRT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Rectum,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Rectum,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7267134189605713,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.7267134189605713,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.8100781440734863,Do not report,KIT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.907165288925171,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9120943546295166,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Primary,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.8100781440734863,Do not report,PIK3C2G,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727034091949463,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Primary,Localized,2.3874475955963135,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,DEL
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727034091949463,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Primary,Localized,2.3874475955963135,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9120943546295166,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Primary,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727034091949463,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Primary,Localized,2.3874475955963135,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.7267134189605713,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9120943546295166,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Primary,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.907165288925171,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.8100781440734863,Do not report,PTPRT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.907165288925171,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PIK3C2G,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PTPRT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,SNP
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,KIT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PIK3C2G,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,KIT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/21,Female,Abdominal Wall,10.0,1.7727116346359253,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,No,NS,Small Intestine,Small Intestine,White,0.0,Recurrence,Metastasis,Localized,2.387444496154785,OTHER,Medical Therapy,634.1590760940126,UNKNOWN,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.7266637086868286,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,1096.0,UNKNOWN,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9119595289230347,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,NILOTINIB,Medical Therapy,335.0,CR,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PTPRT,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/32,Female,Abdominal Wall,10.0,1.8100955486297607,Do not report,PTPRT,ONGOING,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,677.0,CR,15.0,INS
P-0013776-T01-IM5,1011.0,40.0,66.0,73.0,Non-Hispanic,11/31,Female,Abdominal Wall,10.0,1.9070258140563965,Do not report,PIK3C2G,NS,1.0,2.762,DECEASED,P-0013776,NS,NS,Small Intestine,Small Bowel,White,48.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,365.0,CR,15.0,INS
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Female,Not Applicable,7.0,0.3341091573238373,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,2343.0,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Female,Not Applicable,7.0,0.5505614876747131,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,CR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Female,Not Applicable,7.0,0.547882616519928,Do not report,KIT,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,38.0,NE,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Female,Not Applicable,7.0,0.5505614876747131,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,92.0,NR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Female,Not Applicable,7.0,0.5252639055252075,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.3543449640274048,OTHER,Medical Therapy,259.33828197178104,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.33411604166030884,Do not report,TP53,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,2343.0,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,TP53,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,CR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5482114553451538,Do not report,TP53,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,38.0,NE,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,TP53,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,92.0,NR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5254172682762146,Do not report,TP53,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.35434526205062866,OTHER,Medical Therapy,259.33828197178104,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.33411604166030884,Do not report,PDGFRA,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,2343.0,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,PDGFRA,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,CR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5482114553451538,Do not report,PDGFRA,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,38.0,NE,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,PDGFRA,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,92.0,NR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5254172682762146,Do not report,PDGFRA,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.35434526205062866,OTHER,Medical Therapy,259.33828197178104,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.33411604166030884,Do not report,KIT;TP53,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,2343.0,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT;TP53,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,CR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5482114553451538,Do not report,KIT;TP53,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,38.0,NE,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT;TP53,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,92.0,NR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5254172682762146,Do not report,KIT;TP53,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.35434526205062866,OTHER,Medical Therapy,259.33828197178104,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.33411604166030884,Do not report,KIT;PDGFRA,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,2343.0,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT;PDGFRA,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,CR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5482114553451538,Do not report,KIT;PDGFRA,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,38.0,NE,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT;PDGFRA,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,92.0,NR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5254172682762146,Do not report,KIT;PDGFRA,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.35434526205062866,OTHER,Medical Therapy,259.33828197178104,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.33411604166030884,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,2343.0,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,92.0,CR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5482114553451538,Do not report,KIT,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,38.0,NE,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,92.0,NR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5254172682762146,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.35434526205062866,SUNITINIB,Medical Therapy,259.33828197178104,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.33411604166030884,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,2343.0,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,CR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5482114553451538,Do not report,KIT,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,38.0,NE,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,NR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5254172682762146,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.35434526205062866,REGORAFENIB,Medical Therapy,259.33828197178104,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.33411604166030884,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Stomach,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,2343.0,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Stomach,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,CR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5482114553451538,Do not report,KIT,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Stomach,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,38.0,NE,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Stomach,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,92.0,NR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5254172682762146,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Stomach,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.35434526205062866,OTHER,Medical Therapy,259.33828197178104,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.33411604166030884,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Colon,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,2343.0,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Colon,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,CR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5482114553451538,Do not report,KIT,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Colon,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,38.0,NE,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Colon,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,92.0,NR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5254172682762146,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Colon,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.35434526205062866,OTHER,Medical Therapy,259.33828197178104,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.33411604166030884,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Rectum,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,2343.0,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Rectum,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,CR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5482114553451538,Do not report,KIT,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Rectum,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,38.0,NE,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Rectum,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,92.0,NR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5254172682762146,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Rectum,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.35434526205062866,OTHER,Medical Therapy,259.33828197178104,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.33415544033050537,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,2343.0,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5506719946861267,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Metastasis,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,CR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5479868650436401,Do not report,KIT,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Metastasis,Localized,0.0,SORAFENIB,Medical Therapy,38.0,NE,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5506719946861267,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Metastasis,Localized,0.0,OTHER,Medical Therapy,92.0,NR,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5253093242645264,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Metastasis,Localized,0.3543487787246704,OTHER,Medical Therapy,259.33828197178104,UNKNOWN,15.0,DEL
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.33411604166030884,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,2343.0,UNKNOWN,15.0,SNP
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,CR,15.0,SNP
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5482114553451538,Do not report,KIT,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,38.0,NE,15.0,SNP
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,92.0,NR,15.0,SNP
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5254172682762146,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.35434526205062866,OTHER,Medical Therapy,259.33828197178104,UNKNOWN,15.0,SNP
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.33411604166030884,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,2343.0,UNKNOWN,15.0,INS
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,92.0,CR,15.0,INS
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5482114553451538,Do not report,KIT,ONGOING,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,SORAFENIB,Medical Therapy,38.0,NE,15.0,INS
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.550864577293396,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,NS,Neoadjuvant,Small Intestine,Small Bowel,White,77.0,Recurrence,Primary,Localized,0.0,OTHER,Medical Therapy,92.0,NR,15.0,INS
P-0013789-T01-IM5,839.0,90.0,54.0,61.0,Non-Hispanic,11/21,Male,Not Applicable,7.0,0.5254172682762146,Do not report,KIT,NS,1.0,41.819,DECEASED,P-0013789,No,Neoadjuvant,Small Intestine,Small Bowel,White,0.0,Recurrence,Primary,Localized,0.35434526205062866,OTHER,Medical Therapy,259.33828197178104,UNKNOWN,15.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Male,Not Applicable,30.0,0.3355097472667694,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Male,Not Applicable,30.0,0.3355097472667694,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Male,Not Applicable,30.0,0.3355097472667694,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Male,Not Applicable,30.0,0.3355097472667694,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Male,Not Applicable,30.0,0.33115968108177185,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356743335723877,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Male,Not Applicable,30.0,0.33115968108177185,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356743335723877,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Male,Not Applicable,30.0,0.33115968108177185,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356743335723877,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Male,Not Applicable,30.0,0.33115968108177185,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356743335723877,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Male,Not Applicable,30.0,0.33115968108177185,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356743335723877,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Male,Not Applicable,30.0,0.3355097472667694,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3351549506187439,Do not report,PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3351549506187439,Do not report,PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3308126926422119,Do not report,PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3308126926422119,Do not report,PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3308126926422119,Do not report,PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3351549506187439,Do not report,PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT;TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT;TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT;TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT;TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT;TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT;TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT;TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT;TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT;TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT;TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT;PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT;PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT;PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT;PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT;PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT;PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT;PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT;PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT;PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT;PDGFRA,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3351549506187439,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3351549506187439,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,SUNITINIB,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3308126926422119,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,SUNITINIB,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3308126926422119,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,SUNITINIB,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,SUNITINIB,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,SUNITINIB,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,SUNITINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3351549506187439,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3351549506187439,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,REGORAFENIB,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3308126926422119,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,REGORAFENIB,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3308126926422119,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,REGORAFENIB,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,REGORAFENIB,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,REGORAFENIB,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,REGORAFENIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3351549506187439,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3351549506187439,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3308126926422119,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3308126926422119,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3351549506187439,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3351549506187439,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3308126926422119,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3308126926422119,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Colon,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3351549506187439,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3351549506187439,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3308126926422119,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3308126926422119,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Rectum,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.3349417746067047,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3349417746067047,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3349417746067047,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3349417746067047,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.3305884599685669,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,4.356730937957764,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3305884599685669,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,4.356730937957764,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3305884599685669,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,4.356730937957764,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3305884599685669,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,4.356730937957764,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3305884599685669,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,4.356730937957764,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,SNP
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3349417746067047,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3351549506187439,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3351549506187439,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3308126926422119,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3308126926422119,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,DEL
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,4/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3351549506187439,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3351549506187439,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3351549506187439,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,6/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TP53,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,12/15,Female,Not Applicable,30.0,0.3308126926422119,Do not report,PIK3R1,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,18/22,Female,Not Applicable,30.0,0.3308126926422119,Do not report,INSR,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3308126926422119,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/11,Female,Not Applicable,30.0,0.3308126926422119,Do not report,TET2,ONGOING,1.0,4.734,DECEASED,P-0013795,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,4.356736183166504,OTHER,Medical Therapy,187.01304836601307,UNKNOWN,6.0,INS
P-0013795-T01-IM5,775.0,40.0,78.0,79.0,Non-Hispanic,11/21,Female,Not Applicable,30.0,0.3351549506187439,Do not report,KIT,ONGOING,1.0,4.734,DECEASED,P-0013795,NS,Palliative,Stomach,Gastric,White,0.0,Recurrence,Primary,Metastatic,0.0,IMATINIB,Medical Therapy,130.0,NE,6.0,INS
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Male,Not Applicable,45.0,0.15206143260002136,Do not report,KIT,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741767406463623,OTHER,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Male,Not Applicable,45.0,0.08657461404800415,Do not report,KIT,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Stomach,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15186768770217896,Do not report,TP53,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741758465766907,OTHER,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086308553814888,Do not report,TP53,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Stomach,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15186768770217896,Do not report,PDGFRA,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741758465766907,OTHER,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086308553814888,Do not report,PDGFRA,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Stomach,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15186768770217896,Do not report,KIT;TP53,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741758465766907,OTHER,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086308553814888,Do not report,KIT;TP53,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Stomach,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15186768770217896,Do not report,KIT;PDGFRA,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741758465766907,OTHER,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086308553814888,Do not report,KIT;PDGFRA,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Stomach,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15186768770217896,Do not report,KIT,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741758465766907,IMATINIB,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086308553814888,Do not report,KIT,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Stomach,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15186768770217896,Do not report,KIT,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741758465766907,SUNITINIB,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086308553814888,Do not report,KIT,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Stomach,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15186768770217896,Do not report,KIT,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741758465766907,REGORAFENIB,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086308553814888,Do not report,KIT,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Stomach,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15186768770217896,Do not report,KIT,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741758465766907,OTHER,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086308553814888,Do not report,KIT,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Small Intestine,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15186768770217896,Do not report,KIT,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741758465766907,OTHER,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086308553814888,Do not report,KIT,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Colon,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15186768770217896,Do not report,KIT,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741758465766907,OTHER,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086308553814888,Do not report,KIT,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Rectum,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15174715220928192,Do not report,KIT,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,0.3741800785064697,OTHER,Medical Therapy,269.3314336237598,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086051806807518,Do not report,KIT,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Stomach,Gastric,White,2.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,DEL
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15186768770217896,Do not report,KIT,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741758465766907,OTHER,Medical Therapy,269.3314336237598,UNKNOWN,7.5,SNP
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086308553814888,Do not report,KIT,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Stomach,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,SNP
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.15186768770217896,Do not report,KIT,ONGOING,1.0,39.597190000000026,ALIVE,P-0014165,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,0.3741758465766907,OTHER,Medical Therapy,269.3314336237598,UNKNOWN,7.5,INS
P-0014165-T01-IM5,868.0,70.0,83.0,83.0,Non-Hispanic,11/21,Female,Not Applicable,45.0,0.086308553814888,Do not report,KIT,ONGOING,1.0,39.31474000000003,ALIVE,P-0014165,NS,Neoadjuvant,Stomach,Gastric,White,2.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,UNKNOWN,7.5,INS
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Female,Not Applicable,21.0,0.27726417779922485,Stable,KIT,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Soft Tissue,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Female,Liver,21.0,0.5135660171508789,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.117006778717041,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Female,Liver,21.0,0.5135660171508789,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.117006778717041,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.27748996019363403,Stable,TP53,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Soft Tissue,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,TP53,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,TP53,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.27748996019363403,Stable,PDGFRA,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Soft Tissue,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,PDGFRA,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,PDGFRA,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.27748996019363403,Stable,KIT;TP53,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Soft Tissue,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT;TP53,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT;TP53,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.27748996019363403,Stable,KIT;PDGFRA,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Soft Tissue,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT;PDGFRA,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT;PDGFRA,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.27748996019363403,Stable,KIT,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Soft Tissue,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,SUNITINIB,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,SUNITINIB,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.27748996019363403,Stable,KIT,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Soft Tissue,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,REGORAFENIB,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,REGORAFENIB,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.27748996019363403,Stable,KIT,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Stomach,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.27748996019363403,Stable,KIT,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Small Intestine,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Small Intestine,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.27748996019363403,Stable,KIT,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Colon,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Colon,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.27748996019363403,Stable,KIT,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Rectum,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Rectum,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.2772122919559479,Stable,KIT,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Soft Tissue,Small Bowel,White,6.0,Recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,99.0,NE,2.8,DEL
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,DEL
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.27748996019363403,Stable,KIT,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Soft Tissue,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,99.0,NE,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,SNP
P-0014184-T01-IM6,839.0,70.0,29.0,29.0,Non-Hispanic,11/21,Male,Not Applicable,21.0,0.27748996019363403,Stable,KIT,ONGOING,1.0,79.627,ALIVE,P-0014184,NS,NS,Soft Tissue,Small Bowel,White,6.0,Recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,99.0,NE,2.8,INS
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,Neoadjuvant,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,INS
P-0014184-T04-IM6,657.0,50.0,29.0,33.0,Non-Hispanic,11/21,Male,Liver,21.0,0.5136359333992004,Stable,KIT,NS,2.0,72.723,ALIVE,P-0014184,No,NS,Soft Tissue,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.1170217990875244,OTHER,Medical Therapy,1301.1378566594672,UNKNOWN,2.8,INS
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Male,Not Applicable,25.0,0.14520256221294403,Do not report,KIT,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Male,Not Applicable,25.0,0.14520256221294403,Do not report,NOTCH4,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Male,Not Applicable,25.0,0.14520256221294403,Do not report,ARID1B,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Male,Not Applicable,25.0,0.20311339199543,Do not report,ARID1B,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778019189834595,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Male,Not Applicable,25.0,0.20311339199543,Do not report,KIT,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778019189834595,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Male,Not Applicable,25.0,0.20311339199543,Do not report,NOTCH4,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778019189834595,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.1449134349822998,Do not report,TP53,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.1449134349822998,Do not report,TP53,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.1449134349822998,Do not report,TP53,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.20294298231601715,Do not report,TP53,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.20294298231601715,Do not report,TP53,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.20294298231601715,Do not report,TP53,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.1449134349822998,Do not report,PDGFRA,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.1449134349822998,Do not report,PDGFRA,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.1449134349822998,Do not report,PDGFRA,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.20294298231601715,Do not report,PDGFRA,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.20294298231601715,Do not report,PDGFRA,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.20294298231601715,Do not report,PDGFRA,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT;TP53,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT;TP53,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT;TP53,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT;TP53,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT;TP53,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT;TP53,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT;PDGFRA,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT;PDGFRA,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT;PDGFRA,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT;PDGFRA,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT;PDGFRA,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT;PDGFRA,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.1449134349822998,Do not report,NOTCH4,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.1449134349822998,Do not report,ARID1B,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.20294298231601715,Do not report,ARID1B,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,SUNITINIB,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,SUNITINIB,Medical Therapy,238.6350629935199,UNKNOWN,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.20294298231601715,Do not report,NOTCH4,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,SUNITINIB,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,130.0,NE,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.1449134349822998,Do not report,NOTCH4,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.1449134349822998,Do not report,ARID1B,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.20294298231601715,Do not report,ARID1B,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,REGORAFENIB,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,REGORAFENIB,Medical Therapy,238.6350629935199,UNKNOWN,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.20294298231601715,Do not report,NOTCH4,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,REGORAFENIB,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Small Intestine,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.1449134349822998,Do not report,NOTCH4,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Small Intestine,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.1449134349822998,Do not report,ARID1B,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Small Intestine,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.20294298231601715,Do not report,ARID1B,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.20294298231601715,Do not report,NOTCH4,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Small Intestine,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Colon,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.1449134349822998,Do not report,NOTCH4,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Colon,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.1449134349822998,Do not report,ARID1B,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Colon,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.20294298231601715,Do not report,ARID1B,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.20294298231601715,Do not report,NOTCH4,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Colon,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Rectum,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.1449134349822998,Do not report,NOTCH4,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Rectum,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.1449134349822998,Do not report,ARID1B,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Rectum,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.20294298231601715,Do not report,ARID1B,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.20294298231601715,Do not report,NOTCH4,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Rectum,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.14468662440776825,Do not report,KIT,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.14468662440776825,Do not report,NOTCH4,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.14468662440776825,Do not report,ARID1B,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.20282946527004242,Do not report,ARID1B,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.9778103828430176,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.20282946527004242,Do not report,KIT,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.9778103828430176,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,DEL
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.20282946527004242,Do not report,NOTCH4,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Metastasis,Localized,1.9778103828430176,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.1449134349822998,Do not report,NOTCH4,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.1449134349822998,Do not report,ARID1B,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.20294298231601715,Do not report,ARID1B,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.20294298231601715,Do not report,NOTCH4,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,SNP
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.1449134349822998,Do not report,KIT,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,INS
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.1449134349822998,Do not report,NOTCH4,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,INS
P-0014241-T01-IM6,821.0,80.0,54.0,53.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.1449134349822998,Do not report,ARID1B,ONGOING,1.0,78.641,ALIVE,P-0014241,NS,NS,Stomach,Gastric,White,39.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,14.0,INS
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,20/20,Female,Not Applicable,25.0,0.20294298231601715,Do not report,ARID1B,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,INS
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,11/21,Female,Not Applicable,25.0,0.20294298231601715,Do not report,KIT,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,INS
P-0014241-T01-IM6,821.0,80.0,54.0,54.0,Non-Hispanic,30/30,Female,Not Applicable,25.0,0.20294298231601715,Do not report,NOTCH4,NS,2.0,72.46,ALIVE,P-0014241,No,Neoadjuvant,Stomach,Gastric,White,0.0,Recurrence,Primary,Localized,1.9778048992156982,OTHER,Medical Therapy,238.6350629935199,UNKNOWN,14.0,INS
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.08165673911571503,Do not report,KIT,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Stomach,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Male,Not Applicable,5.0,0.022829577326774597,Do not report,KIT,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.24300217628479004,OTHER,Medical Therapy,422.42899458970146,UNKNOWN,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.08132511377334595,Do not report,TP53,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Stomach,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.022720828652381897,Do not report,TP53,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.24301236867904663,OTHER,Medical Therapy,422.42899458970146,UNKNOWN,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.08132511377334595,Do not report,PDGFRA,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Stomach,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.022720828652381897,Do not report,PDGFRA,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.24301236867904663,OTHER,Medical Therapy,422.42899458970146,UNKNOWN,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.08132511377334595,Do not report,KIT;TP53,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Stomach,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.022720828652381897,Do not report,KIT;TP53,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.24301236867904663,OTHER,Medical Therapy,422.42899458970146,UNKNOWN,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.08132511377334595,Do not report,KIT;PDGFRA,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Stomach,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.022720828652381897,Do not report,KIT;PDGFRA,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.24301236867904663,OTHER,Medical Therapy,422.42899458970146,UNKNOWN,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.08132511377334595,Do not report,KIT,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Stomach,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0,SUNITINIB,Medical Therapy,130.0,NE,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.022720828652381897,Do not report,KIT,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.24301236867904663,SUNITINIB,Medical Therapy,422.42899458970146,UNKNOWN,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.08132511377334595,Do not report,KIT,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Stomach,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0,REGORAFENIB,Medical Therapy,130.0,NE,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.022720828652381897,Do not report,KIT,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.24301236867904663,REGORAFENIB,Medical Therapy,422.42899458970146,UNKNOWN,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.08132511377334595,Do not report,KIT,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Small Intestine,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.022720828652381897,Do not report,KIT,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Small Intestine,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.24301236867904663,OTHER,Medical Therapy,422.42899458970146,UNKNOWN,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.08132511377334595,Do not report,KIT,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Colon,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.022720828652381897,Do not report,KIT,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Colon,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.24301236867904663,OTHER,Medical Therapy,422.42899458970146,UNKNOWN,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.08132511377334595,Do not report,KIT,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Rectum,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.022720828652381897,Do not report,KIT,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Rectum,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.24301236867904663,OTHER,Medical Therapy,422.42899458970146,UNKNOWN,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.08103302121162415,Do not report,KIT,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Stomach,Gastric,Asian,42.0,No recurrence,Metastasis,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.02268582582473755,Do not report,KIT,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Metastasis,Localized,0.24300742149353027,OTHER,Medical Therapy,422.42899458970146,UNKNOWN,5.2,DEL
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.08132511377334595,Do not report,KIT,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Stomach,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,5.2,SNP
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.022720828652381897,Do not report,KIT,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.24301236867904663,OTHER,Medical Therapy,422.42899458970146,UNKNOWN,5.2,SNP
P-0014247-T01-IM6,630.0,80.0,75.0,75.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.08132511377334595,Do not report,KIT,ONGOING,1.0,70.849,ALIVE,P-0014247,NS,NS,Stomach,Gastric,Asian,42.0,No recurrence,Primary,Localized,0.0,IMATINIB,Medical Therapy,130.0,NE,5.2,INS
P-0014247-T01-IM6,630.0,80.0,75.0,76.0,Non-Hispanic,11/21,Female,Not Applicable,5.0,0.022720828652381897,Do not report,KIT,ONGOING,2.0,70.849,ALIVE,P-0014247,No,Neoadjuvant,Stomach,Gastric,Asian,0.0,Recurrence,Primary,Localized,0.24301236867904663,OTHER,Medical Therapy,422.42899458970146,UNKNOWN,5.2,INS
